Blogs

Container closure integrity (CCI) is essential in pharmaceutical packaging, especially for sterile products such as injectables and biologics. Even small defects in a closure system can compromise sterility and product stability.

Helium leak testing is commonly used to detect microscopic leaks in sealed containers. By using helium as a tracer gas, the method provides quantitative leak rate data to support packaging development, validation, and quality assurance.

How Helium Is Used as a Tracer Gas for Leak Testing

Helium leak testing works by introducing helium gas into a sealed container or exposing the package to helium. The container is then placed inside a vacuum chamber where a pressure difference is created.

If a leak is present in the package, helium will escape through the defect. A mass spectrometer detects the escaping helium and measures the amount of gas present. The instrument then converts this signal into a quantitative leak rate.

Helium is commonly used for leak testing because of several important characteristics. The gas is inert, non-toxic, and non-flammable, which makes it safe for use with pharmaceutical packaging. Helium atoms are also very small, allowing them to pass through extremely fine leak paths that may not be detected using other gases.

Another advantage is that helium exists in very low concentrations in the atmosphere. This allows testing systems to detect even small amounts of escaping helium with high accuracy.

Why Helium Leak Testing Is a Highly Sensitive Flow-Based Method?

Helium leak testing is one of the most sensitive flow-based methods for evaluating pharmaceutical packaging integrity. It can detect extremely small leaks that may not be identified using traditional techniques such as dye penetration.

Helium Leak Detection (HLD) is widely used in advanced packaging development because it directly measures the active leak rate from a container. Unlike headspace-based technologies such as Laser Headspace Analysis (LHA), which estimate performance through pressure or concentration changes, HLD measures the actual mass flow of gas escaping from the package. Leak rates are typically expressed in units such as atm·cc/sec, allowing precise evaluation of leak pathways at the sub-micron level.

This direct measurement is especially useful during package development, where small differences in leak rates can influence design decisions. Helium testing also detects leakage immediately, without requiring gas accumulation before measurement. In addition, the method allows leak rate evaluation under different temperature conditions, helping manufacturers better understand packaging performance in real storage environments.

SIMS 1915+ Seal Integrity Monitoring System in Pharmaceutical Packaging

The Seal Integrity Monitoring System (SIMS) 1915+ is a helium-based leak detection technology designed for testing rigid pharmaceutical containers such as vials, syringes, cartridges, and blister cards. It uses helium as a tracer gas to evaluate package integrity and provides quantitative leak rate measurements that exceed the sensitivity of traditional methods such as vacuum bubble or dye penetration testing.

The system features an oil-free detector and can detect leak rates as low as 1 × 10?¹¹ mbar-L/s. Instead of providing only pass/fail results, the SIMS 1915+ generates detailed leak rate data, enabling better evaluation of packaging materials, container designs, and sealing performance.

Applications Across Pharmaceutical Packaging Formats

• Vials:Detects leaks at stopper and crimp seals.
• Prefilled syringes and cartridges:Evaluates sealing components.
• Ampoules:Verifies container integrity.
• Blister packs and foil pouches:Identifies micro-leaks.
• Bottles and medical device packaging:Confirms package integrity.

Helium leak testing is commonly used during development, validation, and production quality control.

Integrating Helium Leak Testing into Quality Assurance

Helium leak testing can be integrated into pharmaceutical quality assurance workflows to support container closure integrity evaluation. During early package development, the method helps engineers compare packaging materials and sealing configurations.

During validation and production stages, quantitative leak rate measurements provide valuable information for monitoring packaging performance. The data generated from helium leak testing can also support stability studies by evaluating how packaging integrity performs under different storage conditions.

Because the method produces detailed and repeatable results, it helps manufacturers make informed decisions about packaging design and quality control strategies.

Conclusion

Reliable container closure integrity is essential for protecting pharmaceutical products and ensuring patient safety. Helium leak testing provides a highly sensitive and quantitative method for detecting micro-leaks in pharmaceutical packaging. Technologies such as the SIMS 1915+ Seal Integrity Monitoring System allow manufacturers to evaluate packaging performance across formats including vials, syringes, cartridges, and blister cards. By generating precise leak rate data, helium leak detection supports packaging development, validation, and quality assurance throughout the pharmaceutical product lifecycle.

The Maximum Acceptable Leak Limit (MALL) is a fundamental concept in Container Closure Integrity (CCI) testing, particularly for sterile pharmaceutical packaging. MALL defines the maximum leak rate a package may exhibit while still maintaining sterility and product stability throughout its intended shelf life. Establishing and verifying MALL is essential for demonstrating that a container closure system provides an effective microbial barrier and complies with regulatory expectations.

Helium mass spectrometry has become an important technology for evaluating MALL due to its unmatched sensitivity and ability to deliver quantitative, reproducible leak rate measurements.

Importance of MALL in Sterile Packaging

Patient safety can be compromised when microleaks in sterile injectable packaging go undetected. The Limit of Detection (LOD) ensures that test methods are sensitive enough to identify these risks. The following points explain why LOD is essential for both patient safety and regulatory compliance:

• LOD defines how small a leak a test method can reliably detect.
• A validated LOD helps ensure critical defects are identified during testing.
• Regulatory guidelines such as USP <1207> and USP <382> require CCIT methods to be validated using deterministic approaches.
• These guidelines link test sensitivity to the Maximum Acceptable Leak Limit (MALL).
• Regulators expect test methods to detect very small defects, often 20 µm or smaller, with some methods capable of detecting leaks down to about 5 µm.

Why Helium Mass Spectrometry Is Important for MALL Verification?

Helium mass spectrometry is widely regarded as a reliable and highly sensitive method for leak testing pharmaceutical packaging, including containers such as bottles, vials, and other sterile systems. This technique is commonly used to identify and measure extremely small leaks that may compromise product quality, sterility, or shelf life.

In a typical helium leak test, the container is filled or exposed to helium and placed inside a vacuum chamber connected to a mass spectrometer. If a leak is present, helium escapes from the container and is drawn into the detection system. The mass spectrometer measures the amount of helium present, allowing the leak rate to be quantified accurately. Because helium is used as a tracer gas, even very small leaks can be detected with high precision

Establishing MALL Across Packaging Formats

MALL must be defined based on the specific design and risk profile of each container closure system:

• Vials and Bottles:Focus on elastomeric closures, crimp seals, and dry-fit performance.
• Parenteral Systems: Assessment of plungers, needle shields, cartridges, and stopper interfaces.
• Blister Cards and Pouches:Evaluation of material integrity and heat-seal perimeters.
• Combination Products:Verification across multiple sealing interfaces and components.

Helium mass spectrometry provides a consistent, quantitative benchmark for comparing sealing performance across these diverse formats.

Relationship Between MALL and Limit of Detection

The effectiveness of helium mass spectrometry in supporting MALL is closely tied to the Limit of Detection (LOD) of the method. LOD represents the smallest leak rate that can be reliably detected. For a test method to be suitable, its LOD must be well below the established MALL, providing confidence that leaks capable of compromising sterility will be identified.

Typical MALL values for sterile packaging are often in the range of 6 × 10?6 mbar·L/s, which corresponds to microbial ingress–relevant defect sizes. Helium mass spectrometry routinely achieves detection limits at or below this level, making it uniquely suited for establishing and defending MALL during packaging development and validation.

Conclusion

The Maximum Acceptable Leak Limit is a critical element of deterministic container closure integrity testing, linking measurable leak rates to the ability of a package to maintain sterility. Helium mass spectrometry provides the sensitivity and quantitative reliability needed to establish and confirm MALL. By applying advanced helium leak detection systems such as the SIMS 1915+, manufacturers can confidently evaluate package integrity, support effective CCI method development and validation, and meet regulatory expectations for sterile product protection.

In the pharmaceutical and biotechnology industries, the integrity of packaging is just as important as the formulation of the drug itself. For highrisk injectables like vaccines, biologics, and complex therapies, even the smallest breach in a container closure system can compromise product sterility and safety. Manufacturers must therefore adopt highly sensitive and dependable test methods to ensure that packaging performs as intended throughout production, storage, and use. One such method that has become indispensable is helium leak testing.

What Is Helium Leak Testing?

Helium leak testing is a deterministic method used to detect and measure leaks in sealed systems by using helium as a tracer gas. Because helium has one of the smallest atomic sizes and does not react with packaging materials or drug products, it can penetrate minute leak pathways that other gases cannot. During testing, a package is exposed to helium, and any escaping gas is captured and measured by a highly sensitive mass spectrometer detector. The amount of helium detected provides a precise leak rate, enabling exact evaluation of container closure integrity.

This approach applies to a wide variety of pharmaceutical packaging formats, including vials, prefilled syringes, cartridges, foil pouches, blister cards, bottles, tubes, and combination products.

Why Helium Is Ideal for Leak Detection

Helium offers several key advantages that make it especially suitable for pharmaceutical integrity testing:

• Small atomic size:Helium atoms can find and travel through extremely fine leak paths, detecting defects that other test methods might miss.
• Inert and safe: It is a nonreactive gas that does not interact with drug products or packaging materials, making it suitable for sterile packaging evaluation.
• Low background interference: Helium’s low natural presence in the atmosphere enhances detection accuracy by producing clear, high signal readings.
• Quantitative data: The detected helium leak rate provides exact measurements, not just a simple pass/fail result. 

These qualities mean that helium testing not only confirms the presence or absence of leaks but also quantifies them, allowing manufacturers to compare packaging materials, designs, and process conditions with a high degree of confidence.

Benefits of Helium Leak Detection

Helium leak detection provides clear and measurable results. Instead of relying on visual inspection or dye-based methods, it directly measures the actual leak rate. This gives manufacturers numerical data that helps them understand packaging performance more accurately

Key benefits include:

• High sensitivity to detect very small leaks
• Quantitative results that support decision-making
• Suitable for development, validation, and production stages
• Reduced risk of product failure or recalls
• Improved process control and quality assurance

Essential Role in Injectable Packaging Integrity

Injectable drug products require robust container closure integrity to prevent the ingress of contaminants such as moisture, gases, or microorganisms. Helium leak testing excels in this role because it can identify the smallest defects that may compromise a sterile barrier. Its quantitative results are highly reproducible, helping quality teams make informed decisions about process control and packaging design.

Unlike probabilistic methods that rely on indirect signals or qualitative interpretations, helium leak testing provides clear, deterministic outcomes. This reduces uncertainty and supports compliance with regulatory expectations that emphasize scientifically justified testing approaches.

Packaging Integrity Challenges in Injectable Systems

• Complex AssembliesInjectable systems rely on multiple parts like glass barrels, rubber stoppers, and plastic caps working together perfectly.
• Multiple Seal PointsEvery connection, such as where a plunger touches a syringe wall, creates a potential path for a leak to occur.
• Microscopic Defects Small manufacturing errors, like a slightly tilted stopper or a loose crimp, can create "micro-leaks" that are invisible to the human eye.
• Material Sensitivity Because glass, plastic, and rubber are different materials, they don't always expand or contract at the same rate.
• Pressure Changes Shipping drugs by air causes shifts in atmospheric pressure that can physically move a syringe plunger and break the sterile seal.

Conclusion

Helium leak testing is a vital part of protecting high-risk injectable drugs. By finding the smallest defects, it ensures that medicine remains sterile and effective. As pharmaceutical products become more advanced, accurate leak detection will continue to be a necessary solution for patient safety.

Ensuring the integrity of biologics and injectable pharmaceuticals is essential for patient safety and product efficacy. Even the smallest packaging breach can compromise sterility, potency, or stability, resulting in significant risks. Helium leak detection detects micro-leaks in complex packaging systems, delivering the precision and reliability that conventional methods often lack.

Unique Packaging Challenges of Biologics

Biologics and injectables present unique packaging challenges due to their sensitivity and high-risk nature. These products often utilize parenteral containers such as vials, prefilled syringes, or cold form blister packs, each with complex closures and elastomeric seals. Maintaining a sterile barrier while accommodating stringent storage conditions, including ultra-low temperatures for cell and gene therapies, requires highly precise integrity testing. Any micro-defect in the closure system, even one invisible to conventional inspection, can allow contamination or degradation, compromising patient safety and regulatory compliance.

Limitations of Conventional Leak Testing Methods

Traditional leak detection methods have inherent limitations:

• Often unable to detect ultra-small leaks or micro-defects in closures.
• Can apply stress or voltage that may impact sensitive biologics.
• May miss non-visible leaks under crimped stoppers or syringe plungers.
• Typically provides only pass/fail results, lacking quantitative leak rate data.
• Limited adaptability for cryogenic or ultra-low temperature testing conditions.

Advantages of Helium Leak Detection for Injectables

• Detects micro-leaks invisible to conventional methods.
• Preserves product integrity during testing.
• Measures leak rates accurately, not just pass/fail.
• Supports ambient and cryogenic testing conditions.
• Accommodates various container types, including vials, syringes, and foil pouches.
• Helium’s inert nature and small atomic size allow precise detection with minimal background interference.

Conclusion

The complex nature of biologics and injectable pharmaceuticals requires rigorous packaging integrity testing. Conventional leak detection methods frequently fail to detect micro-leaks or non-visible defects. Helium leak detection provides a precise and highly reliable solution, ensuring the sterility and efficacy of sensitive pharmaceutical products. For manufacturers dedicated to patient safety, regulatory compliance, and product quality, helium-based leak detection is an indispensable element of a robust Container Closure Integrity strategy.

Pharmaceutical packaging is more than just a container; it acts as a protective barrier that keeps the drug sterile, stable, and safe throughout its shelf life.

During development, checking Container Closure Integrity (CCI) is important to prevent contamination, product damage, and regulatory issues. If packaging is not properly tested earlyon in the development process, companies may face failed stability studies, delayed approvals, and costly rework.

To avoid these problems, the industry uses deterministic and quantitative testing methods that give clear and reliable results. Helium Leak Detection from PTI - Packaging Technologies & Inspection directly measures real leak rates in precise units such as atm cc per second. Using this technology early in development helps manufacturers set proper integrity limits and reduces the risk of validation failures later.

Role of CCI Testing During Early Development

During early development, packaging configurations are evaluated, refined, and aligned with regulatory expectations. Deterministic helium leak testing provides direct measurement of mass flow escaping from a container system, rather than relying on modelled extrapolation from pressure decay or concentration changes. This distinction is essential when design decisions depend on differentiating extremely small leak magnitudes.

Helium leak detection is capable of measuring leakage pathways, delivering quantitative data with high sensitivity and resolution. For example, distinguishing between leak rates such as 1 × 10?8 atm·cc/sec and 5 × 10?8 atm·cc/sec may influence material selection, closure configuration, or sealing parameters. Early access to true leak rate data allows development teams to establish justified acceptance criteria and correlate measured performance with microbial ingress risk and product stability requirements.

Detecting Micro-Leaks Before Design Lock

Micro-leaks often originate at elastomeric interfaces, crimp seals, welds, or complex geometries. If undetected prior to design lock, these defects can trigger requalification, failed stability studies, or regulatory observations. Helium leak detection measures active leakage at time zero, eliminating delays associated with headspace accumulation or equilibrium shifts required by concentration-based methods.

This real-time measurement capability enhances development efficiency and provides direct insight into defect behaviour under actual use conditions. By quantifying leakage without reliance on proxy variables or mathematical back-calculation, helium testing enables precise characterization of closure system performance before commercial tooling and validation activities are finalized. Early identification of marginal seal performance reduces the likelihood of unexpected failures during process validation.

Preventing Failures Through Early Helium Leak Detection

Late-stage validation failures frequently stem from insufficient understanding of package integrity during early development. Helium leak detection mitigates this risk by delivering calibrated, quantitative measurements of active leak rate under controlled conditions. Its sensitivity makes it particularly suitable for high-value biologics, lyophilized formulations, and parenteral drug products where even microscopic leakage can compromise sterility.

Temperature-dependent leakage further underscores the importance of early testing. Cold storage conditions can alter material properties and leak path dynamics. Helium leak detection uniquely enables direct measurement of leak rate at actual storage temperatures, ensuring alignment between laboratory data and real-world distribution environments. Establishing temperature-relevant leak rate thresholds early reduces uncertainty during stability studies and validation execution.

Conclusion

Early-stage helium leak testing provides a scientifically rigorous framework for packaging development. By directly measuring active leak rate with high sensitivity and temperature relevance, helium leak detection enables informed design decisions, justified acceptance criteria, and proactive regulatory alignment. Integrating this deterministic technology early in the development cycle minimizes late-stage validation failures, protects development timelines, and strengthens overall container closure integrity assurance.

Container closure integrity (CCI) is essential to ensuring that pharmaceutical products and medical devices remain safe, sterile, and effective throughout their intended lifecycle. Packaging systems must prevent the ingress of microorganisms, gases, and moisture that could compromise product quality or patient safety. As packaging designs and drug formulations become more complex, traditional integrity testing methods may no longer provide sufficient sensitivity.

In response to evolving regulatory expectations, manufacturers are increasingly adopting deterministic testing technologies. Helium leak detection has gained broad acceptance as a precise and quantitative method for verifying package integrity and supporting patient safety.

Consequences of Container Closure Failure

Failures in container closure systems can lead to serious risks for both patients and manufacturers. Even extremely small leaks may compromise the sterile barrier and go undetected by conventional testing methods.

Key consequences include:

• Microbial contamination and loss of sterility.
• Degradation of drug products due to exposure to oxygen or moisture.
• Reduced therapeutic effectiveness, particularly for injectables and biologics.
• Increased risk of medical device malfunction.
• Regulatory actions, recalls, and reputational damage.

These risks highlight the need for highly sensitive and reliable CCI testing approaches.

Helium Leak Detection as a Deterministic CCI Method

Helium leak detection is a deterministic container closure integrity testing method that uses helium gas as a tracer. Helium’s small atomic size and inert properties allow it to escape through extremely small defects in sealed packages. A mass spectrometer detects and measures the escaped helium, providing a quantitative leak rate.

Key advantages of helium leak detection include:

• High sensitivity for detecting micro-leaks.
• Quantitative, reproducible results rather than subjective pass/fail outcomes.
• Applicability across a wide range of package formats.

Because results are measurable and repeatable, helium leak detection enables manufacturers to establish scientifically justified acceptance criteria based on risk and product requirements.

Implementing Helium Leak Detection in Quality Workflows

To integrate helium leak detection effectively, manufacturers should define acceptable leak rate limits based on regulatory expectations and product requirements. Alignment between engineering and quality teams helps ensure consistent performance standards.

Appropriate equipment selection and regular calibration are essential, as accurate results depend on stable detector sensitivity. Training quality personnel on both equipment operation and basic leak detection principles further supports reliable testing.

Helium leak testing can be applied during pilot production, in-process checks, or final inspection, depending on the product and manufacturing strategy. Strategic placement of the test helps identify defects early and strengthens overall risk mitigation.

Risk Mitigation Across the Product Lifecycle

Helium leak detection plays a critical role throughout the product lifecycle, from development through commercial manufacturing.

• Development:Supports package selection and sealing optimization.
• Validation:Confirms container closure performance with quantitative data.
• Manufacturing:Enables routine monitoring and early detection of variability.
• Stability testing:Verifies long-term package integrity.

Conclusion

Helium leak detection is a critical tool for ensuring patient safety and maintaining product quality in pharmaceutical and medical device manufacturing. Its high sensitivity, deterministic nature makes it a superior alternative to traditional container closure integrity testing methods. By integrating helium leak detection into their CCI strategies, manufacturers can proactively manage risk, meet regulatory expectations, and deliver safe, reliable products across the supply chain.

Packaging integrity is a fundamental quality requirement for products that must remain sterile and stable throughout their shelf life. In pharmaceutical, biotechnology, and medical device manufacturing, even extremely small defects in package seals can permit the ingress of moisture, oxygen, or microorganisms, with potentially serious consequences for product quality and patient safety. Detecting these micro-leaks remain a persistent challenge during package development, validation, and routine manufacturing.

As packaging designs become more sophisticated and production demands continue to rise, conventional leak testing methods often struggle to deliver the sensitivity and repeatability required to identify very small defects. Many traditional techniques were not designed for modern packaging formats or for applications where quantitative, traceable results are expected. In response, advanced helium leak detection technologies have emerged as a reliable solution, using helium as a tracer gas to measure leak rates with a high degree of precision. This quantitative approach supports consistent container closure integrity (CCI) verification and aligns well with current quality and regulatory expectations.

Key Packaging Integrity Challenges

Manufacturers face a range of challenges when attempting to verify package integrity across diverse product lines and packaging formats, including:

• The increasing use of flexible and semi-rigid materials that respond unpredictably under pressure or vacuum-based test conditions.
• Microscopic defects that allow the slow ingress of gases or moisture without causing immediate or visible package failure.
• Variability in seal performance resulting from changes in materials, equipment settings, or environmental conditions.
• Limited applicability of traditional test methods for low-headspace or no-headspace package designs
• A growing mix of packaging formats within a single manufacturing environment
• Higher production volumes that demand faster testing without sacrificing sensitivity.
• The need for repeatable and traceable results to support quality reviews, investigations, and regulatory audits.

Role of Advanced Helium Leak Detection

Advanced helium leak detection directly addresses these challenges through a highly sensitive and quantitative testing methodology. Helium’s inert nature, very small atomic size, and extremely low concentration in the ambient environment allow it to migrate through micro-defects that conventional methods often fail to detect. At the same time, its low background presence minimizes interference during testing, improving result reliability.

Unlike traditional pass/fail techniques, helium leak detection produces deterministic leak-rate measurements. These quantitative results enable manufacturers to establish scientifically justified acceptance criteria based on product risk and packaging performance. This capability supports more informed decisions during package development, validation activities, and routine manufacturing operations. As a result, helium leak detection has become widely adopted within pharmaceutical and medical device quality programs, from early-stage research through finished product integrity verification.

Improving Leak Detection Accuracy with SIMS 1915+

The Seal Integrity Monitoring System (SIMS) 1915+ is a helium-based leak detection solution designed to evaluate the seal integrity of rigid pharmaceutical packaging formats, including vials, prefilled syringes, cartridges, and blister cards. By using helium as a tracer gas, the system enables highly sensitive detection of micro-leaks that methods such as dye ingress or bubble testing may not consistently identify.

One of the key advantages of the SIMS 1915+ is its ability to measure actual leak rates rather than relying on subjective pass/fail outcomes. With sensitivity down to 1 × 10?¹¹ mbar·L/s and an oil-free design suitable for regulated environments, the system delivers reliable and repeatable performance under controlled conditions. This quantitative capability supports package development, validation, and quality assurance efforts by improving confidence in seal integrity and enabling earlier identification of defects before they affect product quality or patient safety.

Conclusion

As packaging technologies evolve and quality expectations continue to increase, verifying package integrity has become both more important and more complex. Conventional leak detection methods often struggle to detect micro-defects, accommodate advanced packaging designs, or generate results suitable for modern quality systems. These limitations can reduce their effectiveness during package qualification and ongoing integrity monitoring.

Advanced helium leak detection overcomes these challenges by providing high-sensitivity, quantitative leak rate measurements that are repeatable and traceable. By supporting informed decisions across development, validation, and manufacturing, helium-based leak detection plays a critical role in maintaining product quality, meeting regulatory expectations, and protecting patient safety.

Container Closure Integrity (CCI) is the ability of a pharmaceutical package to maintain a sterile barrier throughout its shelf life. In sterile drug products such as prefilled syringes, vials, foil pouches, blister packs, and combination products, even extremely small microleaks can compromise sterility and product stability. Regulatory guidance increasingly emphasizes the need for sensitive, scientifically justified test methods to demonstrate container closure integrity. As packaging systems evolve and drug products become more complex, reliable verification of package integrity is essential to ensure patient safety and regulatory compliance.

Limitations of Traditional Leak Testing Methods

Leak testing methods such as dye ingress, bubble emission, and water bath testing have been widely used across industries but present several significant limitations.

• Relies on human interpretation, making results subjective and inconsistent.
• Unable to reliably detect microleaks below 10 microns, which are critical in many pharmaceutical applications.
• Exposure to water, dyes, or chemicals during testing can increase the risk of introducing contaminants into the package.
• Manual processes are time-consuming and unsuitable for high-volume testing.
• Provides only pass or fail results with no precise measurement or digital record.
• Results may vary due to environmental conditions and operator skill.
• Many traditional methods do not meet evolving regulatory expectations for pharmaceuticals and medical devices.

How Helium Leak Detection Works in Pharmaceutical Packaging

Helium leak detection is a technology that uses helium as a tracer gas. Helium is well suited for leak testing because it is inert, non toxic, and has a very small atomic size, allowing it to pass through extremely small, microscopic leaks. In helium leak testing, the package is pressurized with helium or exposed to a helium-rich environment, and any helium that escapes through a leak is detected using mass spectrometry.

PTI’s SIMS 1915+ operates by placing the test sample inside a sealed test chamber. Helium that migrates from the package into the chamber is measured directly by a highly sensitive mass spectrometer. The system then calculates a precise leak rate, providing objective and repeatable data that can be correlated to real world package performance.

Importance of Helium Leak Testing in Pharmaceutical Packaging

Pharmaceutical packaging plays a critical role in protecting the sterility and efficacy of drug products. Even microscopic leaks can allow the ingress of contaminants such as moisture, oxygen, or microorganisms, which may result in the following outcomes.

• Product degradation: Exposure to air or moisture can alter the chemical composition of a drug, reducing its effectiveness or making it unsafe.
• Microbial growth: Leaks may permit the entry of bacteria, fungi, or other microorganisms, posing serious health risks.
• Reduced shelf life: Compromised packaging can shorten product shelf life, leading to increased waste.

Helium Leak Testing Applications

• Seal integrity monitoring during stability studies
• Verification of container closure integrity
• Prediction and validation of shelf life seal integrity
• Support for early-stage pharmaceutical packaging development
• Selection and optimization of closure formulations and configurations
• CCI testing at cold and ultra cold storage temperatures

Helium leak detection is commonly used for pharmaceutical CCI because it delivers the sensitivity, objectivity, and scientific rigor required to ensure package integrity. By directly measuring leak rates using advanced SIMS 1915+ technology, manufacturers can confidently demonstrate container closure integrity, reduce risk, and protect patient safety throughout the pharma product lifecycle.

Pharmaceutical leak testing is a critical quality assurance activity used to verify that drug packaging systems maintain an effective seal throughout their intended shelf life. As a core element of container closure integrity (CCI) testing, it ensures that pharmaceutical products remain protected from external contaminants that can compromise sterility, stability, and patient safety. Even microscopic defects in packaging can allow moisture, gases, or microorganisms to enter the container, making reliable and sensitive leak testing essential in pharmaceutical manufacturing.

Helium leak testing is widely used for pharmaceutical CCI testing due to its exceptional sensitivity and ability to generate clear, measurable results. The method uses helium as a tracer gas and mass spectrometry to detect and quantify extremely small leak rates. Solutions developed by PTI Packaging Technologies support accurate evaluation of package integrity across development, validation, and commercial production, while aligning with global regulatory expectations

Advantages of Helium Leak Testing in the Pharmaceutical Industry

Helium leak testing is compatible with a broad range of pharmaceutical packaging materials and formats. Its high sensitivity enables the detection of micro-leaks that traditional methods, such as dye ingress or vacuum decay, may fail to identify. The technique produces deterministic, quantitative data that support scientifically justified decision-making and align with regulatory guidance, including USP <1207>. By identifying potential package integrity issues early, helium leak testing improves product safety, reduces waste, and lowers the risk of costly recalls.

Common Leak Testing Methods Used in Pharma

Pharmaceutical manufacturers employ several methods to assess container closure integrity, including dye ingress testing, bubble emission testing, and vacuum decay. While these approaches can identify larger defects, they often lack the sensitivity required to detect micro-leaks that can still compromise sterility. Helium leak testing overcomes this limitation by providing highly sensitive, quantitative leak-rate measurements, ensuring that even the smallest defects are reliably detected.

How Leak Testing Prevents Microbial Contamination and Product Degradation

Maintaining container closure integrity is essential to protect pharmaceutical products from microbial contamination and chemical degradation. Even very small defects in packaging can permit the ingress of microorganisms, moisture, or gases, potentially reducing product efficacy, compromising stability, and posing risks to patient safety.

Helium leak testing mitigates these risks by offering a highly sensitive and quantitative approach to micro-leak detection. Using helium as a tracer gas, escaping atoms are measured under vacuum conditions using mass spectrometry, producing precise and reproducible leak-rate data. Early identification of leaks allows manufacturers to take corrective action before products are exposed to harmful conditions, helping ensure sealed packaging, preserved product stability, and extended shelf life. In addition, helium leak testing supports regulatory compliance, reduces contamination risk, and helps prevent costly product recalls.

Conclusion

Helium leak detection provides a reliable and scientifically robust approach to container closure integrity testing in pharmaceutical manufacturing. Its ability to deliver highly sensitive, quantitative leak-rate measurements makes it well suited for identifying defects that could compromise sterility, product stability, and patient safety. Applicable across a wide range of pharmaceutical packaging formats, helium leak testing supports regulatory expectations and enables consistent, data-driven quality decisions. By adopting helium leak detection technologies, manufacturers can strengthen package integrity assurance and maintain high standards of product quality throughout the entire product lifecycle.

Blister packaging is widely used in the pharmaceutical industry for unit-dose protection, product visibility, and patient compliance. By enclosing individual doses in sealed cavities, blister packs shield drugs from moisture, oxygen, light, and microbial contamination. However, the effectiveness of this packaging relies entirely on package integrity. Even microscopic defects can compromise stability, reduce potency, or affect sterility over time.

Pharmaceutical manufacturers increasingly use deterministic container closure integrity testing (CCIT) methods to ensure shelf-life protection. Among these, helium leak testing is recognized as one of the most sensitive and reliable techniques for detecting micro-leaks that other methods might miss.

Common Sources of Package Failure

Blister packages can fail due to a variety of manufacturing, handling, or distribution factors, including:

• Variations in sealing parameters, including temperature, pressure, or dwell time, which may create incomplete or weak seals.
• Material inconsistencies or defects in forming films, lidding foils, or sealant layers that hinder proper adhesion.
• Particulate contamination such as powders, residue, or foreign particles trapped in the seal.
• Mechanical stress during handling, storage, or transportation, which may generate micro-defects over time.

These defects are often invisible to visual inspection but allow slow ingress of moisture and oxygen, directly impacting shelf life.

The Role of Helium Leak Detection in Identifying Micro-Leaks

Helium leak testing is a precise method used to find micro leaks in blister packaging. Helium works well because its atoms are very small and can pass through leaks that other gases cannot. It is also safe, being non-toxic and non-flammable.

During testing, blister packs are placed in a sealed chamber under vacuum. Helium inside the package, introduced during testing escapes through any leaks and is measured with a mass spectrometer. This gives exact leak rate data, not just a pass or fail, helping manufacturers spot weak seals early and prevent problems later.

Advanced technology like PTI’s SIMS 1915+ can detect extremely small leaks, supporting both package development and quality control. By finding micro-leaks that are invisible to the eye, helium testing helps keep products safe, stable, and effective throughout their shelf life.

Best Practices for Blister Pack CCI Testing 

To maximize the effectiveness of helium leak testing for blister packaging, manufacturers should follow established best practices:

• Integrate CCIT early during package development
• Establish scientifically justified leak rate acceptance criteria
• Validate test methods and systems for accuracy and repeatability
• Apply testing throughout the product lifecycle.

Conclusion

Maintaining blister package integrity is critical to protecting pharmaceutical products throughout their labeled shelf life. By enabling highly sensitive, quantitative detection of micro-leaks, helium leak testing supports robust container closure integrity programs, reduces the risk of stability failures, and strengthens overall quality assurance. When implemented with validated systems and sound acceptance criteria, this approach provides manufacturers with confidence that blister packages will perform as intended from release through end of shelf life.

Vial leak testing is a critical component of pharmaceutical quality assurance, ensuring container closure integrity (CCI) and protecting drug products from contamination and degradation. For sterile injectables, biologics, and vaccines, even microscopic leaks can compromise product sterility, stability, and shelf life. Advanced helium leak detection systems, particularly SIMS 1915+ technology from PTI Packaging Technologies, provide highly sensitive, quantitative, and deterministic solutions for assessing vial seal integrity. Integrating SIMS 1915+ throughout the product lifecycle from Research & Development (R&D) to full-scale production supports regulatory compliance, reduces risk, and improves overall product quality.

USP <1207> outlines expectations for container closure integrity testing methods that are scientifically justified and capable of producing measurable and repeatable data. Helium leak detection aligns with these expectations by enabling the detection of very small leak paths that are difficult to identify using conventional techniques.

Best Practices in the R&D Phase

During R&D, vial leak testing focuses on method development, test design, and sensitivity evaluation. Helium leak detection using SIMS 1915+ is widely employed at this stage due to its ability to detect extremely small leaks that could compromise sterility.

The SIMS 1915+ system is a vacuum-based helium mass spectrometry solution specifically designed for pharmaceutical container closure integrity testing. The process involves:

• Introducing helium into the vial headspace.
• Placing the helium-filled vial in a vacuum test chamber.
• Detecting and quantifying any escaping helium using a mass spectrometer.

This approach enables precise measurement of leak rates and identification of critical defects that are invisible to traditional inspection methods.

Key best practices during R&D include

• Comparing vial, stopper, and seal designs to identify optimal combinations.
• Establishing deterministic acceptance criteria based on quantitative leak data.
• Validating container performance under various environmental and handling conditions, including low-temperature storage.

By applying SIMS 1915+ early in development, manufacturers can prevent design flaws from progressing into scale-up, reduce costly rework, and generate strong evidence for regulatory submissions.

Choosing the Right Leak Testing Method

Selecting an appropriate leak testing method is essential for protecting product integrity. While various techniques exist, helium leak testing using SIMS 1915+ offers exceptional sensitivity and reliability for high-risk products.

Helium leak detection enables the identification of microleaks that closely correlate with microbial ingress risk. Helium’s small atomic size and inert properties make it ideally suited for precise and accurate leak detection.

SIMS 1915+ not only delivers quantitative leak rate data but also provides clear pass/fail criteria, supporting both development activities and regulatory compliance. Using a single, validated technology from R&D through production ensures consistency, data integrity, and comparability of results across the product lifecycle.

Best Practices During Production

In commercial production, consistency, efficiency, and compliance are paramount. SIMS 1915+ systems are designed for routine quality monitoring, offering objective and repeatable results at high throughput.

Recommended best practices include:

• Establishing regular testing intervals based on risk assessment.
• Maintaining strict control over test parameters to ensure reproducibility.
• Performing routine calibration and preventive maintenance to sustain system sensitivity.
• Aligning testing protocols with regulatory requirements for container closure integrity, including sterility assurance across the product’s shelf life.

By incorporating SIMS 1915+ into production workflows, manufacturers can monitor batch-to-batch consistency, detect deviations early, and maintain robust process control.

Effective vial leak testing is best achieved through a lifecycle-based strategy that extends from early research and development through full-scale commercial production. The application of SIMS 1915+ helium leak detection technology enables pharmaceutical manufacturers to identify microleaks with high sensitivity, verify container closure performance, and define deterministic, science-based acceptance criteria while meeting regulatory expectations. By adopting these best practices, organizations can strengthen container closure integrity, safeguard patient safety, and minimize the risk of product failures or recalls, thereby supporting consistent quality and reliability in pharmaceutical manufacturing.

Container Closure Integrity (CCI) testing is a critical element of pharmaceutical quality assurance, ensuring that drug products remain sterile, safe, and stable throughout their lifecycle. Even very small defects in packaging can compromise the barrier between a pharmaceutical product and its surrounding environment. For this reason, thorough evaluation of container integrity has become an essential requirement across development, validation, and commercial manufacturing.

USP <1207> outlines expectations for container closure integrity testing methods that are scientifically justified and capable of producing measurable and repeatable data. Helium leak detection aligns with these expectations by enabling detection of very small leak paths that are difficult to identify using conventional techniques.

Why Container Closure Integrity Matters ?

Container closure integrity ensures that pharmaceutical packaging maintains an effective sterile barrier from manufacturing through distribution and end use. Any loss of integrity may allow the ingress of moisture, gases, or microorganisms, which can negatively affect product stability, reduce efficacy, or introduce safety risks to patients. For injectable and other high risk products, these failures can have significant clinical and regulatory implications.

Helium leak detection assesses package integrity by using helium as a tracer gas and measuring its escape with a highly sensitive mass spectrometer. This approach produces quantitative leak rate data that reflects the actual barrier performance of the container closure system. Helium is inert, non reactive, and has a very small atomic size, making it well suited for detecting minute defects that could otherwise remain undetected.

Key Container Closure Integrity Testing Challenges

Challenge 1: Extremely Tight Leak Detection Requirements

Pharmaceutical packaging for parenteral products often requires detection of leaks at micron and sub-micron levels to ensure sterility throughout the product lifecycle. Traditional probabilistic methods, such as dye ingress or microbial challenge testing, may struggle to detect defects of this size consistently. In addition, these methods do not provide measurable outputs, making it difficult to define sensitivity or establish clear acceptance criteria.

Deterministic helium leak detection addresses these limitations by delivering precise, quantitative measurements of package integrity

Challenge 2: Complex Container Closure Systems

Contemporary pharmaceutical packaging formats, including prefilled syringes, cartridges, vials, and blow fill seal containers, present multiple potential leak pathways. Defects may occur at stopper interfaces, crimp seals, plungers, or within the container body. The combination of multiple materials and sealing surfaces increases the difficulty of identifying subtle integrity failures.

Helium-based deterministic testing evaluates the entire container closure system rather than individual components. Technologies such as the SIMS 1915 helps manufacturers to assess overall package integrity, providing confidence that all possible leak paths have been effectively evaluated across a wide range of container designs.

Challenge 3: Regulatory Expectations for Deterministic Methods

Regulatory authorities increasingly expect container closure integrity methods to demonstrate defined sensitivity, reproducibility, and validated performance characteristics. Probabilistic techniques often require additional justification or supplemental studies to support their use in regulatory submissions.

Helium leak detection generates quantitative, traceable data that aligns with the principles outlined in USP <1207>. This approach simplifies validation activities, supports risk-based quality strategies, and provides clear evidence of container closure performance during inspections and audits.

Conclusion

Container closure integrity testing is essential for protecting the safety, sterility, and effectiveness of pharmaceutical products. Manufacturers must address challenges associated with very small leak detection limits, increasingly complex packaging systems, and heightened regulatory expectations for deterministic testing. Helium leak detection technologies, including systems such as the SIMS 1915, offer a scientifically sound approach by providing precise and reproducible integrity data. Incorporating these methods into a comprehensive CCI program supports compliance with USP <1207> and helps ensure patient safety throughout the product lifecycle.

Pre-filled syringes have become a leading format in pharmaceutical packaging due to advances in injectable drug development. Compared with traditional vials or ampoules, pre filled syringes are more complex, with multiple sealing points that must maintain integrity while enabling precise plunger movement. Handling, transport, and environmental factors further increase the complexity of container closure integrity evaluations. Helium leak testing, particularly using SIMS 1915+ technology from PTI, provides a highly sensitive and quantitative method to assess both individual seal points and the entire syringe system. This approach enables manufacturers to ensure reliable sealing and uphold the highest standards of safety and performance.

Key Functions of Plunger

The plunger in a pre-filled syringe serves two essential functions. First, it maintains a sterile barrier, preventing the ingress of contaminants such as microorganisms, oxygen, and moisture throughout the product shelf life. Second, it enables accurate and consistent drug delivery, requiring smooth and controlled movement without compromising seal integrity. Verifying these functions requires a leak testing technology capable of detecting extremely small defects that may not be identified through conventional methods. Using SIMS 1915+ technology, manufacturers can assess whether the plunger maintains its sealing performance under realistic conditions, ensuring sterility assurance while supporting functional performance requirements.

Typical Reasons for Seal Failures

Seal failures in pre-filled syringes can occur for multiple reasons. Common causes include improper material selection, dimensional inconsistencies, surface defects, or damage during assembly and transport. Misalignment or excessive force during filling and capping operations may create micro leaks that compromise integrity. Environmental factors such as temperature fluctuations during storage or shipment can further impact elastomer behavior and sealing performance. Advanced helium leak testing using SIMS 1915+ enables early identification of these failure mechanisms by detecting micro leaks with exceptional sensitivity, supporting root cause analysis and continuous process improvement.

Methods to Verify Seal Integrity

Helium leak testing with the SIMS 1915+ system is widely regarded as reliable CCI solution for evaluating syringe seal integrity. The system uses helium as an inert tracer gas to detect micro leaks with exceptional sensitivity. Helium is introduced into the test chamber or package, and a high sensitivity mass spectrometer measures any escaping gas. Custom tooling allows assessment of individual seal points, including plunger ribs, or evaluation of the entire syringe system as a whole, providing deterministic and reproducible results.

Key advantages of SIMS 1915+ technology include:

• Detection sensitivity down to 1 × 10?¹° mbar L s and below
• Quantitative data supporting statistical process control and trend analysis
• Ability to evaluate both component level and full system integrity
• Strong alignment with regulatory expectations for deterministic container closure integrity testing

Ensuring plunger integrity in pre-filled syringes requires a combination of precise engineering, rigorous testing, and structured quality assurance. Helium leak testing using SIMS 1915+ technology provides highly sensitive and quantitative detection of micro leaks, enabling manufacturers to validate seal integrity with confidence. When integrated with optimized design practices and controlled production processes, this deterministic testing approach helps pharmaceutical companies maintain the highest standards of safety, sterility, and performance in pre-filled syringe packaging.

Pre-filled syringes are now widely used for modern medicines like vaccines and biologics. They make treatment easier by reducing dosing mistakes, improving comfort, and allowing patients to self-inject at home. But with these advantages comes an important responsibility for manufacturers: making sure each syringe stays completely sealed and sterile from filling to final use.

Pre-filled syringes have several small parts, and even a tiny leak that can’t be seen could allow air or bacteria to enter, putting the medicine and the patient at risk.

The Hidden Risks Within a Pre-Filled Syringe

A pre-filled syringe is not a fully closed container like a sealed vial. It has several components that must work together to maintain integrity. Pre-filled syringes introduce distinct risks due to their design and usage conditions:

• Multiple sealing interfaces, such as the plunger and needle area.
• Thin glass or polymer barrels that can develop microcracks.
• Changes in material during cold storage for temperature sensitive drugs
• Handling and transport stresses that may affect seal tightness.

Each of these factors can create leak points that are difficult to identify without the right technology. Traditional integrity tests often miss these microscopic leak paths because they lack the sensitivity required or rely on subjective visual observations.

Why Helium Leak Detection Is the Best Choice

Helium leak detection offers a more reliable and science-driven approach. Because helium atoms are extremely small, they can reveal leak paths that other tests overlook. The technology provides:

• High sensitivity for detecting micro-leaks.
• Quantitative insights to improve process control.
• Suitable for both development studies and ongoing production testing.
• Chemical changes in the formulation 

It also enables rapid troubleshooting during manufacturing, helping companies avoid costly scrap, rework, or product recalls

Pre-filled syringes function as essential delivery systems for vaccines and biologics and advanced therapeutic products. The intricate structure of these syringes requires specific integrity management systems to operate effectively. The protection of product quality and patient safety depends on maintaining sealed and sterile conditions for each syringe.

Helium leak detection has emerged as a trusted and highly sensitive method for verifying container closure integrity throughout manufacturing. This technology provides accurate and measurable data, helping us detect even the smallest leak paths, optimize sealing performance, and confidently release products to the market. The ultimate goal is clear: protect every syringe and protect every patient.

When it comes to protecting pharmaceutical products, making sure every pack is sealed correctly is extremely important. Medicines must stay sterile and safe, and even a very small leak can allow air, moisture, or microbes to enter. This can change the product, reduce its strength, or make it unsafe for patients. 

That is why testing leakage of packages is an important component of pharma manufacturing. It assists in determining that vials, syringes, cartridges, blister packs, and pouches are all properly sealed before they reach market.

It is important to know how leaks occur, detect them, and prevent them. This blog discusses the primary reasons why pharmaceutical packaging leaks, the most effective methods to detect them, and the best practices that have been found to stop them. With the right approach, your products stay safe, stable, and compliant throughout their entire shelf life. 

The Importance of Package Leak Testing

• Keeps products safe from contamination.
• Protects product quality and prevents spoilage. 
• Makes products last longer on the shelf. 
• Meets safety and quality rules.
• Stops losses from damaged or rejected products.
• Builds customer trust with reliable packaging. 
• Finds problems in packaging before products reach patients.

Why Package Leak Testing using Helium Leak Testing Matters in Pharma?

Pharmaceutical products, especially sterile injectables, must remain completely sealed to stay safe and effective. Even a tiny leak in a vial, syringe, or cartridge can create a path for unwanted elements to enter. This may lead to: 

• Microbial contamination 
• Oxygen or moisture getting inside 
• Loss of drug strength
• Chemical changes in the formulation 
• Shortened shelf life
• Costly batch failures or product recalls 

Helium leak testing helps prevent these risks by identifying extremely small leak channels that other methods often miss. The technology can detect leaks as small as 10?¹° mbar·L/s, giving you a precise, measurable leak rate. This ensures that the container –closure system can maintain sterility and protect the product throughout its entire life cycle. 

How Helium Leak Testing Works? 

Helium is used as a tracer gas because it is inert, non-toxic, and small enough to pass through microscopic channels. The process is simple yet precise: 

• The package is filled or exposed to helium. 
• It is placed inside a vacuum chamber. 
• If a leak exists, helium escapes through it. 
• A mass spectrometer captures and measures the helium leakage rate.
• The system produces a pass/fail result based on validated limits.

This deterministic, quantitative method gives manufacturers confidence that even microscopic defects will be detected. 

Practical Applications for Ensuring Package Integrity 

Here is how helium leak detection strengthens each: 

• Vials: Verifies seal integrity to prevent micro-cracks, stopper defects, and contamination in sensitive products.
• Syringes: Ensures airtight plunger-barrel seal, detecting leaks and micro-gaps in prefilled syringes.
• Bottles: Checks cap–bottle closure to protect liquids from oxygen, moisture, and potential spoilage. 
• Blister Packs:Detects pinholes and weak seals to maintain tablet and capsule stability over time.
• Foil Pouches: Confirms uniform sealing and barrier protection for oxygen- and moisture-sensitive products. 

Helium leak testing plays a significant role in making sure pharmaceutical packaging stays secure. As the industry increasingly adopts deterministic, science-based CCI methods, helium leak detection stands out as the most reliable way to ensure sterile barrier protection across vials, syringes, bottles, blister packs, foil pouches, and combination products. 

Seal integrity plays a key role in keeping prefilled syringes safe and effective. Very small leaks around the plunger can go unnoticed but may still affect sterility and product quality. Helium leak testing makes it possible to detect these tiny leak paths early and with confidence. It provides reliable results throughout development and routine manufacturing. This is especially important for sensitive injectable and biologic medicines. Overall, helium leak testing helps manufacturers maintain safety, quality, and regulatory compliance. 

Ensuring package and container closure integrity is crucial in the pharmaceutical, biologics, and medical device industries. Even the smallest leak can allow contamination, reduce shelf life, or affect how treatment is performed. To avoid these risks, manufacturers use a range of leak detection technologies, from traditional methods to advanced helium-based systems. Each testing approach has its own strengths and supports product safety, quality assurance, and regulatory confidence throughout the lifecycle of a sterile product. 

Traditional Leak Testing

Traditional methods, such as visual inspection, dye ingress, and bubble emission, detect leaks by monitoring physical changes, like as fluid intrusion, pressure variations, or bubble formation. 

Why do these methods remain widely used?

• Easy to operate with simple equipment 
• Fast results suitable for high-volume production environments 
• Works on a broad range of package formats 

Traditional testing is best suited for process monitoring, routine checks, and early production screening, but not for confirming sterile barrier integrity in high-risk products. 

Helium Leak Detection: Sensitivity for the Modern Pharma Landscape 

Helium mass spectrometry represents the highest standard in leak detection sensitivity. Helium is introduced inside or around the container. If a leak exists, the helium escapes and is measured using a mass spectrometer. 

Key advantages:

• Detects extremely small leaks that traditional methods cannot identify. 
• Produces precise and traceable numerical leak rates. 
• Supports complex containers like auto-injectors, prefilled syringes, and vials with elastomeric closures. 
• Maintains performance in challenging conditions, including deep-cold biologics storage. 

Where Each Method Delivers Value

Choosing the right leak-testing method depends on the stage of development and the sensitivity required. Each approach contributes uniquely to ensuring packaging integrity, product safety, and regulatory compliance. 

Traditional Methods

• Ideal for early development screening.
• Provide quick, iterative feedback.
• Cost-effective for routine production monitoring.

Helium Leak Detection

• Essential for package validation and qualification.
• Delivers high sensitivity to confirm sterile integrity.
• Critical for high-risk biologics and advanced delivery systems.
• Ensures no micro-leaks compromise product sterility or efficacy.

Helium leak testing plays a huge role in keeping high-value pharma and biologics packaging secure. It catches even the tiniest leaks. This isn’t just about keeping products from getting contaminated or breaking down. It’s also about meeting strict regulations and making sure patients stay safe.

For manufacturers, using helium leak testing isn’t just another box to tick. It’s an essential safety net that guarantees every dose gets to patients exactly as it should—safe, effective, and reliable. Helium leak testing gives manufacturers the confidence they need to trust their packaging. 

Biologic medicines, including vaccines and cell-based therapies, are highly sensitive and expensive to produce. To ensure they remain safe and effective, these products must be stored and delivered in perfectly sealed packaging. Even a tiny, invisible leak can allow air, moisture, or microbes to enter the container, potentially damaging the medicine or making it unsafe for patients.  Therefore, pharma manufacturers have turned to helium leak testing—one of the most accurate ways of verifying container-closure integrity (CCI).

What Is Helium Leak Testing? 

Helium leak testing is a highly sensitive technique used to detect tiny leaks in sealed packages. It involves introducing helium gas into the container or surrounding it, then measuring how much helium escapes.

Why helium? 

• Tiny molecule size: Able to pass through micro-cracks and seal defects 
• Completely inert: Safe, non-reactive, and won’t alter the medication
• Low concentration in air: Enables extremely accurate detection

Using mass spectrometry, helium leak testers can identify leaks as small as 10?¹¹ mbar·L/s, far below what visual inspection or dye tests can detect. 

How Helium Delivers Integrity Assurance at Every Stage

Helium testing plays a critical role from early development through commercial supply:

• R&D + Package Design Understand leak behaviour and component fit
• Process Engineering Optimize sealing parameters before scale-up
• Validation Establish scientifically justified leak limits (USP <1207>)
• Lifecycle Control Monitor risks over time, including supplier or material changes
• Cold-Chain & Cryogenic Systems Detect closure failures at low-temperature material transitions

Protecting High-Value Biologics from Hidden Risks

Biologics are highly vulnerable to environmental exposure. Even tiny leaks can lead to:

Key advantages:

• Potency loss from oxygen exposure
• Moisture-driven degradation
• Sterility failure from microbial ingress
• Seal deformation during cryogenic storage

Helium testing can identify failure mechanisms that other testing methods simply cannot see — before those failures reach patients.

Helium leak testing plays a huge role in keeping high-value biologic packaging secure. It catches even the tiniest leaks. This isn’t just about keeping products from getting contaminated or breaking down. It’s also about meeting strict regulations and making sure patients stay safe.

For manufacturers, using helium leak testing isn’t just another box to tick. It’s a essential safety net that guarantees every dose gets to patients exactly as it should—safe, effective, and reliable. When it comes to biologics, everything’s complicated, and there’s no room for error. Helium leak testing gives manufacturers the confidence they need to trust their packaging.

Leak testing is an essential part of pharmaceutical and medical device manufacturing. Whether it is a vial, a pre-filled syringe, or an autoinjector, every drug delivery system must be sealed properly to keep medicines safe. A tight and reliable seal protects sterility, ensures accurate dosing, and maintains product stability throughout transportation and storage. Even a tiny leak that cannot be seen by the eye can compromise a product and potentially endanger a patient.

Why Leak Testing Matters

Drug products, especially injectable and biologic therapies, are highly sensitive. If the container closure system fails, it can lead to serious problems such as:

• Microbial contamination that could cause infections
• Chemical degradation that reduces drug strength and efficacy
• Shortened shelf life resulting in early product failure
• Inaccurate dosing due to gradual leakage

Because the risk is so high, manufacturers must detect issues early to prevent costly recalls and, more importantly, protect patient health.

How Helium Helps Detect Hidden Leaks?

Among several integrity testing methods used in the industry, helium leak testing is known for being extremely accurate and sensitive. Helium is a preferred tracer gas for several reasons:

• It has a very small atomic size, allowing it to pass through the smallest leak paths
• It is chemically inert, so it will not interact with packaging materials or medications
• It can be detected in extremely low amounts with advanced mass spectrometers

This level of precision helps manufacturers evaluate packaging during development, monitor production quality, and ensure compliance before products reach the market.

The Impact of Inadequate Leak Testing

When leak detection is unreliable or overlooked, the consequences can be significant:

• Risk of patient safety incidents
• Product recalls that can be extremely expensive
• Damage to company reputation
• Disruption in the supply of important medicines

For these reasons, leak testing is more than a regulatory requirement. It is a vital part of delivering safe and effective treatments.

Conclusion

Precision in leak testing ensures that drug delivery systems remain safe and functional until they reach the patient. Helium leak testing provides a highly dependable way to detect even the smallest leaks that other methods may miss. By adopting this advanced approach, pharmaceutical companies can safeguard product quality and support the well-being of patients who rely on their medications. A secure seal may seem like a small detail, but in healthcare, it plays a big role in protecting lives.

Ensuring container closure integrity is essential for the protection and performance of sterile pharmaceutical products. From early formulation work to commercial distribution, each stage of development requires specific leak detection capabilities to confirm packaging reliability and maintain product safety. Vacuum Decay and Helium Mass Spectrometry are widely adopted technologies that play important roles throughout the pharma product lifecycle. Vacuum Decay supports routine process control and high-throughput inspection on the manufacturing floor, helping ensure consistent sealing performance during scale-up and commercial production. Helium Mass Spectrometry provides ultra-sensitive detection suited for packaging research, selection of container systems, and validation activities where precision and traceability are important.

By applying the right testing approach at the right stage, companies can build strong container closure integrity strategies that protect products, meet regulatory expectations, and maintain patient trust over the entire lifecycle.

Vacuum Decay Leak Testing

Vacuum Decay is a deterministic, non-destructive method that monitors pressure changes in a vacuum chamber containing the sealed package. If there is a leak, the chamber pressure rises, indicating compromised integrity.

Why Leak Detection Matters?

Pharmaceutical containers are the first line of defence in protecting drugs from the environment. Even minor leaks can:

Advantages

• Simple setup and operation
• Fast and suitable for high-volume production

Vacuum Decay is often used for routine QC and high-throughput inspections where moderate sensitivity is sufficient.

Helium Mass Spectrometry Leak Testing

For vials, pre-filled syringes, cartridges, and other non-porous packaging, helium mass spectrometry has become the gold standard for leak detection. Unlike probabilistic methods, helium leak testing is deterministic, traceable, and highly sensitive, allowing detection of extremely small leaks that other methods may miss.

How It Works

• The product is placed in a vacuum chamber or connected to a mass spectrometer.
• Helium is introduced as a tracer gas into the container.
• Escaping helium is ionized, accelerated through a magnetic field, and detected by a sector field mass spectrometer.
• The ion current is converted to an electrical signal, directly proportional to the helium concentration, providing a precise leak measurement.

Why Helium is Used?

• Small atomic size allows it to pass through microscopic leaks
• Inert, non-toxic, and non-flammable, safe for products
• Non-condensable, ensuring accurate readings
• Abundant and cost-effective, with minimal background (≤5 ppm in atmosphere)
• Provides rapid, reliable, and deterministic results

Applications in Pharmaceutical Packaging

Helium mass spectrometry is particularly important in container closure integrity testing (CCIT) for:

• Vials and ampoules
• Pre-filled syringes and cartridges
• Blister packs and pouches
• Implantable medical device packaging

It ensures sterility, prevents moisture ingress, and maintains product safety from production to patient use.

Why Helium Leak Testing is Preferred?

Helium leak testing is highly accurate and sensitive, capable of detecting even the smallest leaks that could compromise sterile packaging. Its unique properties—inert, non-toxic, non-flammable, and very small in size allow helium to penetrate microscopic openings, making it ideal for vials, syringes, and other critical medical products. The method provides fast, reliable, and traceable results, ensuring product safety, sterility, and regulatory compliance.

Helium Mass Spectrometry is the top choice for manufacturers who need the most accurate leak detection. Because helium atoms are very small and naturally present in tiny amounts, this method can measure even the smallest leaks, giving precise assurance that products remain intact and safe.

Modern helium testing is guided by standards like the SIMS 1915+. These standards set clear rules for testing conditions, equipment, and acceptable leak levels for hermetically sealed devices. Following SIMS 1915+ helps ensure that critical components, especially in defense and aerospace, meet strict quality and reliability requirements. Helium Mass Spectrometry continues to be a vital and evolving tool for checking the integrity of high-value products.

Even the tiniest leak in a pharmaceutical container can have serious consequences. A small breach in a vial, syringe, or blister pack can allow moisture, air, or contaminants to enter, affecting the drug’s safety, effectiveness, and shelf life. Traditional visual inspections or basic leak tests often miss these microscopic defects.

This is where helium leak testing comes in Helium is a non-toxic, chemically inert gas with very small molecules, making it ideal for detecting leaks that other methods can’t find. Helium leak detection not only identifies leaks but also measures them accurately, helping pharmaceutical manufacturers maintain product quality and meet strict regulatory standards.

Why Leak Detection Matters?

Pharmaceutical containers are the first line of defence in protecting drugs from the environment. Even minor leaks can:

• Reduce drug effectiveness:Moisture or oxygen exposure can degrade active ingredients.
• Compromise sterility:Contamination risks increase if the container is not fully sealed.
• Cause regulatory issues:Compliance with FDA, EMA, and ICH standards requires reliable leak testing.

Helium leak detection addresses all of these risks, offering a sensitive and precise way to ensure container integrity and protect both patients and manufacturers.

Types of Leaks

Helium leak detection can classify different types of leaks, helping manufacturers understand where and why containers fail. Common leak types include:

• Through-Hole Leaks:Small perforations in the container or closure that allow helium to pass directly through.
• Porous or Diffusion Leaks:Gas slowly passes through microscopic pores in packaging material.
• Seal or Interface Leaks:Imperfect seals between container components, like vial stoppers or syringe plungers, can create gaps.
• Microcracks or Fissures:Tiny cracks caused by stress or material fatigue that allow gas to escape.

By identifying the type of leak, manufacturers can target the root cause and improve packaging design or production processes.

Measuring Leak Rates

In addition to detecting leaks, helium leak detection measures the amount of escaping helium, typically in mbar·L/s. Leak quantification is essential for:

• Assessing risk:Knowing the size of a leak helps determine if it could affect product safety.
• Quality control:Monitoring leak rates ensures packaging consistency across production batches.
• Regulatory compliance:Accurate data supports validation reports and regulatory submissions.

Quantifying Leaks

Beyond identifying leak types, Helium Leak Detection quantifies leak rates, typically expressed in mbar·L/s. Quantification provides critical insights:

• Risk assessment:Determines whether the leak could compromise drug safety.
• Process control:Monitors packaging consistency across production batches.
• Regulatory documentation:Supplies precise data for validation and compliance reporting.

Helium testing techniques include vacuum decay, mass spectrometry, and sniffer methods. These approaches provide accurate measurements of helium escaping from the container, enabling manufacturers to assess leak severity and take informed decisions on batch release or improvements.

Helium leak detection is a vital tool in pharmaceutical packaging. By identifying and measuring leaks, from microcracks to imperfect seals, it ensures even the smallest breach is detected before it affects drug quality or compliance. Using helium gas, this method can find microscopic leaks in vials, pre-filled syringes, and blister packs, helping maintain sterility, stability, and product safety throughout the shelf life. Known for its accuracy, reliability, and support for regulatory standards, helium leak testing is a key part of modern pharmaceutical quality assurance. At PTI, we specialize in advanced helium leak detection services, helping pharmaceutical manufacturers ensure container integrity and maintain the highest standards of product safety and quality.

Even the most carefully formulated medicines can face recalls, and often, the problem isn’t the drug itself it’s the packaging. Tiny, invisible leaks in vials, syringes, or blister packs can let air, moisture, or contaminants in, compromising the drug inside. These hidden breaches can reduce potency, change the drug’s stability, or even introduce microbial contamination. That’s why Helium Leak Detection has become an essential tool in pharmaceutical quality control.

Let’s take a closer look at how Helium Leak Detection works, why it matters, and how advanced systems like the SIMS 1915+ help manufacturers prevent packaging failures, maintain product quality, and ensure patient safety.

Why Packaging Integrity Matters

Packaging is more than just a container it’s a protective barrier. Even microscopic leaks can allow moisture, oxygen, or contaminants to enter, potentially degrading tablets or sensitive injectables. No matter how perfect the drug formulation is, compromised packaging can render the medicine ineffective or unsafe.

What Helium Leak Detection Does

Helium Leak Detection is a highly sensitive method that detects even the tiniest micro leaks. Packages are pressurized with helium, and specialized detectors pick up escaping gas molecules invisible to the naked eye. Think of it as a microscope for packaging, helping quality teams identify potential issues before they reach patients.

SIMS 1915+: Advanced Helium Leak Detection

At PTI Helium Leak Testing, we use the Seal Integrity Monitoring System (SIMS) Model 1915+), designed for pharmaceutical, biotech, and life sciences applications. The SIMS 1915+ offers precise quantitative analysis with sensitivity levels as low as 1×10?¹° mbar L/sec and operates in both room and cold temperature conditions. Integrated ETHOS – HLD software manages the detector, processes data, and generates reports fully compliant with 21CFR Part 11. Internal and external calibrated helium standards allow routine calibration, performance verification, and quality assurance. This system supports R&D, tooling qualification, production monitoring, and ongoing package integrity testing, providing manufacturers with accurate, actionable insights.

The Role of CCIs in Recalls

Consumer Complaint Investigations (CCIs) are triggered when patients or healthcare providers notice issues such as:

• Discoloration
• Unusual Odor
• Reduced potency
• Visible contamination

Multiple complaints often point to a systemic problem. In many cases, the culprit is compromised packaging. Detecting and addressing it quickly is essential to prevent larger-scale recalls.

Pinpointing Root Causes

Helium Leak Detection allows quality teams to move from guesswork to precision. For example:

• Moisture damage in tablets may be traced to a single blister-packing machine producing weak seals.
• In injectables, HLD can reveal tiny defects at the glass-to-stopper interface, allowing oxygen to enter and degrade the medication.

Once identified, teams can recalibrate equipment, adjust process parameters, and prevent similar failures in future batches. Helium Leak Detection is a behind-the-scenes hero of pharmaceutical quality control. By detecting even the smallest packaging flaws, Helium Leak Testing helps manufacturers prevent CCI failures, avoid recalls, and ensure medicines reach patients safely and reliably.

Imagine spending years developing a life-saving drug or medical device, only to have it compromised by something as invisible as moisture. In the pharmaceutical and medical device industries, even the smallest amount of moisture ingress can threaten product safety, sterility, and shelf life. In sterile packaging, even a trace of water vapor can cause serious damage.

That’s why preventing moisture ingress isn’t just a packaging requirement; it is an important aspect of ensuring product safety and reliability. One of the most accurate methods to achieve this protection is helium leak testing, a highly sensitive technique widely used in the pharmaceutical, biotechnology, and medical device industries to detect even the tiniest leaks in packaging systems.

How Leaks Affect Sterile Packaging

In sterile barrier systems, even the smallest leak can have serious consequences for product integrity and patient safety. These leaks, often called microleaks, act as unintended pathways that allow the ingress of moisture, oxygen, or microorganisms. Although they may be invisible or difficult to detect, their effects on sterile products can be severe and irreversible over time.

A leak in a sterile package compromises its container closure integrity (CCI), the critical property that ensures a product remains sterile and protected from external contamination. When this barrier is breached, the package can no longer guarantee sterility, exposing the contents to potential degradation or contamination.

Leaks can cause loss of sterility, make drugs break down faster, and mess with how well the product works. If things get really bad, the product could become unsafe or not work at all. That's why it's important to have good ways to find leaks and make sure sterile packaging stays in good shape.

Common Sources of Leaks in Sterile Barrier Systems

Leaks in sterile packaging often result from small imperfections that develop during manufacturing, sealing, sterilization, or handling. These microdefects may be invisible to the eye but can significantly compromise container closure integrity and allow moisture or gases to enter over time.

Below are some of the most common sources of leaks in sterile barrier systems:

• Seal Imperfections - Caused by uneven sealing or trapped contaminants, leading to weak or incomplete seals.
• Pinholes and Microcracks -Tiny defects from stress or sterilization that let moisture or gases enter.
• Closure System Defects - Misaligned stoppers or weak seals that compromise the sterile barrier.

Role of Helium Leak Testing in Moisture Protection

Helium leak testing plays a crucial role in ensuring sterile barrier integrity and protecting products from moisture ingress. It uses helium, an inert, non-toxic, and extremely small gas molecule, as a tracer to detect leaks that are impossible to see or measure with conventional methods. Because helium atoms are much smaller than water molecules, this method accurately predicts how well a package can prevent moisture penetration.

The process involves introducing helium into or around the package and using a highly sensitive mass spectrometer to detect any escaping gas. Even leaks as small as 1 x 10¹° mbar·L/s can be identified, offering a level of precision far beyond traditional dye or bubble tests.

This makes helium leak testing ideal for pharmaceutical and medical device applications where moisture sensitivity is critical. It can be applied to a wide range of package types, including vials, cartridges, pre-filled syringes, flexible pouches, and blister packs. The test provides quantitative, repeatable data to verify container closure integrity and ensure reliable protection for moisture-sensitive products.

By using helium leak testing, companies can spot tiny leaks early. This means every sterile package stays fully protected from start to finish.

Ensuring Product Quality and Regulatory Compliance

Moisture control is essential to maintaining product sterility, safety, and performance. Even a tiny leak can cause contamination or reduce shelf life. Helium leak testing provides the precision and sensitivity needed to detect these microleaks, ensuring packaging integrity.

This method aligns with FDA and USP <1207> guidelines for deterministic testing, offering reliable, measurable results that meet regulatory expectations. By adopting helium leak testing, manufacturers strengthen quality assurance, maintain compliance, and protect patient safety through consistent and proven package integrity verification.

Every time a patient takes a prescribed pill, they place their trust in that medicine. They believe it’s safe to use, stays stable over time, and has the full strength needed to treat their condition. Because of this trust, pharmaceutical companies have a responsibility to ensure that all of their products are safe and effective. For most oral medicines, that protection comes from blister packs, those blister packets look small, sealed plastic-and-foil packages designed to keep out air, moisture, and light.

But even this strong packaging can have hidden problems. One of the most common issues is something called a microleak which means a tiny hole or gap in foil. It’s so small that you’d never notice it just by looking. Still, that little opening can let in air, moisture, or other unwanted particles. With the course of time, they can destroy the medicine within, rendering it weaker, less efficient, or even dangerous to use.

To prevent such risks, manufacturers require reliable methods to check the quality of the seal of the blister packs. The most sensitive solution to this is the helium leak detection. In this blog, we are going to examine its major challenges, applications and benefits.

Challenges Associated with Microleaks in Blister Cavities

It only takes a tiny hole to cause big problems in a blister pack. Moist air from outside can find its way in, even if the leak is invisible to the eye. Over time, this can silently damage the medicine inside. Let’s look at the main challenges caused by microleaks in blister cavities.

Key Challenges:

• Moisture Ingress -The biggest issue is moisture entering the pack. The difference in humidity between the dry air inside and the humid air outside pushes water molecules through even the smallest openings.
• Drug Degradation -When moisture intrudes, it might begin to break down the medicine chemically in it, decreasing its stability and its overall shelf life.
• Loss of Effectiveness - As the drug degrades, it loses its potency. This implies that there is a possibility that the medicine would not act as intended, and this would be a serious threat to the well-being of the patients.
• Physical Damage - Exposure to moisture can make the pill swell, crumble, change color, or become sticky, affecting its appearance and usability.
• Hard to Detect - Traditional quality tests, like dye ingress methods, often miss these microleaks because the dye particles are too large to pass through them. This is why the pharmaceutical industry now relies on advanced methods like helium leak detection to ensure true package integrity.

Detecting Leaks with PTI’s Helium Leak Detection

To address packaging integrity issues, the pharmaceutical industry is adopting helium leak detection, a precise and scientific testing method. This technique uses helium gas, a small, inert, and stable molecule, as a tracer to identify even the tiniest leaks in sealed packages.

During the test, helium is either introduced into or around the package, and a highly sensitive mass spectrometer measures any escaping helium. Because helium atoms are extremely small, they can reveal microscopic leaks that traditional methods often fail to detect.

One of the most advanced systems in this field is PTI’s SIMS 1915+, a helium-based leak detection solution specifically engineered for pharmaceutical, medical device, and biotechnology applications. The SIMS 1915+ delivers exceptional precision, capable of detecting leaks as small as 1 × 10?¹° mbar·L/sec, and can test a wide range of packaging formats from blister packs and vials to pre-filled syringes and cartridges. It also supports testing at both room and cryogenic temperatures, making it a versatile and reliable choice for diverse manufacturing environments.

Microleaks may be invisible, but their impact on medicine safety and effectiveness is far from small. Ensuring the integrity of blister packs is crucial to maintaining drug stability, patient trust, and regulatory compliance. With advanced helium leak detection systems like PTI’s SIMS 1915+, manufacturers can confidently detect even the smallest seal defects, safeguard their products, and ensure that every dose delivered to a patient is as safe and effective as intended.

Pre-filled syringes (PFS) have revolutionized the way injectable therapies are administered, combining convenience, precision dosing, and improved patient safety. Their widespread adoption in biologics, vaccines, and other high-value injectable medications reflects the growing demand for drug delivery systems that can reliably maintain sterility throughout their lifecycle. Despite their advantages, ensuring the container closure integrity (CCI) of pre-filled syringes remains a complex task. The interaction of multiple components, material variability, and exposure to environmental and mechanical stresses can lead to microscopic leaks that are not always detectable using conventional methods. Such leaks, even at extremely low levels, can compromise sterility, reduce shelf life, or impact the efficacy of sensitive drug formulations. Yet, maintaining the container closure integrity (CCI) of PFS presents a demanding challenge. Technologies like Helium Leak Detection provide highly sensitive, non-destructive testing to detect microscopic leaks. This ensures pre-filled syringes maintain sterility and reliability from production to patient use.

Common Integrity Challenges in Pre-Filled Syringes

Pre-filled syringes are composed of multiple components—barrel, plunger, tip cap, and needle shield—all of which must work together to form an airtight and leak-free system. Variability in materials, assembly processes, and storage conditions can affect the sealing performance. One of the main challenges is related to the dynamic interaction between elastomeric components and glass barrels. Small variations in plunger movement or compression force can alter the internal pressure balance, creating microchannels through which gas or moisture may enter. Over time, these micro-leaks can compromise the sterile barrier. Manufacturing processes also contribute to potential risks. For example, mechanical stress during syringe filling or capping, improper handling during transportation, and exposure to low temperatures in biologics packaging can all affect seal integrity. Moreover, as drug formulations become more complex, such as with protein-based biologics, sensitivity to oxygen or moisture increases, making micro-leak detection even more significant.

Helium Leak Detection: A Deterministic Approach for Reliable Integrity Evaluation

Helium Leak Detection (HLD) has emerged as a highly sensitive container closure integrity testing technique for verifying the integrity of pre-filled syringes. Unlike dye ingress or microbial challenge methods that rely on probabilistic detection, Helium Leak Detection uses a deterministic approach, offering quantifiable and repeatable results. In this method, the test article is filled with helium, a small and inert gas that can easily escape through microscopic leaks. The system then measures the rate of helium leakage using a mass spectrometer. Even leaks as small as 1×10?¹² mbar L/s can be detected, making it possible to identify defects that are invisible to conventional techniques. Helium Leak Detection is particularly effective for pre-filled syringes because it can evaluate the entire container system—needle shield, barrel, and plunger area—without causing damage. It allows manufacturers to validate CCI during development, verify process performance, and perform batch testing for ongoing quality assurance. Additionally, HLD supports regulatory compliance with standards such as USP <1207>, which encourages deterministic test methods for CCI evaluation.

Why Use Helium Leak Testing for Pre-filled Syringes?

• High sensitivity -Detects microleaks that could compromise product quality.
• Fast and efficient -Suitable for high-volume production environments
• Precise data -Provides accurate measurement of leak size and location for prompt corrective action.
• Safe and inert - Helium is non-reactive, ensuring no product contamination.
• Cost-effective - Long-term savings by reducing product loss and ensuring packaging integrity.
• Regulatory complianceMeets strict industry standards for product safety and quality.

The packaging design of pre-filled syringes demands rigorous integrity verification to ensure safe and effective drug delivery. Traditional testing methods often fall short in identifying the minute leaks that can affect product quality. Helium Leak Detection offers a dependable solution by delivering quantitative, repeatable, and non-destructive measurements of seal integrity. Its precision not only enhances product reliability but also enables manufacturers to achieve a higher level of process control and assurance in syringe packaging systems.

Understanding Combination Product Integrity

Pharmaceutical vials remain one of the most trusted packaging formats for sterile injectables, vaccines, and biologics. Their reliability depends on the ability of the container closure system to maintain sterility, stability, and product safety throughout the entire lifecycle. However, vial integrity is not guaranteed. Even microscopic leaks—far too small to be visible—can allow gas or microbial ingress, compromising product quality and patient safety.

To mitigate these risks, manufacturers are turning to deterministic, quantitative leak testing methods such as helium leak detection (HeLD). Recognized under ASTM F2391 and referenced in USP <1207>, helium testing delivers unmatched sensitivity for verifying the integrity of vial systems.

Understanding Manufacturing Challenges in Vial Production

Vial manufacturing involves multiple interdependent stages—glass forming, washing, closure placement, crimping, and sterilization—each introducing potential variability.

• Dimensional variation - in glass tubing can impact stopper compression and crimp tightness.
• Stopper or seal misalignment -may form microchannels between components.
• Temperature cycling - during storage and cold chain transport can cause contraction or expansion of materials, especially for elastomeric closures, leading to transient leaks.

For high-value biologics and cell-based therapies, even a single compromised vial can cause costly product loss or supply delays. Maintaining process consistency across these stages is therefore essential to ensuring container closure integrity (CCI).

Helium Leak Detection: A Quantitative, High-Sensitivity Method

Helium leak detection is a deterministic and quantitative approach that uses helium—a small, inert tracer gas—to detect micro-defects in vial systems.

In a typical test, vials are placed in a vacuum chamber after being exposed to a helium atmosphere. If helium escapes through a defect, it is measured by a mass spectrometer, which quantifies the leak rate with extreme precision—down to 10?? mbar·L/s. This level of sensitivity far exceeds that of traditional probabilistic methods such as dye ingress or microbial challenge.Helium testing generates direct, numerical data that can be trended for process control and used to establish acceptance criteria in accordance with USP <1207.1>. Because results are objective and repeatable, manufacturers gain clear insight into seal strength and overall system robustness.

Strategic Applications Across the Vial Lifecycle

• Development & Design Qualification - Evaluate new vial, stopper, and seal combinations to confirm material compatibility and closure performance.
• Process Validation & Optimization -Quantify closure integrity across capping parameters, stopper compression, and glass-to-closure interactions.
• Routine Quality Assurance - Support ongoing monitoring or periodic verification of packaging line performance, especially for critical or cold-chain products.
• Failure Analysis - Identify the exact location and magnitude of leaks to guide root cause investigation and corrective actions.

While helium leak testing is often used destructively, it remains the gold standard for sensitivity and quantitative assurance. For routine 100 % in-line or non-destructive inspection, complementary deterministic technologies such as vacuum decay or high-voltage leak detection (HVLD) can be implemented.

Why Helium Testing Matters for Biologics and Cold Chain Applications

Modern biologics and advanced therapies impose unique packaging challenges. Storage at ultra-low temperatures can stress materials and closures, potentially inducing seal failures not detectable by conventional methods. Helium leak detection provides the sensitivity needed to characterize these micro-defects and validate packaging systems designed for cryogenic or sub-zero environments.

Supporting Global Regulatory Expectations

Global regulators now emphasize deterministic methods for demonstrating CCI.

• USP <1207> - defines helium leak testing as a deterministic method capable of quantitative measurement.
• EU Annex 1 (2023) -calls for a “science-based, risk-based approach” to integrity verification of sterile containers.

Adopting helium leak detection demonstrates scientific rigor and regulatory alignment—key to ensuring patient safety and compliance.

Helium leak testing provides pharmaceutical manufacturers with the precision and confidence required to ensure consistent vial integrity. By delivering quantitative, repeatable data, it supports a robust CCI strategy that minimizes risk, strengthens process control, and protects patient safety.

As part of a holistic integrity testing program—including vacuum decay, HVLD, and seal quality evaluation—helium leak detection remains a cornerstone technology for achieving manufacturing consistency and regulatory compliance in vial production.

Ophthalmic dropper bottles are critical for delivering medications safely and effectively to patient’s eyes. Any compromise in the seal of these containers can lead to contamination, reduced efficacy, and even pose health risks. Ensuring the integrity of these seals is therefore paramount for manufacturers, regulatory bodies, and healthcare providers. One of the most advanced methods to evaluate the integrity of ophthalmic dropper bottles is helium mass spectrometry, a highly sensitive technique that can detect minute leaks that other methods might miss.

Understanding Seal Integrity Challenges

The seals on ophthalmic dropper bottles face multiple challenges. These containers must maintain a sterile environment, protect the formulation from air and moisture, and preserve drug stability over the product’s shelf life. Even microscopic leaks can allow the ingress of contaminants or the escape of active ingredients, leading to compromised product performance. Additionally, the small volume and delicate design of dropper bottles make detecting leaks a complex task. Factors such as cap design, closure torque, material compatibility, and temperature variations further complicate seal reliability.

Limitations of Conventional Testing Methods

Traditional methods for evaluating seal integrity, such as dye ingress or pressure-based leak tests, often fall short when applied to ophthalmic dropper bottles. Dye ingress requires visual inspection and may miss tiny leaks. Pressure decay methods can detect larger leaks but may not reliably identify micro-leaks critical in sensitive formulations. Moreover, these conventional approaches often provide qualitative rather than quantitative results, making it difficult to assess the severity of leaks or ensure consistent product safety across batches.

Helium Mass Spectrometry as a Solution

Helium mass spectrometry offers a precise and sensitive alternative for assessing seal integrity. In this method, helium small, inert, and highly diffusive gas is used as a tracer. The bottle is exposed to helium under control conditions, and a mass spectrometer detects any helium escaping from the sealed container. This approach can identify extremely small leaks, providing quantitative data on leak rates and locations. The sensitivity of helium mass spectrometry allows manufacturers to evaluate even the smallest defects that could compromise sterility or efficacy, ensuring a higher level of quality assurance.

Applications in Ophthalmic Dropper Bottles

The application of helium mass spectrometry to ophthalmic dropper bottles offers several benefits:

• Pre-filled syringes with safety devices - Manufacturers can verify that each batch of dropper bottles meets stringent seal integrity requirements.
• Auto-injectors and pens - New bottle designs, cap materials, or closure mechanisms can be tested for reliability before large-scale production.
• Shelf-Life Studies - The method helps predict how bottles will perform over time
• Ophthalmic delivery systems -Helium leak testing provides documented evidence to satisfy regulatory expectations for container closure integrity.

Ensuring the seal integrity of ophthalmic dropper bottles is critical for patient safety, product efficacy, and regulatory compliance. While conventional methods have limitations in sensitivity and reliability, helium leak testing provides an advanced solution capable of detecting even the smallest leaks. By incorporating this technology, manufacturers can improve quality control, optimize product design, and confidently deliver safe, effective ophthalmic medications to the market.

Combination products such as drug-device systems, pre-filled syringes with safety features, or inhalers with integrated containers have transformed modern healthcare by enhancing patient convenience and therapeutic outcomes. However, their complexity brings new challenges in ensuring package integrity. Even the smallest leak can compromise sterility, safety, and regulatory compliance. This is where helium leak detection emerges as a highly sensitive and reliable solution to safeguard product integrity. Its ability to detect submicron leaks provides manufacturers with precise, quantifiable data that traditional methods often miss. By identifying vulnerabilities early in development, it helps optimize design and assembly processes. Ultimately, this advanced testing method supports consistent product quality, regulatory compliance, and, most importantly, patient safety.

Understanding Combination Product Integrity

Combination products integrate multiple components, often made of different materials and joined through intricate interfaces. Unlike traditional containers, these systems are more prone to microleaks due to their complexity. Ensuring container closure integrity (CCI) is essential, as compromised seals can lead to contamination, reduced efficacy, or product recalls. Regulatory authorities emphasize stringent testing to validate the integrity of such products throughout their lifecycle. These products often involve moving parts, such as plungers, actuators, or valves, which can stress seals over time and increase the risk of leakage. The diversity of materials used plastics, elastomers, metals, and glass creates challenges in maintaining uniform sealing performance. Advanced testing methods are therefore critical to detect even the smallest defects that could compromise safety or stability.

Limitations of Traditional Leak Detection Methods

Conventional leak detection approaches, such as dye ingress or microbial challenge tests, fall short when it comes to complex combination systems. These methods lack the sensitivity required to detect submicron leaks, are often subjective in interpretation, and may not provide quantifiable results. In addition, they can be labor-intensive and inconsistent, making them unsuitable for high-stakes applications where patient safety is non-negotiable. Furthermore, these traditional methods provide limited diagnostic information, making it difficult to pinpoint the exact source or nature of a leak. As a result, manufacturers face challenges in optimizing product design and ensuring consistent quality across production batches.

Applications in Combination Products

Helium leak testing provides unmatched sensitivity, capable of identifying the tiniest leaks that traditional methods overlook. Its quantitative and reliable data makes it particularly valuable for a wide range of combination products, including:

• Pre-filled syringes with safety devices - Detecting leaks at material interfaces or plunger seals.
• Auto-injectors and pens - Ensuring robust integrity in multi-component drug-delivery systems.
• Ophthalmic delivery systems - Protecting sterile formulations against microleaks.

As combination products continue to gain prominence, addressing integrity challenges becomes increasingly critical. Traditional leak detection methods cannot meet the demands of these complex systems. Helium leak detection, with its superior sensitivity and quantitative results, stands out as the preferred method to ensure safety, efficacy, and compliance. For manufacturers, adopting this advanced approach means safeguarding both product quality and patient trust.

Pre-filled syringes (PFS) have become a cornerstone of modern drug delivery, offering convenience, accuracy, and safety for both healthcare providers and patients. Their growing adoption, especially in biologics and vaccines, brings an equally growing responsibility: ensuring that these drug delivery systems remain sterile and stable throughout their lifecycle. Even microscopic leaks in the container closure system can compromise product quality, patient safety, and regulatory compliance.

To address these risks, USP <382> provides a framework for evaluating the functional suitability of elastomeric components in parenteral packaging and delivery systems. Within this framework, helium leak detection has proven to be one of the most reliable and sensitive methods to safeguard pre-filled syringe integrity.

Understanding the Structure and Leak Risks of Pre-Filled Syringes

A pre-filled syringe is made up of multiple components: glass barrel, elastomeric plunger, needle shield, and closure systems that must work together to ensure complete sealing. Each of these interfaces can be a potential weak point. Even the smallest breach can allow microbial ingress or lead to chemical degradation of sensitive formulations, making robust container closure integrity (CCI) testing essential.

USP <382>: A Shift Toward Deterministic Leak Testing

Historically, probabilistic tests like dye ingress or bubble emission were used to assess packaging integrity. However, these methods rely heavily on operator interpretation and often lack the sensitivity to detect micro-defects.

USP <382> emphasizes the importance of functional suitability testing for elastomeric components and aligns closely with the deterministic principles outlined in USP <1207>. This shift underscores the industry’s move toward highly sensitive, quantitative methods that provide scientific, repeatable, and verifiable results.

Helium Leak Detection: Meeting and Exceeding USP <382> Regulation

Helium leak testing has become a benchmark method for CCI testing in pre-filled syringes because of its ability to detect extremely small leaks down to 10?¹° mbar·L/sec.

Key benefits include:

• Exceptional Sensitivity – Detects micro-channels that traditional tests miss.
• Quantitative Results – Provides measurable leak rates for precise analysis.
• Regulatory Alignment – Supports USP <382> compliance and satisfies global regulatory expectations.
• Wide Applicability – Effective for syringes, vials, cartridges, and other parenteral packaging systems.

For pre-filled syringes, helium testing is particularly valuable in verifying the integrity of elastomeric plungers and needle-shield assemblies components most vulnerable to leakage. By integrating helium leak detection in development, validation, and routine quality control, manufacturers can build confidence in packaging integrity and reduce the risk of compliance failures or recalls.

As injectable therapies continue to dominate the pharmaceutical landscape, ensuring the integrity of pre-filled syringes is critical for both patient safety and regulatory compliance. USP <382> sets clear expectations for functional suitability, pushing the industry toward deterministic and highly sensitive test methods. Helium leak detection not only meets these standards but exceeds them, providing unmatched sensitivity and quantitative assurance of container closure integrity.

By adopting helium leak testing, pharmaceutical companies can confidently safeguard product sterility, extend drug stability, and maintain compliance in an increasingly demanding regulatory environment.

In pharmaceutical manufacturing, ensuring the highest level of Container Closure Integrity (CCI) is essential. For sterile injectables, biologics, and advanced therapies, even the smallest leak can compromise sterility, introduce contaminants, or cause product degradation. Regulatory agencies and global standards have moved toward deterministic, quantitative methods to evaluate package integrity, pushing the industry to adopt more advanced leak detection solutions.

Among these, Helium Leak Detection stands out as one of the most precise methods, offering unmatched sensitivity to detect leaks at levels far beyond the capabilities of traditional approaches.

What is Sensitivity in Leak Detection?

Sensitivity in leak detection refers to the smallest defect or leak path that a testing method can reliably identify and measure. It is typically expressed as a leak rate, measured in mbar·L/sec. The lower the value detectable, the more sensitive the method. Traditional dye ingress testing might only detect leaks larger than 1×10–10, while advanced helium-based systems, like those from PTI, can detect leaks as small as 10?¹¹mbar·L/sec.

This difference highlights why sensitivity is such a defining factor in evaluating CCI. A method with low sensitivity may pass a container as “integral” even when microscopic leaks exist, whereas highly sensitive helium testing provides definitive, quantifiable data.

Why Sensitivity Matters in Pharmaceutical Packaging?

Pharmaceutical packaging is not uniform, it varies by container type, material, closure system, and storage environment. Each factor introduces unique risks for leakage. The sensitivity of the helium leak testing method must therefore be aligned with the product’s risk profile.

• For sterile injectables, a micro-leak too small to be seen can still allow microbial ingress, directly threatening patient safety.
• For moisture-sensitive biology, even trace amounts of water vapor entering through microscopic pathways can degrade active ingredients.
• For advanced therapies stored under ultra-low or cryogenic conditions, material contraction can generate stress points that lead to leaks.
• And for high-value, limited batch drugs, missing a small defect could result in significant financial loss and supply chain setbacks.

The more sensitive the leak detection method, the greater the assurance that packaging failures will be identified before products reach patients.

Helium as a Tracer Gas: A Sensitivity Advantage

Tracer gas leak testing is a highly effective method for detecting leaks with outstanding sensitivity, accuracy, and repeatability. Using helium as the tracer gas, it can identify micro-leaks as small as 1x10?4 to 10?? scc/s. The test is done either by injecting helium into sealed packages or filling the headspace after sealing, allowing precise detection of any leakage. The vacuum test method is the most widely used approach, placing seals under stress to capture helium transmission through both the material and closure system. This technique offers superior leak detection by monitoring helium gain in the external environment of the enclosed sample.

Ensuring seal integrity is critical to protecting pharmaceutical products, maintaining patient safety, and supporting evaluations of sustainable or cost-optimized packaging. To meet these needs, PTI’s Helium Leak Detection systems provide advanced, high-performance solutions designed to deliver unmatched sensitivity, accuracy, and reliability for pharmaceutical and biological applications. By setting and validating appropriate sensitivity thresholds, pharmaceutical manufacturers can achieve a higher standard of quality assurance, protecting both product and patient with confidence. Helium’s unique role as a tracer gas makes it not just a testing tool, but an enabler of safety, innovation, and trust in the pharmaceutical supply chain.

The stability of injectable and lyophilized drugs relies heavily on the integrity of their container-closure systems. Vials are designed to act as protective barriers, yet even tiny leaks can compromise product quality by allowing moisture, oxygen, or microbes to enter, or by causing the loss of volatile compounds. Such breaches not only reduce efficacy but also pose serious risks to patient safety and regulatory compliance.

To safeguard against these issues, pharmaceutical manufacturers turn to advanced testing methods that ensure reliable container closure integrity. Among the most effective is helium leak detection, a highly sensitive and quantitative technique that can identify microscopic leaks undetectable by conventional methods. By verifying that vials remain airtight throughout the product’s shelf life, this technology provides confidence in long-term drug stability while supporting global quality standards.

Importance of Container Closure Integrity for Drug Stability

The purpose of a container-closure system is to provide a protective barrier against external factors that can threaten product quality. Common risks include:

• Microbial contamination: Even the tiniest breach can allow bacteria or fungi to enter, compromising sterility.
• Moisture ingress: Sensitive formulations such as lyophilized (freeze-dried) drugs can rapidly degrade in the presence of water vapor.
• Oxygen exposure: Oxidation can alter the chemical structure of certain active pharmaceutical ingredients (APIs), reducing efficacy.
• Volatile loss: For drugs formulated with solvents or sensitive compounds, improper sealing can result in evaporation or potency loss.

How Helium Leak Detection Works in Vial Testing

Helium leak detection is considered to be one of the most precise methods for verifying vial integrity. In this technique, vials are exposed to a helium-rich environment, allowing the gas to penetrate any potential microchannels or defects in the container-closure system. The vials are then placed in a vacuum chamber connected to a mass spectrometer, which detects and quantifies the presence of helium that has escaped. This process is highly sensitive and can identify leaks that are too small to be detected by traditional methods.

Because helium is an inert and tiny molecule, it provides a reliable indication of whether a vial is truly airtight. As a result, manufacturers can confidently verify the robustness of their packaging systems and ensure that the drug remains stable throughout its intended shelf life. The method also delivers quantitative results, expressed as a measurable leak rate, which helps in setting clear acceptance criteria. Unlike qualitative tests, it allows for consistency and repeatability in quality control. Helium leak detection can be applied during R&D phase, production, and validation phases, making it versatile across the product lifecycle. Ultimately, it helps pharmaceutical companies meet stringent global regulatory requirements while minimizing the risk of product recalls.

In conclusion, ensuring the stability of drugs stored in vials is critical to patient safety, product effectiveness, and regulatory compliance. While formulation science plays a key role, the integrity of the container-closure system is equally important. Helium leak detection offers one of the most precise and reliable methods for assessing vial integrity, providing sensitive, quantitative data that ensures drugs remain stable throughout their intended shelf life. By integrating helium leak detection into their quality assurance programs, pharmaceutical manufacturers can not only meet regulatory expectations but also reinforce confidence in the reliability of their products. In the end, this technology safeguards what matters most: the health and safety of patients who depend on these life-saving products and therapies.

In pharmaceutical and medical device packaging, maintaining the integrity of sealed systems is not only a quality requirement but also a critical regulatory and patient safety obligation. As leak detection technologies evolve, helium has emerged as one of the most effective tracer gases for identifying even the smallest breaches in packaging systems. Its unique properties make it particularly well-suited for Container Closure Integrity (CCI) testing, where precision and reliability are essential.

Before helium leak testing became an industry standard, pharmaceutical manufacturers relied heavily on probabilistic methods such as bubble testing, dye ingress, and microbial ingress tests. While these methods could detect significant leaks, they lacked the sensitivity to identify microscopic pathways that could still compromise product sterility.

The introduction of helium as a tracer gas in the mid-20th century revolutionized leak testing. Its adoption in pharmaceuticals followed as industry demand for more deterministic, highly sensitive, and quantitative methods grew. Today, with guidance from USP <1207> and increased regulatory focus on deterministic CCI testing, helium leak detection has become a trusted method for safeguarding product quality and patient safety

Reasons for Using Helium in Pharmaceutical Leak Testing

1. Unique Physical Properties: Helium is an inert, monoatomic gas with the second smallest atomic radius, smaller than hydrogen, which allows it to pass through extremely small leak paths that other gases cannot. Its non-reactive nature ensures it does not interact with packaging materials.

2. Precise Detection Process: In a typical test, a sealed container is placed under vacuum and exposed to helium internally or externally. Any breach allows helium to pass through, where it is detected by a helium-specific mass spectrometer. This enables accurate identification of both the presence and location of leaks.

3. Performance Advantages: Helium’s low molecular weight allows it to diffuse rapidly for quick responses. It clears from the test environment swiftly, enabling faster test cycles and repeatable results, critical for high-volume production where speed, sensitivity, and consistency matter.

4. Critical Applications in Pharmaceuticals: In pharmaceutical manufacturing, particularly for parenteral products, leak testing using helium ensures container closure integrity to maintain sterility, stability, and patient safety. Its high sensitivity, capable of detecting leak rates as low as 10?¹° mbar·L/s, makes it suitable for detecting even microscopic defects that could lead to contamination. Its precise, quantitative results help in:

• Validating new packaging formats and materials
• Verifying the seal integrity of prefilled syringes, vials, ampoules, and blister packs
• Supporting stability studies by confirming packaging robustness over time
• Identifying packaging issues early in production before they escalate into larger quality concerns

In conclusion, helium's unique physical and chemical properties make it an ideal tracer gas for leak detection in pharmaceutical and medical device packaging. Its small atomic size, inertness, and rapid diffusion under vacuum conditions allow for highly sensitive and reliable testing. As regulatory standards continue to prioritize deterministic methods, helium leak detection stands out as a powerful and proven approach for ensuring container closure integrity. For manufacturers committed to product quality and patient safety, helium plays a central role in modern, science-based quality assurance practices.

Pre-filled syringes are increasingly used in modern pharmaceutical delivery due to their convenience, accuracy, and patient-friendly design. However, ensuring the integrity of these devices presents significant challenges. Even the smallest breach in container closure can compromise sterility, pose safety risks, and affect drug efficacy. As regulatory expectations become more stringent, pharmaceutical manufacturers are seeking advanced methods to ensure absolute integrity. One such method is Helium Leak Detection, which offers unmatched sensitivity and reliability in detecting micro-leaks in pre-filled syringes.

Why Traditional Methods Fall Short?

Conventional leak testing methods such as dye ingress have long been used to assess container closure integrity. While suitable for certain applications, these techniques often fall short when applied to complex systems like pre-filled syringes. Its limitations include:

• Low sensitivity: They may not detect sub-micron leaks that are clinically significant.
• Geometry limitations: Irregular surfaces and tight spaces, such as the needle hub or under the plunger, can limit test effectiveness.
• Environmental dependence: Temperature, pressure, and viscosity variations can influence test outcomes, making results less reliable for high-risk products.

Pre-filled syringes have several components: barrels, plungers, and needle shields that create multiple potential leak paths. Traditional methods may struggle to detect extremely small defects, especially those in critical areas such as the needle hub or plunger interface. Furthermore, variations in materials and geometries can impact test sensitivity and consistency. As a result, manufacturers may face limitations in confidently identifying integrity breaches before products reach the market.

Helium Leak Detection: A High-Sensitivity Solution

Helium Leak Detection offers a powerful alternative that addresses these limitations. Using helium a small, inert gas with excellent diffusion properties this method can detect leaks as small as 10?¹° mbar·L/s, far beyond the capabilities of most traditional approaches. During testing, the pre-filled syringe is exposed to helium under controlled conditions. Any escape of helium from the system is measured with precise instrumentation, indicating the presence and size of a leak. This approach provides a quantitative, repeatable measure of integrity, which is critical for high-risk pharmaceutical applications. Additionally, helium’s small atomic size enables it to detect leaks in areas that are otherwise difficult to assess using liquid- or pressure-based methods.

Enhancing Confidence in Product Integrity

Incorporating helium leak detection into the quality control process significantly enhances confidence in the integrity of pre-filled syringes. By reliably identifying microscopic leaks, manufacturers can ensure product sterility, protect patients, and meet evolving regulatory demands. Moreover, the data-driven nature of helium testing allows for better process control and continuous improvement. Manufacturers gain actionable insights into potential failure modes, helping them fine-tune packaging designs, materials, and sealing processes.

In summary, helium leak testing offers the sensitivity and reliability needed to meet the unique integrity challenges of pre-filled syringes. As traditional methods fall short, this advanced technique provides manufacturers with the assurance required to protect product quality, ensure patient safety, and maintain regulatory compliance reinforcing trust in every dose delivered. Its adoption reflects a forward-thinking approach to quality assurance in an increasingly demanding pharmaceutical landscape.

As pharmaceutical and biologic products such as mRNA vaccines, cell therapies, and other biologics become more temperature-sensitive, the need for ultra-cold storage conditions (as low as -80°C or below) is growing rapidly. These extreme environments place significant stress not only on packaging systems but also on the methods used to verify Container Closure Integrity (CCI).

Traditional leak testing methods often fall short under cryogenic conditions. Materials may contract, seals can become brittle, and closures once deemed secure may form micro-leaks that go undetected. This is where helium leak detection offers a unique and powerful advantage.

Key Considerations for Helium Leak Detection in Cryogenic Applications

• Helium's Behavior at Ultra-Low Temperatures

Cryogenic storage often leads to sub-micron leaks that are undetectable by traditional methods. Helium’s small atomic size and low viscosity allow it to penetrate even the tiniest flaws in packaging seals or material interfaces.

Helium leak detection systems can measure leak rates as low as 10?¹¹ to 10?¹² mbar·L/s, offering the deterministic and quantitative results needed for high-risk, sterile pharmaceutical products. This level of precision is essential in cold chain logistics, where even minor integrity breaches can lead to microbial ingress or product degradation.

• Compatibility with Cold-Stored Packaging Materials

Packaging materials behave differently at ultra-low temperatures they may shrink, fracture, or become brittle. Some leak detection methods can interact negatively with these materials, distorting results or causing damage. Helium, however, is an inert, non-reactive gas that does not alter the physical or chemical properties of the packaging during testing. Its non-invasive nature ensures accurate leak detection without compromising the integrity of the primary container even in the harshest cryogenic conditions.

• Fast Detection and Clean Testing Environment

Time and cleanliness are critical in pharmaceutical production. Helium’s rapid diffusion rate allows for fast test cycles, helping maintain productivity even when handling frozen or temperature-sensitive products. Additionally, because helium is non-toxic, odorless, and leaves no residue, it supports a clean testing environment, avoiding contamination risks especially important when dealing with sterile drug products or sensitive biologics.

• Ensuring CCI in Cryogenic Environments with Helium

Leak behavior changes significantly under cryogenic stress, where extreme cold can cause materials to contract, seals to become brittle, and closures that were previously secure to develop micro-gaps. These subtle shifts can compromise Container Closure Integrity (CCI) even in packaging that performs well at room temperature. These micro-leaks can compromise Container Closure Integrity (CCI), allowing moisture, oxygen, or microbes to enter the container, or enabling valuable vapor or active pharmaceutical ingredients to escape. Such breaches not only threaten product efficacy but also pose serious safety risks and potential regulatory non-compliance.

These capabilities make helium leak detection ideal for testing cold chain packaging components, including:

• Vials
• Cartridges
• Pre-filled syringes
• Cryogenic storage containers

With helium’s unmatched ability to detect the smallest breaches, manufacturers can be confident that CCI is maintained even under extreme cold chain conditions.

In conclusion, helium leak testing is the gold standard for ensuring container integrity in ultra-cold storage applications. Helium’s unique properties stability at low temperatures, microscopic detection capability, inertness, and clean test behavior make it the most effective and reliable tracer gas for cryogenic testing. By selecting a helium-based system designed for ultra-cold applications, manufacturers can confidently protect product quality, meet strict regulatory standards, and ensure patient safety across the supply chain.

In the pharmaceutical industry, packaging integrity is a fundamental aspect of ensuring drug safety, efficacy, and regulatory compliance. New packaging formats are constantly being developed to address challenges such as improving product stability, ease of use, and sustainability. However, any compromise in the packaging barrier, no matter how small, can lead to contamination, loss of sterility, or reduced shelf-life issues. These issues carry significant consequences for patient health, manufacturer liability, and brand reputation. Validating packaging integrity during product development is therefore critical.

Helium leak detection is among the most sensitive and accurate methods available to detect extremely small leaks in packaging systems. Its application early in the product lifecycle provides valuable insights that help pharmaceutical developers optimize packaging designs, ensuring robust container closure integrity (CCI) before the product is commercialized.

The Role of Helium Leak Detection in Early-Stage Testing

Packaging for sterile pharmaceuticals, such as parenteral drugs, biologics, and injectables, must maintain a perfect barrier against environmental contaminants throughout the product’s shelf life. Traditional leak detection methods often lack the sensitivity required to identify micro-leaks that can compromise this barrier.

Helium leak detection overcomes this limitation through its use of helium gas, which has unique physical properties: it is inert, non-toxic, and has the smallest atomic size among gases. This allows helium atoms to pass through microscopic openings that other gases cannot. During testing, the new packaging format is filled with helium gas or exposed to it externally and then placed into a vacuum chamber connected to a mass spectrometer.

The vacuum environment inside the chamber causes any helium escaping through leaks to be detected at exceptionally low concentrations. The mass spectrometer precisely measures the amount of helium that escapes, quantifying the leak rate in units as small as 10^-10 mbar·L/s. This quantitative data allows manufacturers to identify even the smallest defects in seals, closures, or materials that could pose a risk.

Testing can also be conducted under various simulated conditions such as temperature fluctuations, mechanical stress, or after transportation simulation to evaluate how the packaging will perform in real-world scenarios. This early detection of potential failure modes allows product developers to modify design parameters, materials, or manufacturing processes to enhance overall package integrity.

Ensuring Compliance Before Commercialization

Regulatory agencies worldwide, including the FDA, EMA, and ICH, have increasingly emphasized the importance of scientifically sound, quantitative testing methods for packaging integrity. Container Closure Integrity Testing (CCIT) guidelines like USP <1207> highlight leak testing as a critical requirement for sterile pharmaceutical products.

Helium leak detection is often considered the benchmark method due to its sensitivity and ability to provide clear, numerical leak rates that can be benchmarked against acceptance criteria. This helps manufacturers demonstrate to regulators that their new packaging formats consistently meet or exceed safety thresholds.

By incorporating helium leak testing into the product development and validation process, pharmaceutical companies can:

• Mitigate risk: Identify and correct packaging flaws before commercial production, reducing the chance of product recalls or contamination events.
• Strengthen regulatory submissions: Provide robust, quantitative data supporting packaging claims that align with evolving regulatory expectations.
• Enhance quality control: Develop acceptance criteria and quality checks that ensure ongoing packaging integrity throughout production and distribution.
• Optimize design: Use early-stage test results to refine materials, closure systems, and manufacturing parameters to improve performance.

Validating new pharmaceutical packaging formats using helium leak detection is a crucial step in ensuring product safety and regulatory compliance. Its exceptional sensitivity to microscopic leaks allows manufacturers to uncover and address potential packaging failures early in the product lifecycle. By integrating helium leak testing into development workflows, pharmaceutical companies can optimize packaging design, meet stringent regulatory requirements, and ultimately deliver safer, more reliable sterile products to market.

In the pharmaceutical industry, product recalls are more than just a financial burden; they carry serious consequences for patient safety, brand credibility, and regulatory standing. A large percentage of recalls can be traced back to packaging failures that compromise Container Closure Integrity (CCI). When the packaging of sterile drug products fails, even at a microscopic level, it can lead to contamination, loss of sterility, and reduced drug efficacy.

This risk is especially critical for parenteral drugs, biologics, and sterile injectables, where maintaining a sterile barrier is essential. To minimize such risks and meet evolving regulatory expectations, pharmaceutical manufacturers must adopt more precise and reliable quality assurance technologies. Among the most advanced and effective of these is PTI’s Helium Leak Testing equipment and services. Helium is a highly sensitive method for ensuring package integrity.

Why Traditional CCI Testing Methods Fall Short in Preventing Recalls

Traditional testing methods such as dye ingress, bubble tests, and microbial immersion have been widely used for CCI testing. However, their limitations leave gaps in detection that can allow compromised units to pass inspection.

• Low Sensitivity Leads to Missed Defects: Traditional methods often cannot detect leaks below 10–20 microns, small enough to allow microbial ingress but too small to be seen by dye tests.
• Inconsistent, Subjective Results Increase Risk: Manual methods depend on human judgment, leading to variability and missed leaks, especially in high-throughput environments.
• Lack of Quantitative Data Weakens Quality Assurance: Without measurable leak rates, it’s difficult to establish compliance or justify batch release decisions during audits.

Helium Leak Testing Enables Early Detection and Prevents Market Failures

PTI’s Helium Leak Detection systems offer unmatched precision by detecting submicron leaks that traditional methods miss. This is vital in sterile product manufacturing, where even the smallest breach can lead to a recall.

How the Technology Works:

• The container is filled with or exposed to helium gas.
• It is placed in a vacuum chamber.
• If there’s a leak, helium escapes and is measured by a mass spectrometer.
• The leak rate is calculated and compared to acceptance criteria.

Product recalls in the pharmaceutical industry are often the result of packaging failures that compromise container closure integrity. As regulatory expectations rise and drug products become more sensitive, the need for highly accurate, reliable, and reproducible testing methods becomes critical. Helium Leak Testing stands out as a proven, data-driven solution that enables manufacturers to detect microleaks early, ensure product sterility, and prevent defective units from reaching the market.

As the demand for biologic drugs continues to grow, so does the need for robust container closure integrity solutions. These high-value, sensitive products require the highest assurance of package integrity to ensure patient safety and therapeutic efficacy. Even microscopic leaks in a container closure system can compromise sterility, leading to product degradation or contamination.

PTI’s helium leak detection method offers a highly sensitive and reliable solution for detecting leaks in pharmaceutical packaging, especially for biologic drug products. This advanced approach plays a crucial role in enhancing pharmaceutical leak detection standards and ensuring that every dose delivered to the patient is safe and effective.

Limitations of Traditional Leak Testing Methods

Conventional leak testing technologies, such as dye ingress or visual inspection have long been used for integrity testing. While these methods are accessible and straightforward, they come with critical limitations, particularly when testing complex or high-risk drug products.

• Limited Sensitivity: Traditional methods often lack the sensitivity needed to detect tiny leaks that could still allow microbial ingress.
• Subjectivity: Visual-based tests, such as dye ingress, can lead to inconsistent results due to human interpretation.
• Incompatibility with Certain Formats: Some test methods may not be suitable for testing modern container systems such as pre-filled syringes or flexible packaging.
• Slower Throughput: Testing time and lack of repeatability can hinder efficiency, especially in high-volume manufacturing settings.

Helium Leak Detection for Biologic Drugs

PTI's helium leak testing technology addresses the shortcomings of traditional methods by offering a more precise and science-driven approach to pharmaceutical leak detection.

Helium, an inert gas with extremely small molecules, is used as a tracer to detect the smallest of leaks with unmatched accuracy. In PTI’s systems, the test sample is filled with helium and placed in a vacuum chamber. Any helium escaping through leaks is quantitatively measured using a mass spectrometer.

Key Benefits of PTI’s Helium Leak Testing Approach:

• High Sensitivity: Capable of detecting leak rates as low as 1 x 10?¹° mbar·L/s, far exceeding the detection limits of traditional methods.
• Quantitative Results: Provides measurable and reproducible data rather than subjective pass/fail outcomes.
• Versatility: Suitable for a wide range of container types, including vials, syringes, and flexible formats used for biologic products.
• Regulatory Alignment: Aligns with current FDA and USP expectations for deterministic leak testing approaches.

The rise of biologic drugs demands a new standard in container closure integrity testing. Relying on traditional leak detection methods may no longer be sufficient to ensure product safety and regulatory compliance. PTI’s helium leak testing offers a highly sensitive and accurate solution tailored to the unique requirements of biologics, reinforcing confidence in product quality and patient safety.

With a proven track record in pharmaceutical leak detection, PTI continues to lead the way in container integrity assurance, bringing science, precision, and reliability to the forefront of pharmaceutical manufacturing.

In the medical device and pharmaceutical packaging industries, maintaining product integrity isn't just about quality; it's about patient safety, regulatory compliance, and preserving therapeutic efficacy. Even the smallest micro-leak in a sterile barrier system or drug container closure can lead to contamination, reduced shelf life, or failed audits. That’s why manufacturers turn to PTI’s Helium Leak Detection solutions to ensure the highest standards of leak detection accuracy and control.

Helium leak testing offers a level of sensitivity far beyond traditional methods such as bubble testing, or dye ingress. It enables precise, quantitative measurements of leak rates, ensuring early detection of defects that may not be visible or detectable through other means. This level of performance is essential in meeting stringent global regulations and avoiding costly recalls or patient risk. As the demand for high-performance packaging increases, helium leak testing has become a critical tool in proactive quality assurance programs across the industry.

How Helium Leak Testing Works

PTI’s helium leak detection systems capitalize on the unique properties of helium, its inertness and exceptionally small atomic size which enable it to penetrate leaks that other gases simply cannot detect. This makes helium an ideal tracer gas for identifying even the most minute breaches in packaging integrity. The testing process typically involves introducing helium either inside the test article or around its exterior surface, depending on the chosen methodology. Once helium is introduced, a highly sensitive mass spectrometer, precisely tuned to detect helium atoms, monitors the surrounding environment for any escaped gas, signalling the presence of a leak.

These detection instruments are engineered for exceptional sensitivity and operational stability, capable of measuring leaks at incredibly low rates, often expressed in units as minute as mbar·L/s. This precision allows for reliable differentiation between acceptable and defective seals, ensuring consistent quality control. Moreover, helium’s chemical inertness ensures that it does not react with or degrade the materials being tested, preserving product integrity during the evaluation process.

PTI’s expert team works closely with clients to carefully assess each application and recommend the optimal helium leak detection configuration tailored to the product’s design, materials, and lifecycle stage. This ensures that testing is not only highly accurate but also compatible with production requirements and regulatory standards.

Implementing Helium Leak Testing in Quality Assurance

Integrating helium leak testing into your quality assurance workflow requires a structured approach. Begin by clearly defining acceptable leak thresholds based on regulatory requirements and product specifications. Collaborate with engineering and quality teams to ensure alignment on performance standards. Next, select the appropriate detection equipment and ensure regular calibration and maintenance. Precision is critical, so even minor drift in detector sensitivity can lead to incorrect pass/fail results.

Training is another critical component. Quality Assurance personnel should be familiar with both the theory and practice of helium leak testing. Hands-on experience with the equipment, combined with an understanding of common failure modes, will lead to more consistent and accurate results. Finally, identify where helium leak testing fits best in your workflow, whether at the end of assembly, during intermediate checks, or in pilot production stages.

Benefits of Helium Leak Testing

• High Sensitivity: Detects leaks as small as 10?¹² mbar·l/s
• Faster Detection: Reduces testing time with accurate localization
• Regulatory Compliance: Meets standards in critical industries (e.g., FDA, ISO)
• Improved Product Reliability: Minimizes field failures and recalls

Helium leak testing is a powerful quality assurance tool, especially when implemented with PTI’s advanced systems. From choosing the right method to training personnel and ensuring regulatory compliance, PTI offers end-to-end support for reliable leak detection in high-stakes environments.

By leveraging PTI’s helium leak detection solutions, your organization can achieve unmatched product integrity, process control, and customer confidence. Whether you're developing next-gen medical devices or mission-critical aerospace components, PTI helps you set a new standard in quality.

Helium leak testing services are precision methods used in the pharmaceutical and medical device industries to detect even the smallest leaks in packaging. Using helium as a tracer gas, this technique ensures sterile barriers remain intact, which is critical for patient safety and product efficacy. It is especially valuable for testing sealed containers like vials, blister packs, and pre-filled syringes. By verifying seal integrity, helium leak testing supports regulatory compliance with strict industry standards. This process helps manufacturers reduce the risk of contamination, product recalls, and compromised shelf life.

What Helium Leak Testing Services Include?

PTI's Helium Leak Testing Services offer comprehensive solutions for ensuring the integrity of pharmaceutical and medical device packaging. Our services encompass a range of offerings to support clients in maintaining high-quality standards and regulatory compliance.

• System Installation & Qualification: This includes installation, operational, and performance qualification (IQ/OQ/PQ) to meet strict regulatory standards.
• Method Development & Feasibility Testing: Offers lab-scale studies or on-site validation to develop compliant and effective test methods before full implementation.
• Onsite or In-House Testing: Flexible testing options at client facilities or PTI’s Centres of Excellence, including capabilities for cold storage testing.
• Training & Support Services: Comprehensive on-site training and service contracts for ongoing maintenance, calibration, and repairs.
• Regulatory Compliance & Accuracy: Deterministic testing method aligned with USP <1207>, delivering precise, reliable results that eliminate subjectivity and support compliance.

Benefits of Helium Leak Testing in Packaging

Helium-based testing is an advanced solution for ensuring container closure integrity (CCI) in pharmaceutical packaging. By using helium, a small, inert, and non-toxic gas, as a tracer, this method delivers unmatched sensitivity and precision in leak detection.

Key Benefits:

• Unmatched Sensitivity: Helium leak detection can detect extremely small leaks (down to 1×10¹° mbar·L/sec), far beyond the capabilities of traditional methods. This makes it ideal for critical pharmaceutical applications where even microscopic breaches matter.
• Quantitative, Reliable Data: The method provides measurable leak rates, enabling not just pass/fail results but also in-depth comparisons across package types, materials, production lines, and storage conditions.
• Fast and Efficient Testing: Most helium test cycles are under 1 minute, with some as short as 30 seconds, supporting rapid testing, even on 100% of production units.
• Supports Regulatory Compliance: With growing regulatory emphasis on deterministic CCI testing, helium leak detection aligns perfectly with modern standards, helping eliminate reliance on traditional sterility tests and ensuring robust contamination prevention.

Helium leak testing services play a vital role in modernizing pharmaceutical and medical device packaging processes. They provide manufacturers with advanced tools to proactively ensure product safety and quality. With its precision and adaptability, helium testing supports both innovation and risk mitigation across packaging lines. As the industry moves toward more deterministic and data-driven quality control, helium leak detection stands out as a trusted and future-ready solution.

Ensuring the sterility and integrity of injectable drug products has always been a critical requirement in pharmaceutical manufacturing. As regulatory standards evolve, companies must continuously reassess their quality control strategies to keep pace. One such change is the upcoming implementation of USP <382>, a chapter focused on evaluating the functional performance of elastomeric closures used in injectable pharmaceutical packaging.

Slated to take effect on December 1, 2025, USP <382> places increased emphasis on deterministic, science-based testing approaches. Among the various technologies available, Helium Leak Detection (HLD) is gaining traction for its precision and sensitivity in assessing container closure integrity (CCI). This blog explores how HLD can help manufacturers meet the new regulatory expectations under USP <382> while reinforcing a proactive quality assurance framework.

Understanding USP <382>: What’s Changing?

USP <382>, officially titled “Elastomeric Closure Functionality in Injectable Pharmaceutical Packaging/Delivery Systems,” is designed to supplement existing requirements around parenteral container systems. While USP <1207> remains the cornerstone for CCI testing, <382> zooms in on the performance of elastomeric components—particularly their ability to maintain closure integrity across a product’s shelf life.

Key focus areas include:

• Functional testing of closure systems
• Suitability and robustness of elastomers under various stress conditions
• Encouragement of deterministic testing methods for closure integrity

Simply put, the chapter is aimed at ensuring that elastomeric closures reliably protect the drug product from microbial ingress or leakage—throughout storage, handling, and administration.

The Role of Helium Leak Detection

Helium Leak Detection is a deterministic test method that utilizes helium as a tracer gas to identify leaks in a sealed container system. Leveraging mass spectrometry, the technique can detect extremely small quantities of helium escaping through microscopic breaches, offering quantifiable, reproducible results that are difficult to achieve with traditional probabilistic methods.

Why HLD Stands Out:

• Ultra-high sensitivity — capable of detecting leaks as small as 1 x 10?¹° mbar·L/s
• Objective and repeatable results — ideal for batch comparisons and statistical evaluations
• Supports validation and process control — with numerical leak rate data for trend monitoring

In the context of USP <382>, these attributes align perfectly with the chapter’s push for more rigorous, functional integrity testing.

Bridging USP <382> Expectations with HLD

• Meeting Functional Integrity Requirements

At its core, USP <382> asks manufacturers to demonstrate that closures maintain integrity under real-world conditions—such as aging, thermal stress, and physical transport. Helium Leak Detection allows for a direct assessment of the seal quality by detecting minute channel leaks or closure failures that might otherwise go unnoticed.

For elastomeric components, this kind of sensitivity is essential. These materials may experience subtle changes in elasticity or sealing behavior over time, which HLD can readily detect.

• Deterministic vs Probabilistic: Regulatory Preference

While methods like dye ingress or microbial challenge have long been used for CCI, they fall short in terms of quantifiability and reproducibility. Helium Leak Testing, on the other hand, is deterministic—producing consistent, scientific measurements rather than subjective pass/fail outcomes.

This determinism is not just preferred—it’s increasingly expected. Both the FDA and EMA have shown growing support for deterministic methods as part of a risk-based approach to product quality. By implementing HLD, companies position themselves to meet both USP <382> and broader global regulatory expectations.

• Quantitative Analysis and Leak Rate Thresholds

Unlike older methods that rely on visual inspection, HLD provides a numerical value for the leak rate. This allows manufacturers to:

• Define acceptance criteria based on leak rate thresholds
• Establish control limits during stability testing
• Perform trend analysis across production lots

These capabilities are especially valuable when developing or validating closure systems for new drug products, where precise data can support sound decision-making.

USP <382> represents a critical step forward in pharmaceutical packaging integrity standards. It challenges manufacturers to go beyond tradition and adopt rigorous, functional testing approaches to safeguard injectable drug products. Helium Leak Detection offers a proven, scientifically robust method to meet these demands—delivering the precision, reproducibility, and sensitivity that regulators now expect.As the compliance deadline approaches, investing in a deterministic, helium-based CCI testing strategy isn’t just advisable—it’s becoming essential.

Helium leak testing is considered the gold standard for detecting micro leaks in packaging due to its unmatched reliability and sensitivity. It is essential in ensuring the safety, quality, and longevity of packaged products across various industries. This method is trusted by regulatory bodies and manufacturers alike for meeting strict quality assurance standards. Its ability to consistently identify even the most minute leaks has set a benchmark for leak detection practices. As such, helium leak testing has become an integral part of modern packaging validation and integrity testing protocols. Its widespread adoption reflects the growing demand for precision in quality control. Ultimately, it helps protect consumer health, maintain brand reputation, and ensure compliance with regulatory requirements.

Importance of Micro-Leak Detection for Container Integrity

Micro-leak detection helps ensure the integrity of containers used in packaging, especially in industries like pharmaceuticals and medical devices. Even the smallest leaks can compromise product sterility, safety, and effectiveness. Detecting micro-leaks prevents contamination from external elements such as moisture, oxygen, or bacteria. This is particularly important for products sensitive to environmental changes or those that require a sterile barrier. Maintaining container integrity also supports regulatory compliance and helps avoid costly recalls or product failures. Early detection of leaks during production promotes consistent quality assurance and minimizes the risk of damage during storage and transport. Ultimately, micro-leak detection strengthens both product protection and user safety.

Technology Overview

Helium leak testing is a method used to detect leaks in various enclosed or sealed systems by employing helium as a tracer gas. These systems can include a wide range of packaging formats, such as vials, syringes, cartridges, foil blister cards, bottles, and foil pouches or sachets, where helium can be introduced before or during the leak test cycle. This technique relies on a highly sensitive mass spectrometer detector to precisely assess the integrity of each sealed package or system.

Helium leak detection provides reliable assurance of the integrity and safety of sealed systems across a wide range of industries. Its exceptional sensitivity and accuracy make it indispensable for identifying even the smallest leaks in critical applications such as pharmaceuticals and medical device. By utilizing helium as a tracer gas, manufacturers can uphold strict quality control measures and comply with regulatory standards. This technology’s ability to deliver consistent and reliable results helps prevent contamination, enhance product safety, and optimize manufacturing efficiency. As industries continue to advance, helium leak detection will remain a trusted and essential solution for maintaining the highest standards of quality and safety.

In conclusion, helium leak testing has rightfully earned its place as the gold standard for detecting microleaks in packaging due to its unmatched sensitivity, reliability, and consistency. It is essential for safeguarding product integrity, ensuring consumer safety, and meeting stringent regulatory requirements across various industries. By enabling early detection of even the smallest leaks, this method helps prevent contamination, reduce recalls, and maintain brand trust. Its proven effectiveness and adaptability make it an indispensable tool in modern quality assurance processes. As the demand for higher standards in packaging continues to grow, helium leak testing will remain a critical component in ensuring product safety and performance.

Container Closure Integrity (CCI) testing is used to verify that medical device packaging maintains a consistent barrier against external contaminants over time. This process helps determine whether the seal and structure of a package can effectively prevent the ingress of moisture, oxygen, or microorganisms. In the context of medical device manufacturing, the packaging must not only preserve the device’s sterile condition but also maintain its functionality until it reaches the end user. CCI testing enhances quality control processes, offering manufacturers greater confidence that their packaging will hold up under real-world conditions. Among the various CCI testing methods available, helium leak detection is recognized for its exceptional sensitivity and consistent accuracy. This makes it particularly well-suited for high-risk devices, where even the smallest breach in packaging could lead to significant safety concerns.

Importance of Leak Detection

Effective leak detection in packaging safeguards the sterility and functionality of pharmaceutical containers and medical devices throughout their shelf life. It helps prevent contamination from external elements such as bacteria and moisture, which can compromise patient health. Early identification of leaks supports efficient quality control and minimizes the risk of defective products reaching the market. It also enables manufacturers to refine packaging materials and sealing processes for improved reliability. In high-risk applications like implants or surgical instruments, even minor packaging failures can lead to serious consequences, making leak detection a critical safeguard. Leak detection techniques help manufacturers identify such defects before products are released. This not only enhances product reliability but also supports a consistent standard of quality in production. By integrating helium leak testing into quality control protocols helps prevent situations that could lead to contamination, product recalls, or patient exposure to unsafe devices.

How does Helium Leak Detection work?

Helium leak detection works by using helium gas as a tracer to identify and quantify leaks in sealed packages or containers. The process begins by introducing helium into the test item, either by direct injection or placing it in a helium-rich environment. The test item is then placed in a vacuum chamber, where any helium escaping through potential leaks is drawn out. A highly sensitive mass spectrometer detects the escaping helium by measuring the partial pressure of the gas. Inside the spectrometer, the helium atoms are ionized, accelerated, and deflected by a magnetic field. The resulting ions generate an electric current that corresponds to the size of the leak. This current is amplified and displayed as a leak rate, allowing precise detection of even the smallest defects.

In conclusion, Helium leak detection is a highly effective method for ensuring container closure integrity in pharmaceutical and medical device packaging. Its sensitivity allows for the detection of even the smallest leaks that could compromise sterility. By identifying packaging flaws early, manufacturers can enhance product quality and reduce the risk of recalls. This method also supports compliance with strict regulatory requirements in the healthcare industry. Overall, helium leak detection contributes significantly to maintaining the quality and reliability of medical devices.

Optimizing leak detection for pharmaceutical packaging is crucial to ensuring product integrity and safety. Advanced leak detection technologies are used to identify any potential breaches in packaging that could compromise the sterility or potency of the product. These methods help detect even the most micron-size leaks, preventing contamination and ensuring compliance with strict industry regulations. Optimizing these processes involves improving sensitivity, reducing testing time, and integrating real-time data analysis to streamline operations. Pharmaceutical companies can reduce waste, improve quality control, and safeguard patient health by enhancing leak detection efficiency.

The Role of Helium in Leak Detection

Helium leak testing is a method used for Container Closure Integrity (CCI) testing to detect leaks in pharmaceutical and medical device packaging. This technique involves using helium and measuring the change in its concentration as it escapes due to leakage, commonly applied to packaging formats like vials, pre-filled syringes, foil pouches, and cold form blister cards. These packaging formats are designed to protect the contents from environmental contaminants while maintaining the sterility of the enclosed product.

The Seal Integrity Monitoring System (SIMS) 1915+ enhances this process by utilizing helium-based leak detection, offering highly sensitive and quantitative testing for a wide range of packaging systems. SIMS 1915+ surpasses traditional methods, such as vacuum bubble and dye penetration, with a sensitivity as low as 1 x 10^-10 mbar/L/sec, providing detailed data rather than simple pass/fail results. This system is ideal for testing pharmaceutical and parenteral products under both ambient and cryogenic storage conditions. Custom-built to meet client-specific standards, each SIMS 1915+ system is tailored to fit the unique packaging configurations and requirements of pharmaceutical manufacturers.

Benefits of the SIMS 1915+ System

• High Sensitivity: Detects even the tiniest leaks, ensuring product integrity.
• Quantitative Results: Provides precise leak rate measurements.
• Versatility: Applicable to a wide range of packaging formats.
• Regulatory Compliance: Adheres to strict industry standards and regulations.
• Cost-Effective: Long-term savings by preventing product recalls and quality issues.

In conclusion, optimizing leak detection for pharmaceutical packaging is critical to ensuring the integrity and safety of medical products. The SIMS 1915+ helium-based leak detection system stands out for its high sensitivity, enabling the detection of even the smallest leaks. By providing accurate, quantitative leak rate measurements, it ensures compliance with industry regulations and enhances overall quality control. Its versatility across various packaging formats and cost-effectiveness further contribute to preventing potential product recalls and quality issues. Ultimately, improving leak detection processes strengthens both operational efficiency and patient safety in the pharmaceutical sector.

Detecting microleaks with high precision is crucial in many industries, where even the smallest breach can compromise safety and quality. Achieving unmatched sensitivity in leak detection requires advanced methods that can identify leaks invisible to traditional techniques. This blog explores how helium leak detection technology achieves such high levels of sensitivity and why they are essential for ensuring package integrity. The ability to detect even the most minute leaks is vital for maintaining product safety, especially in industries like pharmaceuticals, where packaging integrity is directly tied to patient health. Helium leak detection provides a rapid and reliable solution, enabling real-time results that help manufacturers identify issues before they escalate. This technology is particularly effective for ensuring airtight seals in sensitive packaging, such as vials, syringes, and medical devices.

What Makes Helium Leak Testing Ideal for Detecting Microleaks?

Helium leak testing is ideal for detecting micro leaks due to its sensitivity and precision. The small atomic size of helium allows it to pass through even the tiniest openings that other gases cannot, making it perfect for identifying micro leaks that would otherwise go unnoticed. Additionally, helium's inert and non-reactive properties ensure that it won’t interfere with the system being tested, providing a reliable means of detection.

The use of a mass spectrometer in helium leak detector enhances their accuracy by isolating and measuring only helium ions, ensuring that even the smallest amounts of helium are detected. This combination of high sensitivity, non-reactivity, and the ability to detect even the most minute leaks makes helium leak testing the preferred choice for applications that require the highest level of leak detection, such as in the pharma and medical industries. The precision of helium leak testing also enables manufacturers to meet stringent regulatory standards by ensuring that their products maintain the integrity required for safety and performance. This testing method allows evaluation, ensuring that products can be tested without compromising their functionality or quality. This process is especially valuable in industries where maintaining a sterile or sealed environment is essential, such as in pharmaceutical packaging or medical devices.

Why is Helium Gas Ideal for Leak Testing in Packaging?

• Non-toxic, inert, non-condensable, present in the atmosphere in trace amounts.
• Helium gas is one of the smallest molecules to consistently and rapidly break the pathway.
• Helium is non-flammable, widely available, and inexpensive.
• Since it is an inert gas and does not interact with the testing component, it is, therefore, safe to use.

In conclusion, detecting micro leaks is essential for ensuring the integrity and safety of critical systems across various industries. Helium leak testing stands out as the most effective method due to its unmatched sensitivity, allowing it to detect even the smallest breaches that other methods may miss. This level of precision is crucial in industries where safety and quality are non-negotiable, such as pharmaceuticals, biologics, medical devices, and other industrial applications. By detecting micro leaks that could compromise product performance or safety, helium leak testing helps prevent costly recalls, regulatory violations, or catastrophic failures. Additionally, this method enables manufacturers to ensure compliance with industry standards, providing peace of mind to both companies and consumers.

Ensuring package integrity in pharmaceuticals and life sciences is crucial for maintaining the safety, efficacy, and sterility of products. Packaging must provide a secure barrier against contamination, environmental factors, and physical damage. Advanced testing methods, such as helium leak detection, is used to identify any defects or leaks in packaging that could compromise the product. Regulatory standards require stringent testing to ensure that pharmaceutical and life science products meet quality and safety guidelines. By maintaining package integrity, manufacturers can ensure that their products remain effective, safe, and compliant with industry regulations.

Package Integrity Testing with PTI's SIMS 1915+

The Seal Integrity Monitoring System (SIMS) 1915+ is an advanced helium-based leak detection solution designed to ensure the integrity of pharmaceutical and medical device packaging. By utilizing helium as a tracer gas, the system provides highly sensitive and quantitative leak detection, offering accuracy far beyond traditional methods like vacuum bubble and dye penetration testing. It is particularly effective for testing a wide range of pharmaceutical products, including vials, syringes, cartridges, and blister cards, ensuring the sterility and safety of these sensitive items.

The SIMS 1915+ offers a remarkable sensitivity of 1 x 10-10 mbar/L/sec, generating detailed data sets that provide a deeper understanding of the package’s integrity. Custom-built to meet specific client requirements, it ensures reliable performance under both ambient and cryogenic conditions, making it an ideal solution for life sciences packaging testing.

Advantages of using SIMS 1915+

• Cold Temp Testing: Accurate leak detection down to -160°C.
• Enhanced Integrity: Identifies leaks not visible at room temperature.
• Improved Quality & Safety: Ensures product integrity at storage temperatures.
• Versatility: Customizable to meet specific needs.
• High Sensitivity: Detects even the smallest leaks.
• 21 CFR Part 11 Data Integrity Software - ETHOS

SIMS 1915+ Options

• Low-Temperature Add-on Systems LT80, LT85 and LT150 for ultra-cold CCI testing utilizing helium leak detection methods.
• Various sizes of Vacuum Test Fixtures to accommodate all package types and sizes.
• Helium leak testing for non-vacuum chamber applications with custom test fixtures.
• External helium leak standards in a variety of leak rate ranges.
• Helium Sniffer Probe - for determining leak sites on a site-by-site basis.
• Vacuum clamps, O-ring seals, chamber gaskets, and other components.

In conclusion, the PTI SIMS 1915+ Helium Leak Detector is a crucial tool in ensuring the integrity and safety of pharmaceutical and life sciences packaging. Its ability to detect even the smallest leaks, including under cryogenic conditions, ensures that sensitive products remain sterile and effective. Ultimately, the SIMS 1915+ provides reliable performance, contributing to the overall safety and compliance of life sciences products

Pre-filled syringes are often used for injectable medications, where the integrity of the container is directly tied to patient safety and product effectiveness. Any breach in the syringe's closure can lead to contamination, dose variability, or reduced stability of the drug. Additionally, the complexity of evaluating Container Closure Integrity in pre-filled syringes involves considerations such as material interactions, sealing mechanisms, and storage conditions. As a result, rigorous testing is necessary to ensure the sterility, potency, and safety of the medication throughout its shelf life and use.

Importance of Evaluation of Pre-filled Syringes

• Pre-filled syringes must remain sterile to prevent contamination and adverse reactions.
• Evaluation ensures pre-filled syringes deliver the correct, consistent dose without leaks or inconsistencies.
• Evaluations ensure the drug's stability is preserved, preventing interaction with packaging or environmental factors.
• Leak detection and CCI testing ensure the syringe seal remains intact, preventing contamination or loss of potency.
• Rigorous testing helps reduce the risk of defects, ensuring syringes are safe for patient use.
• Regular evaluations ensure pre-filled syringes maintain integrity and efficacy throughout their shelf life.

To guarantee the safety, effectiveness, and reliability of pre-filled syringes, comprehensive evaluation is essential. Among the various testing methods, , helium leak testing stands out as a highly precise technique for assessing container closure integrity.

Helium Leak Testing for Pre-filled Syringe Package Integrity

Helium leak testing is a highly effective method for detecting leaks in sealed systems by using helium as a "tracer" gas. In this process, the package is filled with helium and subjected to a vacuum, and the amount of escaping helium is measured with a helium leak detector, providing a precise leak rate. This technique is not only crucial for container closure integrity (CCI) testing but also plays a significant role in product design, quality analysis, failure analysis, and validation. When it comes to pre-filled syringes, the testing becomes more complex due to the additional consideration of plunger movement during transit and handling. These complexities make CCI evaluations of pre-filled syringes even more critical, ensuring total system integrity and preventing contamination or loss of product efficacy.

In conclusion, Container Closure Integrity (CCI) evaluations of pre-filled syringes are essential to ensure the sterility, safety, and effectiveness of injectable medications. Given the complexity of syringe design, material interactions, and storage conditions, rigorous testing methods like helium leak testing are necessary to detect potential leaks and maintain product integrity. The evaluation process helps mitigate risks such as contamination, dose inconsistencies, and reduced drug stability. Ultimately, consistent and thorough testing ensures that pre-filled syringes provide safe, reliable, and effective delivery of medications to patients.

Ensuring product safety and integrity is crucial in the pharmaceutical and medical packaging sectors. With its advanced testing capabilities that ensure packaging reliability throughout its lifecycle, the PTI SIMS 1915+ system is transforming package design and quality assurance. This technology assists healthcare organizations in optimizing their package designs to secure delicate products and adhere to strict regulatory standards.

The SIMS 1915+'s accuracy and adaptability are essential in reducing the risks such as contamination or product deterioration. The SIMS 1915+ is establishing new benchmarks for packaging innovation and quality control as the industry continues to place a high priority on patient safety and operational effectiveness.

Helium Leak Testing using SIMS 1915+

The Seal Integrity Monitoring System (SIMS) 1915+ is a helium based leak detection method that has proven highly effective for various pharmaceutical and medical device packaging systems. By utilizing helium as the tracer gas, this method allows for precise quantitative testing, surpassing the capabilities of traditional vacuum bubble and dye penetration tests. It is suitable for a wide range of pharmaceutical and parenteral products, including vials, syringes, cartridges, and blister cards.

The SIMS 1915+ offers sensitivity as low as 1 x 10^-10 mbar/L/sec, providing detailed data sets rather than simple pass/fail results and enabling testing at both ambient and cryogenic temperatures. Each SIMS 1915+ unit is custom designed to meet specific client requirements and packaging configurations. PTI specializes in engineering custom test fixtures tailored to the exact component being tested, ensuring precision and accuracy to support your study objectives, package configurations, and quality monitoring needs. 

Benefits of SIMS 1915+

• The package to be tested, such as an IV bag, is placed in a sealed test chamber.
• Quantitative Leak Detection: Provides precise leak rate measurement for better quality control and analysis.
• Versatile and Comprehensive: Suitable for a wide range of packaging formats, including bottles, syringes, vials, and blister cards.
• Customization for Specific Needs: Tailored to customer specifications for packaging types and production environments. 
• Enhanced Regulatory Compliance: Provides verifiable evidence of packaging integrity, ensuring compliance with industry regulations. 
• Data integrity – ETHOS 21 CFR PART 11 compliant software.

SIMS 1915+ Options:

• Low-Temperature Add-on Systems LT80 and LT150 for ultra-cold CCI testing using helium leak detection methods. 
• A range of Vacuum Test Fixtures available to suit different package sizes and types.
• Helium leak testing for non-vacuum chamber applications, with custom test fixtures available.
• External helium leak standards offered in various leak rate ranges. 
• Helium Sniffer Probe to detect leak sites individually.
• Vacuum clamps, O-ring seals, chamber gaskets, and other essential components. 

The PTI SIMS 1915+ represents a significant advancement in packaging integrity testing, offering unparalleled sensitivity and precision for critical industries. Its adaptability and customizability ensure it can meet the diverse needs of modern packaging, ultimately enhancing product safety and reliability. Consequently, the SIMS 1915+ is instrumental in establishing new standards for packaging innovation and assurance, driving progress in maintaining the highest levels of product integrity.

Helium leak detection is a highly reliable and sensitive method used across various industries, particularly in pharmaceutical, biologics and medical device applications. This technique is widely recognized for its ability to detect even the smallest leaks, ensuring the integrity of packaging systems. Helium, being an inert and non-toxic gas with a small atomic size, can easily penetrate micro-channels, making it ideal for leak testing. It is extensively used in quality control for glass vials, pre-filled syringes, bottles, blister packs, foil pouches, and combination products. The method provides precise and consistent results, enabling manufacturers to meet stringent regulatory requirements. By implementing helium leak detection, companies can ensure product safety, prevent contamination, and maintain high-quality standards.

Applications of Helium leak detection

• Pharmaceutical & Biologics: Ensures the packaging integrity of vials, syringes, bottles, blister packs, and foil pouches while detecting leaks in multi-chamber combination products and preventing contamination of sterile drugs and biopharmaceuticals.
• Medical Device Industry: Verifies the integrity of implantable devices, catheters, and diagnostic equipment while ensuring life-saving devices remain sealed and function properly.

Technology Overview

Helium leak testing is a method used to detect leaks in various enclosed or sealed systems by employing helium as a tracer gas. These systems can include a wide range of packaging formats, such as vials, syringes, cartridges, foil blister cards, bottles, tubes, and foil pouches or sachets, where helium can be introduced before or during the leak test cycle. This technique relies on a highly sensitive mass spectrometer detector to precisely assess the integrity of each sealed package or system.

Helium leak detection plays a vital role in ensuring the integrity and safety of sealed systems across multiple industries. Its exceptional sensitivity and accuracy make it indispensable for identifying even the smallest leaks in critical applications such as pharmaceuticals and medical device. By utilizing helium as a tracer gas, manufacturers can uphold strict quality control measures and comply with regulatory standards. This technology’s ability to deliver consistent and reliable results helps prevent contamination, enhance product safety, and optimize manufacturing efficiency. As industries continue to advance, helium leak detection will remain a trusted and essential solution for maintaining the highest standards of quality and safety.

The pharmaceutical industry depends on deep cold storage for delicate drug and biologic formulations, but traditional packaging may not withstand extreme temperatures, leading to potential leaks and degradation. PTI’s LT add-on units for SIMS helium leak detectors offer an innovative solution by evaluating package integrity at temperatures ranging from 0°C to -160°C. This advanced technology helps manufacturers identify defects and optimize packaging designs, ensuring superior performance under deep cold storage conditions.

LT Low Temperature Systems for SIMS Helium Leak Detectors

PTI’s SIMS 1915+ LT add-on units combine advanced helium leak detection with precise temperature conditioning to provide an effective solution for cold temperature leak detection. These systems are designed to test packages at ultra-low temperatures, ranging from 0°C to -160°C, ensuring package integrity is maintained in deep cold storage environments. Integrating a chiller allows the system to condition and monitor the package temperature while simultaneously conducting helium leak tests. Helium is introduced into the package, and any leaks, particularly in critical areas like elastomeric seals, are detected by the SIMS 1915+ helium leak detector.

This technology enables manufacturers to detect potential leaks in materials like elastomeric closures, which may become brittle or undergo physical changes at low temperatures. By evaluating package performance under cold conditions, manufacturers can optimize packaging designs to prevent leaks and maintain product quality. The LT systems improve product quality by identifying and addressing leaks early in the packaging process. Additionally, the system ensures compliance with regulatory standards such as USP 1207 and USP 382, ensuring product safety and reliability.

By combining precise temperature control with advanced helium leak testing, these systems help manufacturers identify and address potential leaks, particularly in critical areas like elastomeric seals. This technology not only enhances product quality but also improves packaging design and component evaluation to meet regulatory standards. Ultimately, the LT systems ensure the safety, reliability, and performance of delicate drug and biologic formulations in cold storage environments, ultimately protecting life-saving drugs and therapies.

The integrity of packaging is crucial in maintaining the safety, sterility, and quality of pharmaceutical products. Ophthalmic bottles, such as those for eye drops and ocular medications, demand strict quality control to ensure reliability. The PTI SIMS 1915+ provides a precise solution for evaluating the package integrity of these bottles. By introducing helium into the packaging and detecting any leaks, even the most minute breaches can be identified. This advanced testing method ensures the medication's potency and sterility, ultimately safeguarding patient health.

SIMS 1915+ for Ophthalmic bottles

PTI Seal Integrity Monitoring System (SIMS) Model 1915+ is a helium-based leak detection system specifically designed for a broad range of pharmaceutical packaging applications, including ophthalmic bottles, pre-filled syringes, vials, cartridges, combination products, and blister cards. By using helium as a tracer gas, the system allows for precise quantitative evaluation of packaging integrity, offering enhanced accuracy over traditional vacuum bubble and dye penetration tests. This approach facilitates detailed comparisons across various packaging materials, formats, production line conditions, and storage stability, supporting the entire product lifecycle.

The SIMS 1915+ offers sensitivity levels as low as 1 x 10^-10 mbar/L/sec. The SIMS 1915+ is housed in a durable console frame with a stainless-steel working surface and an optional dual test port manifold. Designed as a freestanding unit, it includes locking wheels and an articulating arm system for easy operation and portability. Each SIMS 1915+ unit is tailored to meet the specific requirements and packaging configurations of the customer, including those for ophthalmic bottles.

SIMS 1915+ Options:

• Low-Temperature Add-on Systems LT80 and LT150 for ultra-cold CCI testing using helium leak detection methods.
• A range of Vacuum Test Fixtures available to suit different package sizes and types.
• Helium leak testing for non-vacuum chamber applications, with custom test fixtures available.
• External helium leak standards offered in various leak rate ranges.
• Helium Sniffer Probe to detect leak sites individually.
• Vacuum clamps, O-ring seals, chamber gaskets, and other essential components.
• Vacuum clamps, O-ring seals, chamber gaskets, and other essential components.

The SIMS 1915+ is an essential tool for ensuring the quality and safety of ophthalmic products. By detecting and addressing potential leak sources, manufacturers can prevent contamination, product degradation, and harm to patients. This highly sensitive and accurate system protects the integrity of ophthalmic packaging, maintaining the potency and sterility of the medication. Through thorough testing and analysis, manufacturers can optimize packaging design and production processes, ultimately improving patient safety and satisfaction.

Pharmaceuticals often require deep cold storage, but standard packaging may fail at such extreme temperatures, risking leaks and product damage. PTI's LT add-on units for their SIMS helium leak detectors address this by evaluating package integrity from 0°C down to -160°C, enabling manufacturers to identify packaging defects and optimize designs for these challenging conditions.

How does it transform the integrity of ultra-cold storage?

PTI's LT system, used with their SIMS helium leak detector, transforms ultra-cold storage integrity by enabling leak detection at temperatures as low as -160°C. This allows manufacturers to identify leaks that only occur at these extreme temperatures, specifically addressing the challenges posed by elastomeric component changes and primary seal failures, common in deep cold storage. By testing at actual storage temperatures, the LT helps optimize packaging design and assembly, minimizing leakage and ensuring product integrity in compliance with USP 1207 and USP 382, ultimately improving the safety and efficacy of temperature-sensitive pharmaceuticals.

Low-Temperature Helium Leak Testing

Integrating a chiller with a helium leak detector, such as the LT, enables precise package testing at temperatures as low as -160°C. This capability helps manufacturers detect potential leaks in packaging components, including elastomeric closures, that may arise under extreme cold conditions. Gaining insights into packaging performance at these temperatures allows manufacturers to enhance product integrity, minimize waste, and meet rigorous regulatory requirements.

The LT series offers several significant benefits for the pharmaceutical industry:

• Precision Leak Detection at Ultra-Low Temperatures – Effectively identifies leaks in packaging materials under extreme cold conditions.
• Improved Product Integrity – Protects sensitive pharmaceutical products from degradation, ensuring their stability and efficacy.
• Minimized Product Waste – Reduces losses caused by leaks and spoilage, leading to better inventory management and cost savings.
• Regulatory Adherence – Complies with stringent guidelines such as USP 1207, ensuring products meet the highest safety and quality standards.

With the pharmaceutical industry's increasing dependence on deep cold storage for temperature-sensitive products, reliable packaging is essential. Helium leak detection offers a precise and effective method for evaluating container closure integrity, ensuring that packaging remains intact in ultra-low temperature environments. By detecting and addressing potential leaks early, manufacturers can maintain product quality, reduce waste, and ultimately enhance patient safety.

The pharmaceutical industry requires deep cold storage for intricate drug and biologic formulations. Traditional packaging may not endure these extreme temperatures, resulting in leaks and product degradation. PTI's LT add-on units for SIMS helium leak detectors provide advanced solutions that assess package integrity at temperatures ranging from 0°C to -160°C. This helps manufacturers detect defects and optimize packaging for reliable performance in deep cold storage.

How does Cold Temperature Leak Detection with PTI's SIMS 1915+ LT add-on units work? 

Cold temperature leak detection with PTI's SIMS 1915+ LT add-on units work by combining advanced helium leak detection technology with a cooling system that allows for accurate testing of packages at ultra-low temperatures, down to -1600°C. The system incorporates a Chiller that conditions and monitors the temperature of the package while simultaneously performing helium leak testing. Helium is introduced into the package, and any leaks, particularly in critical areas like elastomeric seals, are detected by the SIMS 1915+ helium leak detector. The add-on units enable manufacturers to evaluate package integrity under cold storage conditions, ensuring materials like elastomeric closures, which may experience physical changes at low temperatures, are tested for potential leaks. This process helps manufacturers optimize packaging designs, improve product quality, and ensure compliance with regulations like USP 1207 and USP 382. The SIMS 1915+ LT system offers a comprehensive solution for assessing package integrity in deep cold storage environments.

The LT systems provide several important benefits for the pharmaceutical industry:

• Precise Low-Temperature Leak Detection: Effectively detects leaks in packaging materials at extremely low temperatures.
• Improved Product Quality: Maintains the integrity of sensitive products, preventing degradation and preserving potency.
• Minimized Product Loss: Reduces waste caused by leakage and spoilage, optimizing inventory and lowering costs.
• Regulatory Compliance: Meets stringent regulatory requirements, such as USP 1207 and USP 382 ensuring the safety and quality of products.

By combining helium leak detection with precise temperature conditioning, these systems help manufacturers detect leaks, particularly in vulnerable areas like elastomeric seals, and optimize packaging designs to maintain product quality. With the ability to test packages at temperatures ranging from 0°C to -160°C, the LT systems offer significant advantages, including improved product quality, reduced waste, and regulatory compliance with standards like USP 1207. This comprehensive approach to cold temperature leak detection ensures the safety, reliability, and efficacy of sensitive pharmaceutical products, safeguarding both product integrity and patient outcomes.

Blister packs are widely used across various industries, including pharmaceuticals, to protect products from external contamination and environmental factors such as moisture, air, and light. Maintaining the integrity of these packages is paramount for ensuring product quality and adhering to regulatory standards. Among the available leak testing methods, helium leak testing has proven to be a highly reliable and precise technique for verifying the integrity of blister packs. This method not only ensures compliance with stringent industry regulations but also enhances product reliability by identifying potential packaging failures before they reach the end-user. Therefore, helium leak testing offers a significant advantage in maintaining the quality and safety of goods packaged in blister packs.

Key Standards for Blister Package Leak Detection 

• USP 1207: Guidance for container integrity testing principles and methods.
• ASTM Standards: Standards for packaging materials and testing methods.
• FDA Regulations: Regulations for packaging and labelling, including leak prevention.

Factors influencing the sensitivity and accuracy of helium leak detection 

• Exceptional Sensitivity: Detects even the smallest leaks that could compromise product quality.
• High Throughput: Ideal for high-volume production environments, ensuring efficient testing.
• Product Safety: Helium is non-reactive and inert, guaranteeing no product contamination.
• Precise Leak Identification: Accurately pinpoints the location and size of leaks
• Cost-Effective: Reduces product loss and enhances packaging integrity, resulting in long-term cost savings.
• Regulatory Compliance: Meets stringent industry standards for product safety and quality assurance.

Why is Helium Leak Detection Ideal for Blister Pack Testing? 

Helium is considered an ideal choice of tracer gas because of multiple reasons. Helium is non-toxic, non-flammable, non-condensable and its presence in the atmosphere is not more than 5ppm. The small atomic size of helium makes it easier to pass through leaks. Since helium does not react with other materials, it is relatively safe to use. Additionally, compared to other tracer gases helium is less expensive and is available in multiple cylinder sizes. Under this method, a helium leak detector otherwise known as Mass Spectrometer Leak Detector (MSLD) is used to identify and calculate size of the leak. The test part is first connected to a leak detector and then the tracer gas, helium is introduced. In the presence of a leak, helium escapes from the test parts and this partial pressure is measured and results are displayed on the meter.

In conclusion,helium leak detection is indispensable for ensuring the integrity of blister packs in the pharmaceutical and medical device industries. Its high sensitivity guarantees the detection of even minute leaks, safeguarding product safety and ensuring regulatory compliance. PTI's expertise and customized solutions empower manufacturers to seamlessly integrate this vital testing method into their quality assurance processes, thereby protecting both product integrity and patient health.

Foil pouches packaging solution for various industries, including pharmaceuticals and medical devices. Ensuring the integrity of these pouches is crucial to maintain product quality and safety. Helium leak detection systems such as SIMS 1915+ helium-based technology play a vital role in this process. By identifying potential leaks early on these systems help prevent product contamination, extend shelf life, and safeguard customer health.

Foil pouches offer a straightforward and effective solution for sterile barrier packaging, particularly well-suited for medical equipment and pharmaceuticals. Ensuring the integrity of these pouches is crucial to maintain product quality and safety. SIMS 1915+ helps in safeguarding product integrity. The integrity of foil pouches is crucial to maintain product quality and safety. Pouch defects can compromise product quality and introduce contamination risks, potentially leading to product degradation and health hazards for patients. Consequently, rigorous testing of foil pouches is essential to ensure package quality and reliability.

Why are foil pouches used in pharmaceutical industry

Foil pouches are lightweight, flexible, and cost-effective, making them easy to store and transport. Foil pouches can be resealed, extending product shelf life and preventing contamination. Package property of foil pouches help protect sensitive medications from moisture, oxygen, and light, ensuring product integrity. Foil pouches are also compatible with various sterilization methods, making them suitable for sterile product. It can be customized to accommodate different product sizes and shapes, offering versatility in packaging design. By using leak detection systems like SIMS 1915+, manufacturers can further enhance the quality and safety of foil pouch packaging, ensuring medications reach consumers in pristine condition.

Foil pouches package integrity testing using SIMS 1915+

The SIMS 1915+ is a helium leak detection system specifically designed for the pharmaceutical and medical device industries. It utilizes helium as a tracer gas to accurately detect leaks in a variety of packaging formats, including foil pouches, bottles, vials, blister cards, syringes, and cartridges. Unlike traditional methods like vacuum bubble and dye penetration tests, SIMS 1915+ provides quantitative measurements, ensuring a higher level of precision. This advanced system offers numerous applications, including package design validation, tooling certification, manufacturing line setup, and ongoing quality control. Its oil-free pump, detector, and integrated power system are tailored to the specific needs of the industry, enabling the detection of leaks as small as 1 x 10-10 mbar L/s at room temperature. Each SIMS 1915+ device can be customized to meet the unique requirements of individual clients, providing a flexible and reliable solution for maintaining product integrity.

Applications of SIMS 1915+ include:

• Pre-filled syringes
• Bottles
• Blister packs
• Foil pouches
• Vials
• Combination products (cartridges)

Benefits of SIMS 1915+ in foil pouches

• Detects microscopic defects invisible to the eye, ensuring product integrity.
• Provides precise leak rate measurements for rigorous quality control.
• Offers rapid testing cycles for efficient production.
• Adapts to diverse foil pouch configurations.
• Ensures adherence to regulatory standards and industry best practices.

The integrity of packaging plays a critical role in ensuring the safety, sterility, and quality of pharmaceutical products. Ophthalmic bottles designed for eye drops and other ocular medications require stringent quality control to ensure product integrity. Helium leak detection offers a precise method to assess the package integrity of these bottles. By introducing helium gas into the bottle and monitoring for leakage, even the smallest breaches can be identified. This advanced technique safeguards the medication's potency and sterility, ultimately protecting patient health.

Ophthalmic Bottles - Applications

Eye Drops

• Single-use and multi-use bottles
• Dropper bottles
• Pump bottles

Contact Lens Solutions

• Bottles
• Pouches

Specialized Eye Care Products

• Diagnostic solutions
• Therapeutic eye drops

CCI testing of bottles using helium leak detection

To ensure the quality and safety of ophthalmic bottles, helium leak detection is employed as a sensitive and highly accurate method. This technique involves introducing helium gas into the bottle and then monitoring for any leakage. The bottles are subjected to a vacuum chamber, exposing the closure and neck to vacuum pressure. A small hole is created in the bottle base to allow helium gas to fill the interior. Helium gas is introduced into the bottle and sensitive detectors monitor for any leakage. By identifying and addressing potential leak sources, manufacturers can prevent contamination, product degradation, and patient harm. This method is particularly effective for detecting even the smallest leaks, ensuring the integrity of the packaging and safeguarding the quality of the ophthalmic product.

Technology Overview

• Helium gas, employed as a tracer, is utilized to detect and pinpoint leaks within ophthalmic packaging.
• Helium gas, escaping through any potential breach in the packaging, undergoes ionization when exposed to an electric beam.
• The ionized helium ions, generated from the leaked gas, are subjected to analysis based on their mass-to-charge ratio.
• By meticulously measuring the concentration of helium ions within the system, the leak rate can be precisely determined.
• The accurate determination of the leak rate enables a comprehensive assessment of the overall integrity of the ophthalmic packaging.

Helium leak detector is a critical tool for ensuring the quality and safety of ophthalmic products. By identifying and addressing potential leak sources, manufacturers can prevent contamination, product degradation, and patient harm. This sensitive and accurate method safeguards the integrity of ophthalmic packaging, protecting the potency and sterility of the medication. Through rigorous testing and analysis, manufacturers can optimize packaging design and production processes, ultimately enhancing patient safety and satisfaction.

Pharmaceutical and medical device packaging is a critical component of the healthcare supply chain. It ensures product safety, efficacy, and sterility, protecting sensitive medications and medical devices from contamination and degradation. The integrity of the packaging is paramount, as compromised packaging can lead to product spoilage, loss of potency, and potential harm to patients.

Container Closure Integrity (CCI) testing is a rigorous quality control process that assesses the integrity of the packaging system. It involves various techniques to detect and quantify potential leaks or defects in the packaging material, seals, and closures. By identifying and addressing packaging issues early on, CCI testing helps to prevent product recalls, minimize economic losses, and safeguard public health.

Leak Detection Methods

Helium Leak Detection:

• A highly sensitive technique that utilizes helium gas as a tracer.
• Helium is introduced into the package, and any leakage is detected by a mass spectrometer.
• This method is particularly effective for detecting micro-leaks.

Dye Ingress Testing:

• A destructive method where a dye solution is applied to the package's seal.
• If the dye penetrates the seal, it indicates a leak.

Microbial Ingress Testing:

• A destructive method that involves exposing the package to a microbial challenge.
• If microorganisms penetrate the seal and grow, it indicates a leak.

The Unique Properties of Helium Gas

Helium's small size and inert nature allow it to penetrate and be detected in even the tiniest micro leaks. Its low atmospheric abundance ensures accurate detection without interference. These properties make it ideal for verifying the integrity of pharmaceutical packaging, ensuring product quality and patient safety.

Helium Leak Detection Process

• The package or container is filled with helium gas. This can be done using various methods, such as direct injection or through a vacuum chamber.
• The package is placed in a vacuum chamber, and a vacuum is applied to draw any helium out of the package through any potential leaks.
• A mass spectrometer is used to detect and measure the amount of helium escaping from the package. This instrument is highly sensitive and can detect even minute quantities of helium.
• The measured helium leak rate is analysed to determine the severity of the leak. A higher leak rate indicates a larger defect in the package.
• The leak rate data is compared to pre-determined acceptance criteria. If the leak rate is within acceptable limits, the package is deemed to be leak-tight. If the leak rate exceeds the limit, the package may be rejected or further investigated.

A helium leak detector uses a mass spectrometer to identify and quantify leaks. Helium gas escaping from a leak is ionized, accelerated, and deflected by a magnetic field. The deflected ions are collected, generating an electric current proportional to the leak rate. This current is amplified and displayed, providing a visual indication of the leak. This technique is highly sensitive and accurate, making it essential in various industries.

Benefits of Helium Leak Detection

• High Sensitivity: Detects even the tiniest leaks, ensuring product integrity.
• Quantitative Results: Provides precise leak rate measurements.
• Versatility: Applicable to a wide range of packaging formats.
• Regulatory Compliance: Adheres to strict industry standards and regulations.
• Cost-Effective: Long-term savings by preventing product recalls and quality issues.

Helium leak detection is a critical tool in the pharmaceutical industry for container closure integrity. It ensures product integrity and patient safety by identifying leaks in various packaging formats. This technology, leveraging helium's unique properties, offers reliable, sensitive, testing. As regulatory standards tighten, helium leak detection becomes essential for maintaining product quality and compliance.

Helium leak testing offers a highly sensitive and reliable method for ensuring the integrity of IV bags. By detecting microscopic leaks that other methods might miss, pharmaceutical companies can significantly reduce the risk of product contamination, patient harm, and costly recalls. This technology provides a crucial quality control measure for IV bag manufacturers, safeguarding patient safety and product efficacy.

Importance of IV Bag Integrity

Intravenous (IV) bags is a class of parenteral product, designed to deliver medications and fluids directly into a patient's bloodstream. To ensure patient safety, these bags must be free from any defects that could compromise their integrity. Even the smallest breach in the bag's seal can lead to contamination, leakage, or air exposure, potentially causing serious health risks. Helium leak testing is a highly sensitive technique that can detect microscopic defects that could lead to these issues. By preventing the administration of compromised IV fluids, this technology significantly reduces the risk of adverse health effects and helps pharmaceutical companies comply with strict regulatory standards in pharmaceutical package leak detection.

Helium Leak Testing for Testing Integrity of IV Bags

Helium leak detection is a precise technique that utilizes helium gas to identify leaks in sealed systems. This method is particularly important for pharmaceutical packaging, as even minor breaches can compromise product integrity and patient safety.

How does Helium Leak Detection Work?

• The package to be tested, such as an IV bag, is placed in a sealed test chamber.
• A small amount of helium gas is introduced into the chamber.
• If a leak exists in the package, helium gas will permeate through the defect and enter the chamber.
• Highly sensitive detectors, often mass spectrometers, continuously monitor the chamber's atmosphere for the presence of helium.
• If helium is detected, it indicates a leak. The system can pinpoint the exact location of the leak with remarkable accuracy.

Benefits of Helium Leak Testing

• Helium leak detection system is a highly sensitive, detecting even the smallest leaks.
• This method provides quantitative measurements of leak rates, allowing for precise comparisons between different packaging materials, formats, and production processes.
• Helium leak testing helps pharmaceutical companies comply with stringent regulatory standards for container closure integrity.
• By identifying and addressing potential leaks early in the production process, helium leak testing can help improve product quality and reduce the risk of product recalls.

Pharmaceutical cartridges are small, sealed containers designed to hold specific dosages of liquid or solid medications. They are often made of glass or plastic and are designed to be used with specific equipment, such as pre-filled syringes and autoinjectors. Traditional sterility testing has been replaced by advanced technologies such as Container Closure Integrity (CCI) that provide more efficient test procedures. The main objective is to make sure that impurities, including gases (particularly reactive ones), microbes, and other external materials, are unable to break down a closed system's barrier of defense. Otherwise, these impurities may damage the system's sterility or the enclosed drug product.

Pharmaceutical manufacturers place a high premium on the integrity of packaging components in a field where the risks are extremely high. Serious consequences, such as contamination and decreased efficacy of life-saving medications, might result from a defect in a vial, syringe, or ampoule. Helium leak testing has become a commonly used technique for evaluating the integrity of different pharmaceutical components in order to guarantee that packaging stays airtight and secure. Helium leak testing is a critical quality control method used in the pharmaceutical industry to ensure the integrity of drug containers, including cartridges.

Helium Leak Testing vs. Traditional Methods

Helium leak testing offers significant advantages over traditional methods for detecting leaks in pharmaceutical cartridges. Unlike pressure decay tests, which measure pressure loss over time and are less sensitive to small leaks, helium leak testing utilizes the unique properties of helium gas to detect even the micro leaks and defects. This technique surpasses the limitations of dye ingress test, which relies on visual inspection and is less sensitive to micro-leaks. By providing quantitative results, helium leak testing enables precise measurement of leak rates, allowing for data-driven quality control. Its versatility further enhance its efficiency and reliability, making it a preferred choice for ensuring product integrity and patient safety.

Testing Integrity of Pharmaceutical Cartridges Using Helium Leak Detection

Helium leak testing is a quality assurance process for pharmaceutical cartridges. This technique utilizes helium gas, an inert and atomically small tracer gas, to detect minute leaks in sealed cartridges. By pressurizing cartridges with helium and subjecting them to a vacuum environment, any defects will allow helium to escape, triggering sensitive detectors.

Helium leak testing is highly sensitive, capable of detecting leaks as small as 10^-10 mbar L/s. It is also fast and efficient, allowing for high throughput testing without compromising accuracy. Moreover, it is versatile, applicable to various cartridge designs and materials. By using helium leak detection, pharmaceutical manufacturers can adhere to strict regulatory standards and deliver reliable, safe products to patients.

Beyond standard testing conditions, helium leak testing proves invaluable for products stored at ultra-low temperatures. As the pharmaceutical industry increasingly relies on deep cold storage for complex formulations, helium's ability to maintain reliability in extreme conditions ensures the integrity of cartridges and their contents.

Helium leak testing is essential in the pharmaceutical sector to guarantee secure and efficient drug delivery, particularly in cartridges. This protects patient safety and product quality by using the special qualities of helium to find minute leaks. Helium leak testing is still a crucial instrument as laws and patient expectations rise. It enables producers to provide dependable pharmaceuticals, reaffirming their dedication to patient care and industry development.

In the pharmaceutical industry, bottles are used for a wide range of products, like liquids, tablets, and capsules. Depending on the contents within, a bottle may be made of glass or plastic. To ensure the seal integrity of pharmaceutical bottles before shipment, leak testing is necessary. Weak or partial seals can occur during the final sealing stage, hence, a non-destructive leak testing method is required to minimize recalls and reduce costs.

We at CCIT offer a range of non-destructive and deterministic leak testing systems, specially designed to rapidly test for leaks in a wide variety of pharmaceutical and medical device packaging.

SIMS 1915+ for Bottle Leak Testing

PTI Seal Integrity Monitoring System (SIMS) Model 1915+ is a helium based leak detection system specially designed for a variety of pharmaceutical packaging systems, including pharma bottles. Pre-filled syringes, vials, cartridges, combination products and blister cards are other applications of SIMS 1915+. Using helium as a tracer gas, the packages can be quantitatively evaluated to levels much above the vacuum bubble and dye penetration test procedures. This quantitative method supports the entire lifespan by allowing direct comparison across multiple packing materials and formats, production line settings, and stability storage conditions. SIMS 1915+ allows for quantitative analysis of packages with a sensitivity level as low as 1 x 10-10 mbar/L/sec.

Seal Integrity Monitoring System (SIMS) Model 1915+ helium-based leak testing system is built into a console frame assembly with a stainless-steel working surface and an optional dual test port manifold. The freestanding units are equipped with a locking wheel and an articulating arm system for mounting the computer and accessories, making them easy to operate and move. Each SIMS 1915+ helium leak testing device is manufactured to the specifications and package configurations of the individual customer.

Applications of SIMS 1915+

• Vials
• Pre-filled syringes
• Combination products
• Bottles
• Foil pouches
• Blister packs

SIMS 1915+ Options

• Low-Temperature Add-on Systems LT80 and LT150 for ultra-cold CCI testing utilizing helium leak detection methods.
• Various sizes of Vacuum Test Fixtures to accommodate all package types and sizes.
• Helium leak testing for non-vacuum chamber applications with custom test fixtures.
• External helium leak standards in a variety of leak rate ranges.
• Helium Sniffer Probe - for determining leak sites on a site-by-site basis.
• Vacuum clamps, O-ring seals, chamber gaskets, and other components.

The quality of packaging is essential to ensuring drug stability, whether you are a pharmaceutical packaging operator, pharmaceutical manufacturer of blister packs, pharma bottles, sachets, pouches, or medical devices. Any defects can reduce the shelf life and effectiveness of the contents. In order to guarantee patient safety, highly sensitive deterministic leak testing methods are preferred over probabilistic methods.

In an industry where the stakes are exceptionally high, the integrity of packaging components is a top priority for pharmaceutical manufacturers. A defect in a vial, syringe, or ampoule can have serious repercussions, including contamination and reduced effectiveness of life-saving drugs. To ensure that packaging remains airtight and secure, helium leak testing has become a widely embraced method for assessing the integrity of various pharmaceutical components.

This testing approach leverages the unique properties of helium, a small, inert gas, to identify even the tiniest leaks that could jeopardize product quality. The sensitivity of helium leak testing not only provides assurance of sterility but also supports compliance with stringent regulatory standards. As a result, manufacturers can maintain high quality and safety standards throughout their production processes, ultimately safeguarding patient health and well-being.

Reasons to Choose Helium for Leak Testing in Pharmaceutical Industry

Helium leak testing stands out as one of the most effective methods for validating packaging integrity. Here are some reasons why helium is the go-to choice for leak testing in the pharmaceutical industry:

• Exceptional Leak Detection Sensitivity: Helium’s ability to detect incredibly small leaks makes it ideal for pharmaceutical applications where precision is paramount. The sensitivity of helium leak testing allows for the identification of micro-leaks down to 10^-10 mbar L/s, ensuring packaging maintains its sterility.
• Safe for Sensitive Drug Products: Helium is an inert, non-reactive gas, meaning it won’t compromise sensitive pharmaceutical products during testing. This is particularly important for high-value drugs, biologicals, and vaccines that require sterile packaging and must remain unaffected by external substances.
• Fast and Efficient Process: The speed of helium leak detection offers a significant advantage in production settings. Testing cycles are rapid, allowing manufacturers to maintain high throughput without sacrificing accuracy or quality control—critical in an industry where meeting tight production schedules is essential.
• Reliable Detection in Diverse Packaging Types: From glass vials and ampoules to flexible pouches and pre-filled syringes, helium leak testing can be applied across a wide range of pharmaceutical packaging formats. This versatility ensures a robust testing solution, regardless of packaging material or design.
• Testing products at ultra-cold storage temperatures: Complex drug and biologic formulations have resulted in a continuous drive toward deeper cold storage in an effort to maintain product quality attributes. In an effort to maintain product quality attributes of increasingly complex and delicate formulations, life science companies continue to drive toward deeper cold storage. These products, often cell or gene therapies, or proteinaceous in nature, often require storage at temperatures below -20°C, and are involved in storage and distribution environments at times down to -160 C. While the products demanding such intense cold storage may be complex, oftentimes, the package systems in which the products are placed are rather traditional in nature, such as a screw or crimp top vial. However, at these temperatures, many of the materials used in these package systems and responsible for maintaining package integrity are not typically assessed at these temperatures.
• Compliance with Regulatory Guidelines: The pharmaceutical industry must adhere to strict regulatory standards, such as those set by the FDA and USP for container closure integrity (CCI). Helium leak testing is widely recognized and accepted as a validated method for achieving compliance, making it a reliable choice for manufacturers aiming to meet industry regulations.
• Ability to Detect Hard-to-Find Leaks: Due to the small atomic size of helium, the gas can penetrate even the tiniest leaks that might go undetected by other testing methods. This makes helium an invaluable tool for ensuring the integrity of sterile products and safeguarding against contamination risks.
• Trusted Across High-Risk Applications: Helium leak detection is trusted by pharmaceutical companies for products that demand the highest level of quality assurance, such as injectables, vaccines, biologics, and other sterile drugs. This trust is built on helium's proven reliability and consistency in leak detection.

By using helium for leak testing, pharmaceutical companies ensure their products are safe, sterile, and fully compliant with industry standards—ultimately protecting both their brand reputation and patient health.

As regulatory standards become increasingly stringent, the reliance on robust testing methods like helium leak detection will only intensify. This method not only facilitates compliance but also enhances overall product quality and safety, reinforcing the commitment to patient well-being. In a landscape where trust is paramount, helium leak testing serves as a cornerstone for delivering reliable, safe, and effective pharmaceutical products to the market.

Package integrity is actually the capacity of a package to prevent product loss, obstruct the entry of harmful gases or other substances, and block microorganism ingress. This ensures that the product fulfills all relevant safety and quality criteria. Sterility of products is critical to reduce and prevent patient infection when using a product. Therefore, testing for package integrity is essential for regulatory clearance of sterile pharmaceutical products, medical products, and medical devices. Leak testing and seal quality inspection of the packing system are both included in the pharmaceutical package integrity testing process. Foil pouches, vials, prefilled syringes and blister packs are some of the pharmaceutical package formats.

Overview of Foil Pouches

Foil pouches are one of the most common types of flexible packaging used in the pharmaceutical and medical device industries. Pouches provide several packing advantages that cannot be found in other packaging options. In most cases, foil pouches are used as a part of a multi-layered packaging system. Different package integrity test methods can be used for testing foil pouches. Helium leak detection is one such approach.

Evaluating Integrity of Foil Pouches Using SIMS 1915+

Seal Integrity Monitoring System (SIMS) 1915+ is a helium-based leak detection method that has been effectively used in a wide range of pharmaceutical and medical device product packaging systems. Packages may be quantitatively evaluated to levels that exceed those achieved using the vacuum bubble and dye penetration test techniques using helium as the tracer gas. This method may be used with a variety of pharmaceutical and parenteral goods, including vials, syringes, cartridges, and blister cards.

SIMS 1915+ enables testing to be carried out at room temperature as well as cryo storage conditions, providing quantitative analysis of packages at a sensitivity level as low as 1 x 10-10 mbar/L/sec. It gives relevant data sets in place of a simple pass/fail criteria. Each SIMS 1915+ Helium Leak Testing instrument is custom built according to the specifications and package configuration specified by the client. We specialize in creating and developing unique test fixtures that are specifically tailored to the component being tested, ensuring precision and accuracy to fulfill your research objectives, package configurations, and quality monitoring requirements.

SIMS 1915+ Options

• Low-Temperature Add-on Systems LT 80, LT 85 and LT 150 for ultra-cold CCI testing utilizing helium leak detection methods.
• Helium leak testing for non-vacuum chamber applications with custom test fixtures.
• External helium leak standards in a variety of leak rate ranges.
• Helium Sniffer Probe - for determining leak sites on a site-by-site basis.
• Vacuum clamps, O-ring seals, chamber gaskets, and other components.
• Vacuum test fixtures come in a variety of sizes to meet all package types and sizes.

High-barrier pouches are employed in the pharmaceutical and medical industries to transport and store products safely. Foil pouch packaging provides the optimal conditions for storage and transportation for everything from medical samples to pharmaceutical prescriptions. Testing pouches is critical for ensuring the package integrity.

Container Closure Integrity Testing (CCIT) is one of the most effective methods used by manufacturers to ensure that their products are sterile until the point of use. Testing the integrity of container closures determine if they can maintain a sterile barrier against potential contaminants that might impair the quality of the final pharmaceutical and biological products. There are several ways to perform tests on the integrity of container closures, each having advantages and limitations of its own. For instance, methods such as dye ingress and microbiological ingress damage the test samples. Therefore, manufacturers choose deterministic methods such as helium leak detection for package integrity testing.

Helium leak testing is the process of identifying leaks in some type of sealed or enclosed systems by utilizing helium as a "tracer" gas and monitoring the concentration of the gas as it leaves as a result of a leak. In this method, the package is helium-filled and placed under vacuum. A helium leak detector is used to monitor the volume of helium that is leaving the package quantitatively. The result is expressed as leak rate.

Helium Leak Detector

Helium leak detector, commonly referred to as a Mass Spectrometer Leak Detector (MSLD), is used to identify leaks that enter or leave a system or containment device and to measure its size. Helium, the tracer gas, is introduced into a test component that is attached to the leak detector. The system allows the helium that is leaking through the test portion to enter, and this partial pressure is monitored. The results are then displayed on a meter.

For a number of reasons, helium is the ideal tracer gas to locate leaks. It is non-toxic, inert, non-condensable, non-flammable, and just traces of it are often found in the atmosphere (5 ppm). Helium is a gas that quickly passes through leaks due to its tiny atomic size. The only non-inert molecule smaller than helium is hydrogen. It comes in several size cylinders and is also relatively inexpensive.

Explain Various Calibration Standards Offered by PTI's Helium Leak

PTI's Helium Leak offers complete sets of calibrated helium leak standards in addition to instruments and accessories to provide routine usage, daily performance verification or system suitability checks, and scheduled qualifications.

Internal Leak Standards:

An internal helium leak standard is included with every PTI SIMS 1915+ leak detection system. This apparatus is calibrated to discharge a certain amount of helium at a defined leak rate. It is utilized either on demand for a point-of-use auto calibration before analysis or automatically by the instrument on each day of usage.

External Leak Standards:

Every external helium leak standard developed by PTI's Helium Leak releases helium at a known leak rate, much as the internal leak standards. They attach to the test port, much like a sample fixture would be mounted to the system, rather than residing inside the instrument. The external nature of these leaks makes them perfect for routine PV or SS activities as well as qualification activities to assess the accuracy of the system. It is possible to perform an industry-standard, multi-point check across leak rate ranges of interest, since external leak standards are accessible in a variety of leak rates.

With every new instrument purchase, PTI's Helium Leak provides the following Internal and External Leak Standards (with certifications of calibration):

• External Helium Leak Standard E-6 3 x 10 -6.
• Internal Leak Standard - Set at E-7 1 x 10 -7.
• External Helium Leak Standard E-7 3 x 10 -7.
• External Helium Leak Standard E-8 3 x 10 -8.

A certificate of calibration that details the standards to which the leak was tested and the tolerance range for which that leak is certified should be attached to every calibrated helium leak. PTI's Helium Leak provides both external and internal leak standards with certificates of calibration.

Over the past few decades, the pharmaceutical industry has experienced tremendous growth on a global scale. Assuring the quality of the packaging is of utmost importance to every manufacturer since any defect in the packaging of pharmaceuticals can have major consequences. Pharmaceutical products must be free from microbiological contamination and safe to use from the time of manufacturing until the end of their shelf life. Through contamination in the form of oxygen, humidity, or microbial entry, the stability of the drug may be negatively impacted. Container closure integrity tests with great sensitivity are needed to reduce these risks. Hence, manufacturers choose helium leak detection technology.

Overview of SIMS 1915+

Helium Leak Detection using Seal Integrity Monitoring System (SIMS) 1915+ is a highly sensitive test method for inspecting the integrity of pharmaceuticals to identify leaks. Helium as a tracer gas may be used to quantitatively evaluate packages, providing higher degrees of accuracy than conventional vacuum bubble and dye penetration test methods. This approach makes it possible to compare various package types, sizes, and configurations, as well as manufacturing line settings and storage conditions, throughout the lifespan. LDA SIMS 1915+ is a tried-and-true technique that can be used for a range of package types, including cold form blister cards, foil pouches, parenteral vials, syringes, bottles, pre-filled syringes, and other unique medical devices. It can also be used for package design, tooling qualification, production line setup, and ongoing product quality monitoring.

SIMS 1915+ Low Temperature Add-on Test Systems

In an effort to maintain product quality aspects, complex pharmaceutical and biologic compositions have led to a constant drive towards deeper cold storage. These products, which are frequently protein-based or cell or gene treatments, must be stored in conditions that may include dry ice (-78.5°C) or even liquid nitrogen (-200°C) for storage and delivery.

The packaging system such as screw or crimp cap vials in which the products are enclosed is frequently quite conventional in nature, even if the products necessitating such deep cold storage may be complex. At these temperatures, many of the materials employed in these package systems and responsible for preserving package integrity are not normally evaluated. When subjected to deep-cold or ultra-cold temperatures, elastomeric components in particular may undergo physical changes when materials reach or exceed their glass transition state, resulting in leaks at low temperatures that would not normally be visible at room temperature. This type of leakage is frequently seen in primary seal regions, such as the interface between an elastomeric closure and a glass vial, when the temperature is below -60°C. In order to minimize leakage and demonstrate a deep understanding of a package system's performance in accordance with USP 1207, manufacturers need a method for evaluating container closure integrity while at these low temperatures. This significantly led them to decide on the best package choice and design as well as assembly parameters.

PTI and LDA’s engineering team developed the LT80, or Low Temperature -80°C, Test System, for use with the SIMS range of helium leak detectors to satisfy the market need for analyzing fine leakage at low temperatures. The LT80 system, which incorporates an SP Corporation Chiller, enables simultaneous temperature conditioning, temperature monitoring, and helium leak testing of packages down to -80°C. LT80 combines the recently announced features of the market-leading, Agilent Technologies-based SIMS 1915+ with 21 CFR Part 11 compliant SIMS Software. This is available as an upgrade for current SIMS units in the field or as a complete system. The SIMS 1915+ LT80 package is the first helium leak testing equipment particularly designed for low temperature testing down to -80°C. Sample testing close to -150°C is possible with the LT150 add-on low temperature unit.

LDA (a PTI Company) is the leading global producer of specially designed leak detection systems for pharmaceuticals and medical equipment. LDA’s low temperature add-on systems are ideal for evaluating fine leakage at cold temperatures using Helium Leak Detection Technology.

Combination products, which provide effective and novel treatment options and approaches across various disease states, have made a significant influence on the healthcare landscape in recent years. The acceleration of growth in this field of science and medicine is expected to continue propelling at an increased rate. The packaging and device industry has focused its innovation specifically on combination therapeutics to fulfill the demands of both drug developers and patients. To ensure that the best results may be obtained, these therapeutic products need to be tested for integrity and quality using a very sophisticated approach.

Challenges Faced by Combination Products

Patient safety can be improved by addressing these three challenges.

• Device Robustness and Reliability

If a pharmaceutical or biologic is not administered safely, properly, and consistently, it cannot benefit the patient. The delivery method for this is a sturdy, dependable device, and the technique to make sure that the device performs as intended is through the design control process. Verification testing is an important stage that ensures the device has been developed appropriately and operates dependably in accordance with established patient needs and drug specifications. Additionally, it assesses how well the product will withstand in the most adverse circumstances, which may include drops, climatic extremes, and moisture exposure.

• Drug - device integration

When developing combination products, it's crucial to take the interaction between the device and the drug into consideration. The FDA categorizes combination products into nine separate categories, which include pre-filled drug devices or delivery systems as well as devices that have been coated, impregnated, or mixed with drugs or biologics. The development process can be considerably influenced by the precise combination of components as well as the crucial interfaces.

• Accommodating various volumes

Large drug volumes have been difficult for patients to self-administer using devices like autoinjectors, pens, or pre-filled syringes. But the development of wearable devices is changing the game by enabling greater volumes to be administered subcutaneously over a longer period. This increases the potential for patient-centered healthcare but poses a number of manufacturing and packaging challenges.

Here, we will discuss how helium leak testing helps in testing the combination products.

Testing Integrity of Combination Products Using Helium Leak Testing

Helium leak detection is a highly sensitive technology for identifying leaks in any closed or sealed system using helium gas and monitoring the concentration of the gas as it escapes due to a leak. The integrity of a variety of complicated pharmaceutical and parenteral products may be evaluated using helium leak detection. Combination products, cold form blister packs, foil pouches, pre-filled syringes, and many more drug packages can be tested using helium leak testing. This technique is the best option for verifying the integrity of pharmaceutical products since it can accurately determine integrity between certain major container closure system components.

Helium leak detection works as follows: The package is initially vacuumed and helium filled. The quantity of helium leaving the package is then measured quantitatively and expressed as a leak rate using a helium leak detector. Helium leak testing is used in product design, product quality evaluations, failure analyses, and validation in addition to examining the integrity of container closures. It is possible to test "in-leakage" or "out-leakage" as well as the location of leaks using helium leak testing, which may be employed with or without a test chamber.

Helium Leak Testing Applications

• Seal integrity monitoring during stability studies.
• Useful in the early stages of developing a drug product packaging system.
• Selecting closure formulation and configuration.
• Ensuring container closure integrity.
• Verify and predict shelf-life seal integrity.

The need for complex drug delivery systems and combination products continues to fuel the development of new products and innovation within the medical device industry. At PTI, we understand that the combination of medical devices and pharmaceuticals opens a world of promising new opportunities. PTI has the experience and expertise necessary to seize these opportunities and assist clients in testing combination products.

Container closure integrity is essential for patient safety as well as pharmaceutical product efficacy, and container closure integrity testing (CCIT) is a critical step in the manufacturing process. A paradigm change is currently taking place in the pharmaceutical industry, moving it away from conventional probabilistic procedures and toward deterministic alternatives. LDA (a PTI Company) dives into the area of CCIT, giving the industry a thorough understanding of its practices and introducing innovative helium leak detection technology.

For non-porous packaging including vials, syringes, and cartridges, helium mass spectrometry has become the new leak detection standard. The approach is favored by producers and authorities because of its greater sensitivity, quicker test times, traceability, and determinism in contrast to the probabilistic conventional methods.

Role of Helium Mass Spectrometry in Leak Testing Vials

Helium mass spectrometry is a leak detection standard for various pharmaceutical packaging formats, including vials. Mass spectrometer leak detector is an equipment often used for discovering and identifying leaks within or outside the product. Typically, it works with a vacuum chamber and a closed container filled with helium. Helium leakage from the container is measured by the mass spectrometer. In this technique, the product connected to the detector is filled with helium tracer gas. Helium from the tested product escapes into the detector, where it is measured and indicated as partial pressure.

The sector field mass spectrometer works as the fundamental component of leak detection. Helium gases are ionized as they enter the vacuum. Next, voltage is added to accelerate the helium ions, which are subsequently separated in a magnetic field. A specific detector is used to change the ion current into an electric current. Utilizing leak detecting units, this current is accelerated and displayed on the screen. The leak will be determined by the current since it is directly proportional to the helium concentration.

Why is Helium Used in Leak Detection?

• It is an inert gas molecule that is among the smallest.
• It may consistently and readily breach pathways due to its small atomic size.
• Helium is non-toxic, non-condensable, and non-flammable.
• Relatively safe to use as it will not interact with the components being tested.
• Helium is less expensive and readily available when compared to other tracer gases.
• There is no more than 5 ppm of helium in the atmosphere.

For Maximum Allowable Leakage Limit (MALL) testing in the pharmaceutical industry, LDA helium leak detection technologies are ideal. It is crucial that you control the tracer gas concentration while doing the measurement to guarantee accuracy. This is particularly challenging when working with vials or other sealed containers. Therefore, LDA (a PTI company) provides solutions to test the integrity of pharmaceutical vials.

Do you rely only on the traditional blue dye leak test method to ensure the integrity of blister packaging? While background knowledge of preventing blister pack leaks is recommended, package integrity testing is necessary.

Pharmaceutical package leak detection ensures that the product remains safe and effective in the packaging while maintaining sterility. A proper sterile container prevents air penetration and maintains product safety and effectiveness. Ingress of air from blister pack leaks, such as micro leaks and pinholes, may have a severe negative impact on pharmaceuticals, therefore you must be completely confident in your pharmaceutical package integrity, ensuring it passes the required integrity test. The best way to ensure that the pharmaceutical packaging has no significant blister pack leaks is with the helium leak detection method.

SIMS 1915+ for Blister Pack Leak Testing

Seal Integrity Monitoring System (SIMS) 1915+ helium leak detection is an ideal solution for testing the integrity of cold form blister packs. The packages may be quantitatively evaluated using helium as the tracer gas, which provides more precision than typical vacuum bubble and dye penetration test processes. This approach allows for the lifetime comparison of various packing materials and forms, as well as production line settings and stable storage conditions. LDA SIMS 1915+ is a tried-and-true method for a wide range of package types, including foil pouches, parenteral vials, syringes, bottles, pre-filled syringes, and unique medical devices. It can be used for package design, tooling qualification, production line setup, and ongoing product quality monitoring.

Each SIMS 1915+ helium leak testing equipment is built to the customer's specifications. It is composed of an oil-free pump, detector, and integrated power system that enables quantitative analysis of package systems at sensitivity levels as low as 1 x 10 -10 mbar L/s at room temperature. The most basic component is the Helium Leak Detector Module (HLDM), which is built within a Console Frame Assembly that includes a Stainless Steel working surface and an optional Dual Test Port Manifold. The freestanding consoles are easy to use and relocate since they include a locking wheel and an articulating arm mechanism for attaching the computer and accessories.

Helium Leak Detection SIMS 1915+ Configurations for CCI

• Helium Leak Detector Module (HLDM): Oil-Free, Production version in Console Frame Assembly, with Stainless Steel working surface and Nitrogen Vent Supply System for the Helium Leak Detector Module.
• Vacuum Test Fixture Model (VTFM): a custom-made fixture for testing vial container samples.
• Model VM-2 Head Space Analyzer Module (HSAM): includes three (3) Puncture Probes (two spares) for determining Helium Concentration in the headspace of vial containers.
• Dual Test Port Manifold that allows concurrent use of VTFM & HSAM on HLDM unit.
• An integral Calibration Chamber (with Calibrant Gas Flow Meter/Controller) for HSAM Calibration and a Universal Holder for various vial sizes are offered.
• Helium Leak Standard Calibrated Externally for System Calibration/Validation.

Blister Packs are intended to protect the contents from both internal leakage and contamination from outside sources. Helium leak testing is a CCI test method used to locate and measure leaks in medical and pharmaceutical packaging to ensure package and seal integrity. The package can be tested alone or with the contents inside. With over 25 years of expertise in the pharmaceutical packaging industry, LDA (a PTI Company) is continually looking ahead to enhance blister pack leak detection.

USP <1207> Package Integrity Evaluation of Sterile Products provides an overview of relevant and authorized test procedures that may be utilized to achieve certification criteria. Developing a basic knowledge of these methodologies will allow you to make an informed decision on the most effective test methodology for a specific container and package system. Various CCI test methods are available today. Among them, helium leak testing has proven to be the most chosen method due to its extreme test sensitivity.

Why Use SIMS 1915+ for Leak Detection?

Seal Integrity Monitoring System (SIMS) 1915+ is the perfect choice for a helium-based leak detection system. Using helium as the tracer gas, packages may be quantitatively analyzed to levels much above the vacuum bubble and dye penetration test processes. This quantitative technique supports the entire lifetime by providing direct comparison across numerous packing materials and types, production line settings, and stable storage conditions. SIMS 1915+ can be used for package design, tooling qualification, manufacturing line setup, and continuous product quality monitoring. Each SIMS 1915+ helium leak testing equipment is built to the customer's specifications. SIMS 1915+ can do quantitative CCI analyses on packages with sensitivity as low as 1 x 10 -10 mbar L/s.

What are the Applications of SIMS 1915+?

• Vials

Vials composed of glass and polymer are the most widely used package systems tested using helium leak detection. Vials are provided with a variety of capping to fulfill specific storage or handling needs. Vials are commonly used to store drugs or laboratory samples. Micro leaks in vials that carry sensitive drugs cannot be detected with a visual inspection. Helium leak testing is an ideal method for component qualification for empty components as well as a product-filled vial.

• Pre-filled syringes

The use of pre-filled syringes has increased significantly in the pharmaceutical industry. CCI analyses of pre-filled syringes are more complicated, but they are much more important in ensuring entire system integrity. Helium leak testing for leak detection of pre-filled syringes has proven to be an effective method for evaluating the CCI of pre-filled syringes.

• Bottles

Bottles made of glass or plastic are cost-effective traditional dosage forms ideal for the oral administration of syrups, solutions, and suspensions. Helium leak testing offered by LDA, a PTI company, quickly and effectively tests bottles for leaks and thereby defective bottles can be removed from the production line easily.

• Blister packs

Due to the extreme sensitivity offered, the helium-based test method for evaluating the integrity of a blister card containing solid dose pharmaceutical drugs has been proven to be the most effective approach. Helium remains an ideal test method for qualifying the material components of CFF blister cards.

• Foil pouches

Pharma manufacturers typically use foil pouches when a drug product requires multi-layered packaging. Helium leak testing of foil pouches is a viable and highly sensitive approach to meet strict regulatory requirements.

• Combination products

These are multi-chamber systems that require unique test requirements. Helium Leak Detection as per ASTM F2391 is a well-established and widely used method for testing combination products. Testing combination products using helium leak testing ensure all components meet the strict leak rate requirements.

LDA’s (a PTI company) Seal Integrity Monitoring System (SIMS) 1915+ is an efficient method for a wide range of package types such as pre-filled syringes, cold form blister cards, foil pouches, parenteral vials, and unique medical devices. Seal Integrity Monitoring System (SIMS) Model 1915+ Helium Based Leak Testing System is designed specifically for the needs of the pharmaceutical and medical device industries.

With the rapid growth of the cell and gene therapy sector, there is a higher demand than ever to prove Container Closure Integrity (CCI) at low temperatures. Most cell and gene therapy drugs are maintained at temperatures below -60°C to preserve the effectiveness of the product. Many of these items are packed in vials or cryogenic freezing bags. Vials made of glass or plastic are the most commonly used containers for packing. They are used to preserve pharmaceuticals or laboratory samples. Each of these container closure systems presents a unique challenge for determining CCI at low temperatures. In this blog, we will discuss how the integrity of vials can be tested using low-temperature package test systems.

Low-Temperature Test Systems for Vial Integrity Testing

The most common challenge in storing vial systems at ultra-low temperatures is the occurrence of transient leaks. While a vial system may achieve leak rates at or below the maximum permissible leakage limit (MALL) at room temperature, the same may not necessarily be true at -80°C or lower. However, many of the materials used in these package systems and those responsible for maintaining the integrity of the package are not normally evaluated at these temperatures. Physical changes can occur, especially in elastomeric elements, when in contact with deep-cold or ultra-cold temperatures, causing the material to reach its glass transition state or higher. This results in leakage at low temperatures, which is not observed at room temperature. This type of leakage is most commonly found in primary sealing areas between elastomeric closures and glass vial, such as below -60°C. Having a reliable method to test container closure integrity while at these low temperatures enables manufacturers to minimize leakage.

LDA has developed the LT80, low temperature -80°C add-on test system for use with LDA SIMS helium leak detector to meet market demand for cold temperature leak analysis. Concurrent temperature conditioning, temperature monitoring and helium leak testing of packages approaching -80°C are all possible on the LT80 system. Helium leak detection is an effective way to ensure container closure integrity, even at temperatures below -80°C. Although there are alternative methods for measuring CCI, many of them are ineffective at temperatures below -80°C. LT150 low-temperature add-on unit allows sample testing at temperatures as low as -150°C.

Applications of Helium Leak Detection

• Ensuring container closure integrity.
• Seal integrity monitoring during stability studies.
• Verify and predict shelf-life seal integrity.
• Useful in the early stages of developing a drug product packaging system.
• Selecting closure formulation and configuration.

Helium leak detection is a rapid, efficient, and deterministic method of determining the inherent CCI of a vial system at any temperature. Due to the sensitivity of helium leak detection, it is excellent for testing CCI for products that must retain both headspace gas and sterility. During the package development phase of the product life cycle, helium leak detection is most commonly utilized in evaluating component performance at ultra-low temperatures.

Pharmaceutical bottle integrity testing is an important step in assuring that the product is safe and unadulterated. It analyzes the strength and integrity of the closure mechanism as well as its capacity to maintain a sterile barrier. Container closure integrity testing analyzes the materials and chemicals for the possibility of migration or leaching into the drug product, resulting in contamination. Microorganisms, gases, and other chemicals are examples of contaminants. Container system integrity testing involves evaluating primary packaging, or everything that comes into direct touch with the product, as well as secondary packaging components required for package assembly. Helium leak detection, airborne ultrasound, vacuum decay, and high voltage leak detection are all methods for verifying the safety of container closures.

Helium Leak Detection to Ensure the Integrity of Bottles

Helium leak detection is referred to as a method of finding leaks in a sealed or enclosed system using the helium tracer gas method. The amount of helium that leaks through a breach is measured and is stated as a leak rate. It is an effective container closure integrity test technique for determining the integrity of pharmaceutical and parenteral products. Helium leak testing guarantees the sterility of drug substances and drug products packaged and, therefore, enhances patient safety.

In this method, the package is filled with helium and subjected to vacuum. The quantity of helium that exits the package is measured using a helium leak detector. The result is expressed as the leak rate. Helium leak testing, in addition to being a highly sensitive container closure integrity test technique, is also useful in product design, product quality analyses, failure analysis, and validation.

What are the Applications of Helium Leak Testing?

Some of the most important applications of helium leak testing include:

• Ensuring container closure integrity.
• Selecting closure formulation and configuration.
• Seal integrity monitoring during stability studies.
• Verification and prediction of shelf-life seal integrity.
• Useful in the early stages of developing a pharmaceutical product packaging system.

Helium leak detection offered by LDA (a PTI company) is one of the commonly used leak testing methods that can be used for pharmaceutical package leak detection. Bottles can be tested very effectively using this method. The applications of helium leak detection are also found in vials, prefilled syringes, foil pouches, and cold form blister cards. LDA has long-time expertise in designing leak testing equipment for pharmaceuticals and medical devices.

Foil pouches are a simple solution for sterile barrier packaging. These are ideal for medical equipment and pharmaceuticals as well. Aluminum foil, which is impermeable to moisture, oxygen, and other gases, as well as microorganisms and light, helps to preserve pharmaceuticals in perfect condition for a longer period of time. These materials are used to create films that are free of contaminants and toxins. As a result, one advantage of foil pouches is that they may be used to package both food and non-food products. Another benefit of utilizing foil pouches is their low cost. Foil pouches are less expensive than many packaging materials.

Leak testing foil pouches is a challenging process. Leaking pouches may destroy the quality of the product by destroying the outside package. More significantly, leaking pouches provide a point of entry for contamination into the product, which can result in product degradation and potential health risks for patients. This creates the necessity of testing foil pouches and helps assure package quality.

How Helium Mass Spectrometer Detect Leaks in Foil Pouches?

Helium leak testing is a CCI testing method for leak testing foil pouches. It is the process of finding leaks in an enclosed system using helium as the tracer gas. Helium leak testing is one of the most accurate and rapid leak detection methods which employ a mass spectrometer for analyzing/measuring leaks. For a variety of reasons, helium gas is used to locate leaks. These include the fact that it is present only 5 ppm in air, resulting in very low background levels. Helium has a low mass and is completely inert/non-reactive. Helium is also non-flammable, abundantly available, and inexpensive.

Helium mass spectrometer is a device that helps in detecting and locating leaks. The device being tested is either pressurized from the inside or pressurized with helium from the outside. The gas from any possible leaks is collected and pumped into the mass spectrometer for analysis, and any value over the helium background trace indicates a leak. The mass spectrometer works as follows-any helium molecules vacuumed into the spectrometer are ionized, and these helium ions then fly into the ion trap, where the ion current is measured and recorded. The leak rate is then calculated using the ionization current.

Benefits of Helium Leak Testing

• Identification and measurement of leaks with high sensitivity.
• The majority of the testing is done in a dry, temperature-independent environment.
• Reduced cost and processing time with shorter cycle time.
• Due to the inert properties of helium, no effect on the substances under test.

Helium mass spectrometry is ideally suited for determining the intrinsic integrity of a packaging system. Helium mass spectrometer leak detection system for foil pouches offered by LDA (a PTI company) can be used to identify both large and small leaks. These are often employed in a vacuum chamber containing a sealed container filled with helium. Because of its non-toxic nature, helium is one of the important gases that may be used to identify leaks.

Food and Drug Administration (FDA) requirements for drug testing of combination products are strict. Companies seeking FDA clearance for such products must fully understand the requirements for FDA approval in order to prevent costly and time-consuming errors. Combination products are made up of two or more regulated components, such as pharmaceuticals, devices, or biologicals, that have been physically, chemically, or otherwise combined and formed as a single entity to achieve a therapeutic effect. A combination product can combine at least two of these product categories, and sometimes all three. Traditional drug-device combination products, such as a syringe pre-filled with a drug, auto-injectors containing a filled cartridge and needle, and co-packaged or kitted products, are some of the most common types of combination products.

The constantly increasing demand for combination pharmaceutical products continues to fuel innovation and creates numerous interesting opportunities that will provide the medical community with promising new alternatives for improving patient care and results. However, bringing bio/pharmaceuticals and medical devices together to form a combination product necessitates extensive testing of all product ingredients.

Why Use SIM 1915+ for Leak Testing Combination Products?

A Helium-based leak detection system-Seal Integrity Monitoring System (SIMS) 1915+ is an excellent solution for detecting leaks in combination products. Packages may be quantitatively evaluated using helium as the tracer gas, which assures better levels of accuracy when compared to traditional vacuum bubble and dye penetration test procedures. SIMS 1915+, which has been proven to be an effective leak detection approach, may also be utilized for package design, tooling certification, manufacturing line setup, and ongoing product quality monitoring. PTI custom builds each SIMS 1915+ Helium Leak Testing device to customer specifications. Cold form blister cards, foil pouches, parenteral vials, syringes, pre-filled syringes, and unique medical devices can also be tested using SIMS 1915+.

Technology Overview

SIMS Model 1915+ helium-based leak testing system offered by PTI is specifically designed for medical and pharmaceutical package leak detection. The SIMS 1915+ enables quantitative analysis of package systems at sensitivity levels as low as 1 x 10 -10 cc/s at room temperature. The Helium Leak Detector Module (HLDM), the most crucial component, is built within a Console Frame Assembly with a Stainless Steel working surface and an optional Dual Test Port Manifold. The consoles have a locking wheel and an articulating arm system for attaching the computer and peripherals, making the independent device simple to operate and maneuver.

The SIMS 1915+ Leak Detection System specs and add-on components are shown below.

• Helium Leak Detector Module (HLDM): Oil-Free, Production Version in Console Frame Assembly with Stainless Steel Working Surface and Dual Test Port Manifold.
• Vacuum Test Fixture Model (VTFM): a custom-made fixture for testing vial container samples.
• Head Space Analyzer Module (HSAM): Model VM-2 that includes three (3) Puncture Probes (two spares) for determining the concentration of helium in the headspace of vial containers.
• Integral Calibration Chamber (with Calibrant Gas Flow Meter/Controller) for HSAM Calibration and a Universal Holder for various vial diameters are offered.
• Helium Filling Device designed specifically for vial testing sample prep that allows vials to be filled with helium.
• Low Temperature (LT) Add-on devices created particularly for evaluating products in ultra-cold storage temperatures as low as –140 °C.

SIMS 1915+ Applications

Common applications of SIMS 1915+ include:

• Pre-filled syringes
• Vials
• Bottles
• Combination products
• Foil pouches
• Blister packs

Combination products provide a safe, effective, and convenient method of administering the drug or biologic therapies. The purpose of testing combination products is to obtain information to support the claim that all use-related hazards connected with the product have been reduced to the greatest extent possible. PTI is well-versed in the extensive testing requirements and regulatory criteria for bio/pharmaceutical products and medical devices, and provides complete testing services for these components, both individually and in combination.

Helium leak testing is a non-destructive method to verify the presence of a leak in a component or device by using helium as a tracer gas. Being a highly sensitive method, it measures the amount of helium escaping through the package and is stated as a leak rate. Helium leak detection using Seal Integrity Monitoring System (SIMS) 1915+ is widely used in pharmaceutical and medical device product package systems for quality checking. SIMS 1915+ enable quantitative CCI analyses of packages at a sensitivity level as low as 1 x 10-10 mbar/L/sec. This quantitative method enables direct comparison across multiple packaging materials and formats, production line settings, and stability storage conditions. Each SIMS 1915+ Helium Leak Testing device is custom-built to meet the specifications and packaging configurations of the client. The following are the SIMS 1915+ configurations for CCI.

• Headspace Analyzer Module (HSAM)
• Helium Leak Detector Module
• External Calibrated Helium Leak Standard
• Dual Test Port Manifold
• Vacuum Test Fixture Model (VTFM)

Quality Control Leak Testing using LDA's Head Space Analyzer Module

The Head Space Analyzer Module (HSAM) is a critical component of a Leak Detection Associates (LDA) custom helium leak testing system. The Model VM-2, created by Leak Detection Associates, is the most recent version of this unique device. The HSAM includes a probe, which is essential for determining the helium concentration in the headspace of the container system. This system is simple to use and operate since it has an Integral Calibration Chamber with a Calibrant Gas Flow Control Valve and a Universal Holder that allows multiple diameter systems to be evaluated. Leak Detection Associates will provide three (3) Puncture Probes (two spares) with each unit.

The optional vial filling component enables the test preparation of already-sealed vials by replacing the headspace gas with 100% helium. This module can be used to prepare samples at the moment of testing, after capping, or to prepare samples that have been stored for a period of time prior to testing. When combined with the VM-2, these unique attachments enable accurate and sample-specific readings that may be integrated into flexible study designs.

Uses of Helium Leak Detection

• Ensuring container closure integrity.
• Seal integrity monitoring during stability studies.
• Verify and predict shelf-life seal integrity.
• Useful in the early-stage drug product package system development.
• Selecting closure formulation and configuration.

LDA's Head Space Analyzer Module (HSAM) - SIMS 1915+ configuration ensures highly sensitive leak detection of pharmaceutical pouches. Cold form blister cards, parenteral vials, cartridges, pre-filled syringes, bottles, combination product systems, and medical device products are other applications.

Pharmaceutical containers can be tested for Container Closure Integrity (CCI) in a variety of ways. Blue dye test and bacterial or microbial immersion test come under traditional, probabilistic methods. Whereas Vacuum Decay, Airborne Ultrasound, MicroCurrent HVLD, and Helium Leak Detection belong to the deterministic group of test methods. Each approach has advantages and disadvantages that should be considered while selecting a test method for a certain container type. All the methods are not appropriate for all sample configurations. Some succeed in certain applications while failing in others. Nowadays, the pharmaceutical industry is moving away from the traditional blue dye and bacterial immersion test methods and approaching deterministic methods for CCI testing.

The helium leak rate method is proven to be a strong contender for many applications. Helium leak testing is described as the process of detecting leaks in various enclosed or sealed systems by utilizing helium as a "tracer" gas and measuring its concentration as it leaves due to leakage. Like most CCI methods, Helium Leak Detection is deterministic. This method is more sensitive and not prone to contamination as compared to traditional dye or bacterial immersion methods. Due to its highly sensitive nature, it is possible to detect extremely small leaks, which are not possible with other leak testing methods.

Validating Helium Leak Rate Method for Pharmaceutical Containers

Validation of a Helium leak rate method for pharmaceutical container closure integrity assurance required proof that this physical testing method was as excellent as, if not better than, microbial immersion challenge testing in detecting potential integrity problems. Helium leak rate and microbial challenge tests were performed on one lot of rubber-stopper, broth-filled glass vials, which include faulty vials with known leaks. Glass micropipettes (0.1 to 10 microns) were fitted into the sidewalls of the vials to prepare defective vials. A 10% seeded defect rate was present in the validation lot, with nearly 50% of the leaks having a predicted probability of failing a microbial challenge (> 10%). The test units were charged for 4 hours under 40 psi helium pressure to implant the helium tracer in them. After charging, the crucial leak rate was found to be 10(-7) standard cc/second, and test units with measured leak rates exceeding this value were considered helium leak rate failures.

Microbial immersion challenge was performed by immersing the test units for 24 hours in a bath containing 10(9-10) viable E. coli and B. diminuta organisms, followed by a 13-day incubation period at 35°C. Visually, microbial failures were identified. The mean failure rates of the helium and microbial leak test techniques were compared statistically. The average helium failure rate was 6.9%, whereas the average microbial failure rate was 2.8%. There was a considerable difference between helium and microbial failure rates. As a result, helium leak rate testing has been shown to be an acceptable pharmaceutical container/closure integrity method for container quality assurance.

The helium leak detection method is chosen to be one of the best techniques for ensuring the integrity of pharmaceutical containers. This technique may be used to test the inherent package integrity and the Maximum Allowable Leakage Limit (MALL) during package development. It is applicable to a wide range of package types, can locate leaks, and can measure leak flow rates directly.

Testing a pre-filled syringe is critical when it comes to developing and releasing safe injectables to the market. Pre-Filled syringes are becoming increasingly popular due to their efficiency and simplicity. In addition, they provide a more dependable and safe option for patients as they contain the exact dose. Container closure integrity test techniques can be utilized to satisfy the regulatory, quality, and safety demands of sterile drug products. During development, qualification, and stability testing, the FDA encourages sterile pharmaceutical manufacturers to employ established and deterministic methodologies to confirm CCI.

Ensuring Pre-Filled Syringes Integrity using SIMS 1915+

Seal Integrity Monitoring System (SIMS) Model 1915+ is a helium-based leak testing system specially designed for a variety of pharmaceutical and medical device product package systems. A pre-filled syringe is one of its applications. Vials, cartridges, and blister cards are other applications. Packages may be quantitatively evaluated to levels much above the vacuum bubble and dye penetration test procedures using helium as the tracer gas. This quantitative method supports the full lifespan by allowing direct comparison across multiple packing materials and formats, production line settings, and stability storage conditions. SIMS 1915+ allows for quantitative analysis of packages with a sensitivity as low as 1 x 10-10 mbar/L/sec and will offer meaningful data sets instead of simple pass/fail criteria.

Seal Integrity Monitoring System (SIMS) model 1915+ helium-based leak testing system from PTI includes an oil-free pump, detector, and integrated power system built for the pharmaceutical and medical device industries. The most important component is the Helium Leak Detector Module (HLDM), built into a console frame assembly with a stainless steel working surface and an optional dual test port manifold. The freestanding units are equipped with a locking wheel and an articulating arm system for attaching the computer and peripherals, making them easy to operate and move. Each SIMS 1915+ helium leak testing device is manufactured to the specifications and package configurations of the individual customer.

SIMS 1915+ Options

• Low-Temperature Add-on Systems LT 80 and LT 150 for ultra-cold CCI testing utilizing helium leak detection methods.
• Vacuum test fixtures come in a variety of sizes to meet all package types and sizes.
• Helium leak testing for non-vacuum chamber applications with custom test fixtures.
• External helium leak standards in a variety of leak rate ranges.
• Helium Sniffer Probe - for determining leak sites on a site-by-site basis.
• Vacuum clamps, O-ring seals, chamber gaskets, and other components.

Pre-filled syringes benefit the manufacturer as well as the patient. They help in reducing medication mistakes since they have fewer steps and are easier to use than empty syringes. SIMS 1915+, developed by Leak Detection Associates, is an effective technique for testing leaks in pre-filled syringes. End-users may utilize the technology to ensure that manufacturing and packaging processes are efficient and productive while still satisfying safety requirements, international regulations, and market quality standards.

Container Closure Integrity Testing (CCIT) is essential for maintaining the sterility and stability of sterile injectable products. The optimal test method varies depending on the product. CCI testing is used to determine if there is a leak between the contents of a container and its external environment. This can be done by identifying whether communication can be established between the contents of the container and its surroundings.

Pharmaceutical containers such as vials, syringes, cartridges, and blister packs are frequently tested as part of a stability study to ensure that the closure of the container can maintain a sterile barrier. As part of a stability testing methodology, the Food and Drug Administration (FDA) suggests performing a container closure integrity test instead of a sterility test. Primary packaging methods based on vials for sterile pharmaceutical products must provide protection over the shelf life. This necessitates the demonstration of Container Closure Integrity (CCI), which should be done early in the pharma product development process. Helium leak testing is the most chosen CCI test method due to its high sensitivity when compared to other leak test methods.

What is Helium Leak Testing and How it Evaluates Vial Integrity?

Helium leak testing is one of the Container Closure Integrity (CCI) test methods for testing the leakage of pharmaceuticals and medical devices. This method uses helium and the change in concentration is detected when it exits owing to leakage. The applications of helium leak testing include vials, pre-filled syringes, foil pouches, or cold form blister cards. Each of these packaging types is meant to keep out harmful environmental pollutants such as dirt, microorganisms, or even gases while maintaining the sterility of the medicinal product enclosed. The package is filled with helium and subjected to vacuum in this method. A helium leak detector is used to quantify the amount of helium that escapes the package. The result is expressed as a leak rate.

Why Use Helium as a Tracer Gas?

Due to the following reasons, helium is considered an ideal choice for this type of testing:

• Helium is inert, and it is one of the smallest gas molecules.
• Small atomic size allows it to breach pathways reliably and easily.
• Helium is non-toxic, non-condensable, non-flammable.
• Safe to use as it will not interact with the components being tested.
• Helium is less expensive and readily available when compared to other tracer gases.
• The presence of helium in the atmosphere is not more than 5ppm.

As a highly sensitive quantitative test technique, helium leak testing evaluates Container Closure System (CCS) components for parenteral applications. It offers quantitative leak rate data that significantly exceeds the detection limitations of conventional approaches. The method has proven to analyze the impact of processing factors on container closure systems, such as parenteral vial capping applications, elastomeric closure selection, or changing sealing parameters.

The use of pre-filled syringes (PFS) as a container solution for pharmaceutical products has increased significantly in recent years. It is expected that this trend will accelerate in the future decades. Pre-filled syringes have the benefit of reducing pharmaceutical waste and extending the life of the product for the pharmaceutical industry. In general, pre-filled syringes are recognized as an effective, reliable, and convenient way to dispense drugs. In addition, many injections can be self-administered without worrying about being completely transferred from a vial. It provides a safe and effective option for patients in need of long-term pharmaceutical therapies.

When compared to the conventional vial, pre-filled syringes provide extra complexity in the field of container closure integrity (CCI) inspection. The advantages of pre-filled syringes include ease of use compared to conventional vial packaging. Pre-filled syringes eliminate the necessary procedures before you use the drug in a vial. In addition, since pre-filled syringes contain the correct dose, it helps to avoid dosing errors.

Leak Testing Pre-Filled Syringes Using Helium Mass Spectrometry

The device that detects and monitors leaks within and outside a product is called Mass Spectrometer Leak Detector. This approach makes use of helium as a tracer gas, which is utilized to fill a product coupled to a detector. Helium mass spectrometry is widely known for its suitability for non-porous packaging like vials and pre-filled syringes.

The leak detector works on the basis of a sector field mass spectrometer. In a vacuum, analyzed entering gases (Helium) are ionized. Helium ions are accelerated and separated in a magnetic field using increased voltage. Using a specific detector, the ion current is converted to an electric current. The current is accelerated and displayed on the screen by leak detection units. The current measured is proportional to both, the helium concentration and the measured leakage.

Benefits of Helium Leak Testing

• Leaks may be detected and quantified with a high degree of sensitivity.
• Due to the inert properties of helium, it does not affect the substances under test.
• The testing is mostly conducted in a dry, temperature-independent environment.
• Helium leak testing has a shorter cycle time, which lowers the cost and overall processing time.

For non-porous packaging including vials, pre-filled syringes, and cartridges, helium mass spectrometry has emerged as the new leak detection standard. Unlike probabilistic traditional methods, helium leak detection methods are preferred by manufacturers and regulators for their high sensitivity, fast test time, and detection capability. Pharmaceutical industries usually choose this process during the evaluation and eligibility stages of a new packaging process, where MALL plays an important role.

Foil pouches are commonly used when a product requires multi-layered packaging. They are utilized as the innermost layers of packaging. Since the foil pouches come into direct contact with the packaged product, they must be of the highest quality and extremely hygienic. They are typically composed of aluminum and are used to protect products from high temperatures. Furthermore, foil pouches have a low moisture vapor transfer rate. Foil pouches usually contain three to four layers. The higher the number of layers, the higher the pouch quality. Each extra layer increases the strength of the pouch.

Foil pouch integrity testing offers a unique set of challenges. The occurrence of foil punctures is an issue in most packaging techniques that use foil as the product barrier. These imperfections can occur when the foil is rolled into thin sheets and microscopic particles are rolled into the foil by mistake. Handling of the packages during the assembly of the foil and insertion of the drug product is the most typical source of the defect. Although the human eye can only reliably spot punctures bigger than 100 µm, these faults are difficult to identify. Punctures smaller than this can cause substantial ingress and, as a result, affect the effectiveness of the product.

How to Inspect Foil Pouches for Quality Control Using Helium Leak Test?

A highly sensitive method of detecting leaks in enclosed systems by using helium as a "tracer gas" is known as helium leak testing. Pre-filled syringes, foil pouches, and cold form blister cards are the most common applications of helium leak testing. Each of these package types is meant to keep out harmful environmental pollutants including debris, germs, and even gases while maintaining the sterility of the drug product inside. The leak rate is calculated from the amount of helium that escapes from the package.

The sensitivity of the helium leak detection methods makes it an ideal platform for quality control testing foil-based packaging systems. The test technique is designed to identify helium that has been trapped in the packaging system and has leaked via micro-voids in the pouch. Placing the foil pouch in the custom-designed test fixture and drawing a vacuum is the first step in a test sequence. Helium thus escapes through possible defects in the package as a result of the resultant pressure difference. The flow is directed to the analyzer cell at vacuum pressure, where the escaping helium gas is measured in the cell.

The average test cycle time is between 20 and 60 seconds. The test chamber is evacuated to the environment when the test cycle is completed and the measurement is recorded, and a new sample can be tested. The PTI HSAM helium concentration device is used to detect the helium concentration value of each pouch once all samples in the designated set have been tested. This approach normalizes the helium leak rate to 100%, allowing direct comparison of all test samples as well as the manufacturing line configuration.

Helium leak testing, one of the most commonly used CCI testing methods, is used to accurately determine the tiniest of the leaky opening in the foil pouches. Using this method, leaks can be quantified and detected with a high level of sensitivity and quality control testing. The Food and Drug Administration- FDA has long recognized helium leak detection as a consensus standard for package integrity evaluation.

The integrity of the seal between the container and the closure is a major concern when choosing packaging components for a parenteral drug product. The packaging must protect the pharmaceutical product from a number of possible sources of contamination, such as microbial ingress. Container closure integrity (CCI) is defined as the capacity of a container closure system to preserve a drug product and hence retain its efficiency and sterility throughout its shelf life. The purpose of container closure integrity testing is to determine the effectiveness of packaging closure.

To ensure CCI of pharmaceutical drugs, a number of methods are used. Helium Leak Detection is one of them. In this method, helium is used as a tracer gas, to detect leaks. This testing produces quantitative data that are more repeatable and reliable than qualitative pass/fail results. Despite the fact that it is a destructive test, helium leak testing is widely used because of its sensitivity and ability to run samples at temperatures below ambient. After the sample is prepared, it may be kept and analyzed at the proper temperature.

CCI Testing of Pharmaceuticals at Low Temperature

The CCI of pharmaceuticals may be determined using a variety of approaches. Under sub-ambient temperature circumstances, several methods of container closure integrity testing, such as blue dye ingress, microbial ingress, and vacuum decay, are insufficiently sensitive or simply unsuitable. Helium leak testing is a reliable method for testing closures and ensuring product effectiveness and sterility. This method is more sensitive than other CCI testing methods.

PTI has created the LT80, Low Temperature -80°C, Add-On test system for use with the PTI SIMS helium leak detectors to meet the market demand for analyzing leaks at cold temperatures. Concurrent temperature conditioning, temperature monitoring, and helium leak testing of packages approaching -80°C are all possible with the LT80 system. Even at temperatures as low as –80°C, helium leak detection is an effective method to ensure container closure integrity. While there are alternative methods for measuring CCI, many of them are ineffective at temperatures below –80°C. The LT150 low-temperature add-on unit allows for sample testing at temperatures as low as -150° C. The highly sensitive nature of the instrument allows for leaks as low as a 2µm hole can be recognized as a failure. The quantitative results provide the analyst with a numerical value, which allows for better data trends and greater confidence in the packaging system's performance than qualitative techniques can provide.

Container closure integrity or CCI, on packaging for parenteral drug products, is crucial for drug product preservation. The packaging closing components must be carefully chosen in order to eliminate sources of contamination that could harm the pharmaceutical product. The need to extend container closure integrity testing into the cryogenic temperature range is already becoming apparent. Container closure integrity must be achieved at cryogenic temperatures if pharmaceuticals are to be kept at cryogenic temperatures. For these types of drug items, newer packaging solutions like prefilled syringes and complex self-dosing devices are increasingly being used, and CCI will need to be proved for them as well.

Helium Leak Testing is used to locate and identify extremely tiny leaks in any component that can produce a differential pressure. Helium Leak Rate can be expressed quantitatively (the quantity of leak rate). The helium leak testing method is also used to examine the performance of a component or system, as well as to study or evaluate the lifetime of a product. Helium gas is primarily utilized as a leak testing medium due to its ability to detect and quantify leak rates at very low levels.

PTI offers various helium leak testing services for pharmaceuticals and medical devices. The services are as follows:

Leak Testing Services

• Installation & Quality Assurance of Helium Leak Detector

Leak Detection Associates guarantees that each custom instrument comes with comprehensive service delivery, installation, and validation program that is appropriate for the regulated environments in which the instruments will be used. Prior to delivery, the PTI Engineering Technician will collaborate with delivery site personnel to confirm that the location has the appropriate gas and electrical supplies for instrument functioning. Once the instrument is on-site and in the position specified by the customer, the Engineering Technician will perform a formal Installation Qualification (IQ), Operation Qualification (OQ), and Performance Qualification (PQ). Prior to execution, these can be pre-approved by local Quality Assurance.

• Helium Leak Detector Service Agreement

Leak Detection Associates recognizes that maintaining instrument performance is an important part of the business’s success. While the instruments offered by PTI are simple to use and maintain, it helps to improve productivity by proactively guaranteeing performance with an PTI Annual Service Agreement. Leak Detection Associates provides service contract plans that are customized to the unique needs and specifications. The following are examples of key components of any service program:

1. Repair and replacement parts are available on-site at no additional charge

2. Annual On-Site Preventative Maintenance

3. Detailed Annual Requalification & Calibration

•  Helium Leak Detector Calibration Services

Annual calibration services for all components of the test system, including internal and exterior leak standards and HSAM probes, are also available as an alternative to a full-service contract. Failure to calibrate the leakage criteria may result in a decrease in the accuracy and validity of the results over time, as well as concerns of individuals working in a CGMP or other controlled environment. A complete calibration program at regular intervals is designed to ensure proper instrument readings for the life of the device with minimal instrument downtime. PTI can set reminders when service is required once in our calibration database, ensuring that SIMS 1915+ does not skip a beat.

• Training for Helium Leak Testing

Leak Detection Associates offers on-site training relevant to how the SIMS 1915+ Helium Leak Testing device will be utilized, with the objective of being a comprehensive solutions provider to the clients. More sophisticated parts of leak testing, as well as system care and maintenance, can be covered in training programs. The Leak Detection team has over 20 years of hands-on expertise and can help the organization with anything from basic knowledge and understanding of leak testing basics to specialized leak test method development and validation.

• Helium Leak Detection Feasibility Studies

PTI offers dependable feasibility and method development services. Prior to procuring an instrument or moving on with outsourcing solutions, feasibility services can provide proof of concept for its intended usage, or they can assist to expand existing capabilities by designing solutions for new package systems. PTI also provides full method development utilizing industry-standard positive control techniques in the cases where clients do not have internal resources experience in the development of helium leak detection tests, or where current resources need to be expanded. Methods created at PTI can be transferred and verified at the client site, or they can be utilized frequently at PTI for lab-scale, non-cGMP research.

• Onsite or In-House CCI for Package Systems

PTI offers testing capabilities at both the client's site and our location. A SIMS 1915+ purchased and installed in a controlled context can be used for client onsite testing. With hands-on expertise in cGMP and regulated laboratory and production environments, documentation procedures are quite often in line with internal and external quality standards. PTI also provides the option of bringing one of our test units to a client's site for particular investigations. In-house testing is an alternative for clients looking to analyze package systems or designs on a contract basis.

PTI provides its customers with the highest quality of services. We are the world's leading manufacturer of high sensitivity helium-based leak detection systems for the pharmaceutical and biologic industries. Our engineers and support staff are highly trained and certified, allowing us to provide professional services across a wide range of testing domains.

Blister packages are a convenient format for users and a practical way to keep tablet and capsule quality preserved. The majority of blister package applications are considered low-risk, and they do an excellent job of protecting pharmaceutical products from moisture intrusion, which can cause product degradation. Tablets with a hydrophilic nature, or a natural tendency for absorbing moisture, require extra protection.

Due to an increase in the number of hormone-based and steroidal therapies in recent years, worries concerning the integrity of blister packing have emerged. Given their propensity to degrade and impair treatment outcomes, packaging these and other groups of pharmaceutical products is considered a high-risk application. To combat this, most manufacturers choose a totally aluminum, cold-formed package, which offers the best protection against oxygen penetration, while some industries have packaged very sensitive steroidal therapies in thermoformed blister packaging. As these products are more susceptible to environmental conditions than most other tablets and capsules, it is critical to inspect for tiny leaks, regardless of the packaging utilized in this high-risk application.

Limitations of Blue Dye Test

One or more blister packs are submerged in a chamber holding blue liquid and a vacuum is drawn to conduct the blue dye test. The chamber is then restored to atmospheric pressure, and the packages are retrieved and examined to determine if any dye has entered them. No defect is detected if there is no dye in the blister packaging. The blue dye only enters the package after the vacuum phase, which is the major defect of this method. As a result, when the chamber is returned to atmospheric pressure, nothing prevents the operators from removing the packages from the dye during this final stage.

Package headspace and dye surfactant concentration are the other difficult factors to control in the blue dye test. In reality, the test just determines how easily or quickly the dye may enter the blister cavity. It does not tell you about oxygen or vapor intrusion. This is a significant disadvantage since gaseous pollutants may penetrate foil and film more readily through a tiny leak, which is subject to surface tension. This requires a relatively large single passage to enter the package. Another major disadvantage and difficulty to control is the subjective nature of the operator's inspection.

Leak Testing Blister Packages Using Deterministic Test Method

Helium leak testing is a deterministic method for identifying package leaks in blister packs using helium as a tracer gas. The change in its concentration is measured as it escapes due to leakage. The quantity of helium that escapes from the package is expressed as a leak rate. Helium leak detection is a very sensitive technique for testing pharmaceutical package integrity.

Seal Integrity Monitoring System (SIMS) 1915+ is the optimum leak detection system using helium. When compared to traditional methods such as vacuum bubble and dye penetration test, packages may be quantitatively examined with high accuracy. This method enables a comparison of different packaging materials and forms, as well as production line settings and storage conditions, thus supporting the entire life cycle. Package design, tooling qualification, production line setup and ongoing product quality monitoring are the applications that come under SIMS 1915+. It is specially designed for the pharmaceutical and medical device industries.

Blister packaging is a type of pre-formed plastic packaging that includes a base card with artwork and a clear plastic pocket called the blister. The cavity, which is composed of either plastic or aluminum foil, and the lid, which is made of paperboard, paper, plastic, or aluminum, are the two main components of blister packaging. The product is enclosed in the cavity, and the lid seals the package. Blister packing is used in the pharmaceutical industry to pack tablets, pills, capsules, granules, and lozenges. Blister packaging gets its name from the fact that each item is kept within its own small plastic bubble or blister. Blister packs can provide tamper resistance as well as barrier protection for shelf-life requirements.

Due to its extreme sensitivity, a helium-based test method is used for verifying the integrity of the blister pack. The test method operates by detecting helium that has been enclosed in the package system and is escaping through micro-channels in the package. This test sequence begins with the package being placed in the test fixture and immediately drawing a vacuum. The helium thus escapes through potential holes or cracks in the packaging as a result of the pressure differential.

Blister Pack Leak Testing Using Helium Mass Spectrometry

The Mass Spectrometer Leak Detector is a comprehensive system for locating and detecting leaks within or outside of product. This approach employs the use of helium as a tracer gas, which is utilized to fill the product attached to the detector. Helium leaks into and out of the tested product, causing its partial pressure to be measured and shown on a screen.

The leak detector works on the principle of a sector field mass spectrometer. Helium gas is ionized in a vacuum. Helium ions are accelerated and separated in a magnetic field using additional voltage. The ion current is converted to an electric current using a specific detector. The current is accelerated by leak detection units and displayed on the screen. The measured current is proportional to the helium concentration and equal to the observed leak. Helium leak detection using helium mass spectrometry is widely known for its suitability for packaging such as blister packs.

Helium Leak Detection Benefits

• With a high degree of sensitivity, leaks can be identified and measured
• No effect on the materials under test, due to the inert properties of the helium
• The testing procedure is mostly dry and temperature-independent
• Helium leak testing has a faster cycle time, which reduces the cost and overall processing time

Helium leak detection offered by Leak Detection Associates (LDA) can greatly improve the safety and health of blister package users. Blister packaging ensures that tablets and capsules are properly sealed. It is simple to do a leak test after packaging. Blister packaging is popular because of its convenience of packing, easy dosing for the patient, with its popularity increasing for many new drug solid dose/oral dose products.

LDA, the global leader in helium-based leak detection systems for the pharmaceutical and medical devices industries. Helium leak testing is a technique for locating and identifying leaks in a closed vessel using a tracer gas, helium. The method of helium leak testing is often used to evaluate system performance. Helium gas is commonly employed as a leak testing medium because of its ability to detect and quantify leak rates at extremely low levels.

SIMS Version 1.11.19 21 CFR Part 11 compliant software program

SIMS Version 1.11.19 21 CFR Part 11 is a compliance software application particularly created and manufactured for custom-built helium leak testing equipment. The application was created to support SIMS 1915+ units and makes LDA the only helium-based leak testing system provider on the market that meets all the FDA's (Food & Drug Administration’s) 21 CFR Part 11 data integrity software criteria.

With the growing usage of computer systems and electronic records over the last two decades, the FDA has published a number of guidance documents and directives outlining particular requirements for electronic data management. Users must be able to log in at different levels, utilize electronic signatures and approvals, have secure data management that prohibits changes to current results, and have an electronic audit trail that captures all relevant activities in a time and date stamped pattern.

LDA was able to build a robust and thorough helium leak testing procedure on our custom-designed and built systems. This improves functionality and usability compared to existing software options, by contracting with a development team that specializes in the development of instrument operation software programs and has extensive experience in the Part 11 area. LDA is offering a system software update program for current SIMS devices in the market for quick onsite installation for a client's existing installation base. The 21 CFR Part 11 program consists of all the instruments, including SIMS 1915+ and SIMS 1915+ LT low temperature add-on units.

Leak Detection Associates has been the major provider of custom helium leak detection equipment to the pharmaceutical, and medical device industry for over 20 years. Based on intended usage and target package system configuration, each test system is developed to meet regulated quality system requirements as well as the particular client's specifications. The LDA team creates custom add-on components for clients that need a flexible leak detection system that can be used with a variety of package types and configurations. This ensures flexibility in reaching particular research goals.

Helium leak detection is referred to as the process of detecting leaks in various packaged or sealed systems by utilizing helium as tracer gas and measuring its concentration as it escapes due to leakage. A package system such as a vial that consists of a container and an elastomeric closure, is a good example. The vial is filled with helium and vacuum is applied. The quantity of helium that escapes from the package is quantified and expressed as a leak rate. A pre-filled syringe, a foil pouch, or a cold form blister card are some more examples of package systems. Each of these package types is designed to keep the pharmaceutical product enclosed while keeping out potentially harmful environmental pollutants like dust, bacteria, or even gases. The helium leak testing method can evaluate each of them.

Helium leak testing is widely utilized in the pharmaceutical and medical device industries because of its relevance in guaranteeing package integrity and quality. Now, let us see how these sectors benefit by using this technique.

1. Pharmaceutical Industry: The pharmaceutical industry has experienced enormous progress in terms of technological developments and drug delivery system innovations over the last two decades. However, such developments have created new quality assurance challenges for drug manufacturers. As a result, pharmaceutical manufacturers give major priority to both quality control procedures and pharmaceutical package leak detection.

CCI Testing is a leak detection technique that evaluates the capacity of container closure systems to maintain a sterile barrier against external contamination. These tests may be divided into two types: probabilistic test and deterministic test. Although probabilistic test methods like Bubble Tests and Dye Ingress were initially common, due to technological advancements, non-destructive approaches are now the preferred way for ensuring container integrity. Hence, pharmaceutical manufacturers are encouraged to switch to more dependable deterministic test methods, such as helium leak detection, which offer quantitative findings that are assured and precise. By using helium leak detection early in the development process, companies can improve the quality of their drug delivery system. This not only saves money and time, but also improves safety.

2. Medical Devices Industry: In the medical device industry, package integrity testing is important since product failure presents considerable risks to patients and healthcare professionals, as well as liability for manufacturers. Barriers between fluids or gases are frequently used in medical equipment. These barriers must be functional in order to safeguard the patient and, in many cases, the medical equipment. Some devices operate as channels for delivering or extracting fluids to or from specific parts of the body. If a leak develops along the channel, fluids might be supplied to the incorrect place by mistake or wrong fluids could be extracted, resulting in hazardous effects. As a result, medical device industries use various CCI test methods including helium leak testing to ensure package integrity.

Helium leak testing is the most common tracer gas method in the medical device industry. Helium or a helium-air combination is used to pressurize the test component within a vacuum chamber. The chamber enclosing the part is next evacuated, generating a vacuum that allows the helium to enter the chamber through any leaks. A mass spectrometer designed to detect helium takes a sample of the vacuum chamber and ionizes any helium detected. Even a small amount of helium is easily detected in this method.

The major reason for choosing the tracer gas technique by manufacturers is the necessity for high leak-detection sensitivity in particular medical device equipment applications. Product testing is a crucial part of the device production process in the medical industry. As quality requirements have gotten increasingly strict, leak testing has become increasingly important for medical equipment as well as pharmaceutical manufacturers.

Helium leak detection technology is used to identify tiny leaks in a contained system. Other detection techniques may not be applicable due to operating limitations or if the leaks are so small that other techniques cannot find them. Due to its tiny size and inert nature, helium is an excellent choice for testing purposes. It has no effect on the materials in the item to be tested. Because of a variety of factors, helium is a preferable option as a tracer gas.

• Non-toxic, inert, and non-flammable
• The tiny atomic size makes it easy to pass through leaks

Helium is detected with a mass spectrometer or helium sniffer, however, it is also possible to utilize a residual gas analyzer. In comparison to other methods of finding leaks, helium testing is a thousand times more sensitive.

Various technologies

• SIMS 1915+

SIMS 1915+ is the ideal option for helium leak detection in pharmaceutical and medical device packaging systems. Vials, syringes, cartridges, and blister cards are some of the most common applications. Helium is commonly used to test the rubber stopper on a vial or the plunger on a syringe or cartridge assembly for leaks in parenteral goods. Sensitivity level as low as 1 x 10-10 mbar/L/sec may be measured with SIMS 1915+, which offers useful data sets instead of a basic pass/fail condition while allowing testing to be done at ambient temperature. It is important to note that each SIMS 1915+ Helium Leak Testing device is custom-built to meet client-specific requirements and package specifications.

• Cold storage package test systems

In an effort to retain product quality features, pharmaceutical and biologic firms continue to push for extended cold storage. In addition to requiring storage at temperatures below -20°C, many of these goods also require dry ice (-78.5°C) or liquid nitrogen (-200°C) for storage and delivery. However, many of the materials utilized in these package systems and responsible for preserving package integrity are not routinely evaluated at these temperatures. The glass transition state of elastomeric materials can be reached or exceeded at deep-cold or ultra-cold temperatures, causing leaks at low temperatures that would not otherwise be detected at room temperature.

• HSAM and Vial Filler

When it comes to helium-based leak testing systems, the Head Space Analyzer Module (HSAM) with vial filling assemble is a key component. As part of the HSAM, a probe measures the helium content in the headspace of a container system. With the optional vial filling assembly, previously sealed vials may be prepared for testing by replacing the headspace gas with 100 percent helium before the test is performed. After capping, this module can be used to prepare samples for testing or to prepare samples that have been kept for some time before testing. They may be used in conjunction with the VM-2 to get precise readings that can be included in flexible research designs.

• Sniffer Probe

This simple technique of tracer gas leak detection employs a sniffer probe to detect the gas's presence and locate the location of the leak. The tracer gas is initially applied to the part or system. With the sniffer probe, the operator then conducts a systematic search for probable leak spots. When it comes to finding micro leaks, sniff leak locating is quite successful. It is best used for examining smaller quantities of items. While the cost of sniffer testing depends on the kind of tracer gas utilized, it is a proven option for leak detection and localization.

• Package Test Fixtures

Outside the box, no leak testing is possible using a Helium Leak Detector. An HLD is only one component of a matrix that makes a useable system, just like a display is part of a computer system. Checking for quality packing material and sealing is a part of testing a package. By squeezing and holding it underwater, an operator checks for bubbles in a package using the manual leak testing method. The package retains atmospheric pressure when there are leaks.

• Calibrated Leak Standards

To support everyday usage, daily performance verification or system suitability tests, as well as planned certifications, LDA supplies full sets of calibrated helium leak standards. Each SIMS 1915+ has an inbuilt helium leak standard. Using a given leak rate, this technique releases a certain concentration of Helium. On each day of usage, it is utilized automatically by the instrument, or on-demand for autocalibration prior to analysis. Each external helium leak standard by LDA releases helium at a defined leak rate, similar to the internal leak standards. But instead of living inside the instrument, they attach to the test port in the same manner that a sample fixture would be installed in the system.

Some basic applications

• Glass Vials
• Pre-filled Syringes
• Bottles
• Blister Packs
• Foil Pouches
• Combination Products

Helium leak detection technology is a highly sensitive method used for detecting leaks in an enclosed system. Helium is used as a tracer gas as it is inert, non-condensable, non-flammable, and harmless. Because of its small atomic size, helium passes easily through the leaks. Thus, the change in its concentration is measured and indicated as a leakage rate. Helium is lighter than the next inert gas neon. It is also very cost-effective and can be easily delivered in various cylinders and in pure form. Hydrogen that is not inert is the only molecule smaller than helium.

Helium leak detector works on the principle of field mass spectrometer. The electric beam in the filament of the analysis tube ionizes the leaking helium gas. The ions are accelerated by increased voltage, escape through the split and later pass through the analyzer's magnetic field. The collector can only catch the helium ions and detect helium, as the circular paths of the ions rely on their mass. The ion current is transformed into an electric current using a specific detector. The current is accelerated by utilizing leak detector devices and displayed on the screen. The measured current is equivalent to the concentration of helium and hence equal to the leak.

What makes helium gas ideal for package leak testing?

• Non-toxic, inert, non-condensable, present in the atmosphere in trace amounts
• Helium gas is one of the smallest molecules to consistently and rapidly break the pathway
• Helium is non-flammable, widely available, and inexpensive
• Since it is an inert gas and does not interact with the testing component, it is, therefore, safe to use
• The noise of the instruments caused by the environmental helium is naturally minimal due to its low atmospheric level of less than 5 ppm and thus gives accurate reports

Key benefits of helium-based testing

• Helium leak detection is a highly sensitive detection technique, particularly developed to identify extremely small leaks which cannot be detected with standard leak test methods
• The leak test limit may be set at a level of 1 x 10-10 mbar L/sec, which enables unique comparisons across components, materials, formats, and manufacturing characteristics using a high-speed vacuum approach

Applications of Helium leak detection

Following are some of the common applications of helium leak detection technology:

• Glass Vials

One of the most common package systems for biotechnological and pharmaceutical products. Helium is the most appropriate and sensitive way for qualifying components for empty components and for product-filled vials.

• Pre-filled Syringes

Pre-filled syringes represent the biggest growth area of parenteral packages with the development of more sophisticated drugs for a wide range of injectable substances and increased demand for self-administration. Helium testing techniques can be developed such that these unique package systems have extremely effective test programs.

• Bottles

Bottles are one of the most used packaging methods and helium still remains the standard for quality testing purposes.

• Blister Packs

Helium is still the optimum test technique for qualifying the CFF blister cards' material components. The test procedure is based upon the detection of helium encapsulated in the packaging system as it escapes from the package via micro-channels.

• Foil Pouches

The sensitivity of the helium leak testing method provides an excellent platform to test quality control systems based on foil. This technique normalizes the helium leak rate to 100% so that all test specimens throughout the manufacturing line setup may be directly compared.

• Combination Products

Multi-chamber systems with specific needs for tests are perfectly suited for using helium leak test to guarantee that all components satisfy the rigorous leakage standards.

Like vials package systems, bottles whether composed of plastic materials or glass, continue to be one of the most widely used package systems and Helium remains the gold standard for quality testing purposes.

Evaluating seal integrity of bottles or containers used for liquid contents is what ensures the quality of the bottles surpass the quality parameters. Seal integrity testing of bottles is done to ensure that the contents of the container do not leak out in any condition. As weak seals, partial seals or no seals can occur in the final sealing stage, manufacturers often conduct high-quality seal integrity tests that guarantee reliability and quality of bottle seals.

Thread shape, mating surface shape, and composition of the material used for making the container and the closure are common factors that can affect the seal integrity of bottles. An ideal seal can be generated if the container and closure materials are made up of distinct composition. Seal quality can also be affected by time-dependent factors. This is especially possible if containers, closures, or both are constructed using plastic resins. Similarly, exposing the bottle and its contents to freezing temperatures can affect the seal via expansion and contraction of the materials in threads and mating surface area.

Before dispatching, leak detection of sealed containers is a crucial vital step to ensure container’s seal integrity, food and nutrition, medical device and pharmaceutical industries require highly sensitive leak testing techniques to measure seal strength of the containers. One such method is helium leak detection.

Overview of helium leak testing?

Helium leak testing refers to the process of finding leaks in some type of enclosed or sealed system using helium as a “tracer” gas and measuring its concentration as it escapes due to leakage. It is an effective container closure integrity test method, aimed at evaluating the integrity of pharmaceutical and parenteral products. Helium leak detection works in the following way: Initially, the package is helium filled and subjected to vacuum. Then using a helium leak detector, the amount of helium escaping the package is quantitatively measured and stated as a leak rate. Apart from analyzing container closure integrity, helium leak testing is also applicable in product design, product quality analyses, failure analyses and validation. Helium leak testing is a flexible method that can be used with or without a test chamber in order to test "in-leakage" or "out-leakage", as well as leak location.

Why use helium as a tracer gas?

Helium is considered as an ideal choice of tracer gas because of the following reasons:?

• Helium is non-toxic, non-condensable, non-flammable.
• It is inert, making it safe for use as it will not interact with the components being tested.
• The atom size of helium is really small, allowing it to breach pathways reliably and easily.
• Compared to other tracer gases, helium is less expensive and readily available.
• Its presence in the atmosphere is not more than?ppm.

Pharmaceutical product manufacturers use packaging materials that offer optimal protection and safety allowing to extend product shelf life. Cold form blister packs are manufactured by sandwiching aluminum foil between Polyvinyl Chloride and nylon films using dry bond lamination technology. They provide complete barrier to moisture, light, oxygen, and other gasses. Its ability to offer complete product integrity and protection has made it a favourable choice for pharmaceutical industry.

Oral and solid dose manufacturers aim at producing high quality and cost effective alternatives while manufacturing innovative, convenient packs for end-users. Due to its high efficiency rate and the ability to provide extended shelf life, the cold form blister packs are being extensively used in healthcare packaging. Many pharmaceutical products including tablets, capsules, drugs, vials, ampoules, syringes or liquid products are often packaged using cold form blister packaging. Infact, growing requirements of pharmaceutical companies worldwide had led to the production of cold form foils such as push-through, peelable, peel-push, tear-open and child-resistant. However, the growing demand for cold form blister packs have accelerated concerns about integrity of blister packaging. Although the amount of environmental contaminants that can enter a package vary based on leak size, with blister packages, even minute leaks can become a problem. Depending on the pressure, temperature and duration of exposure, contaminants can easily find path in the seal or any other microscopic crack. Therefore, it’s important for manufacturers to conduct appropriate container closure integrity tests that ensure quantitative and reliable leak testing solution.

Helium leak testing is one of the most sensitive container closure integrity test methods, used primarily for evaluating integrity of critical parenteral or injectable products. In simple terms, it can be understood as the act of finding leaks in some type of enclosed or sealed system using helium as a “tracer” gas, and measuring its concentration as it escapes due to leakage. Apart from being an ideal solution for ensuring container closure integrity, the technology is also applicable in package design, monitoring product quality, failure analysis and line set up and validation.

Helium is considered an ideal choice of tracer gas because of multiple reasons. Helium is non-toxic, non flammable, non-condensable and its presence in the atmosphere is not more than 5ppm. The small atomic size of helium makes it easier to pass through leaks. Since helium does not react with other materials, it is relatively safe to use. Additionally, compared to other tracer gases helium is less expensive and is available in multiple cylinder sizes. Under this method, a helium leak detector otherwise known as Mass Spectrometer Leak Detector (MSLD) is used to identify and calculate size of the leak.The test part is first connected to a leak detector and then the tracer gas, helium is introduced. In the presence of a leak, helium escapes from the test parts and this partial pressure?is?measured and results are displayed on the meter

Applications of Helium Leak testing

• Ensuring Container Closure Integrity
• Using sniffer probe to identify sources of the leak
• Selecting closure formulation and configuration
• Seal integrity monitoring during stability studies
• Using proprietary software to predict shelf- life seal integrity

The global pharmaceutical industry has seen tremendous growth over the past few decades. However, complex nature of the industry coupled with frequent breakthroughs has made it a favorite subject of scrutiny. Adding to that, the COVID-19 pandemic has accelerated pharmaceutical industry challenges. Along with COVID-19 vaccine, the industry has seen a spike in the production of cell and gene therapy treatments, biologics, and other large-molecule products that demand unique storage conditions to maintain sterility of the drug throughout its shelf life or until it is administered.

Since most high-risk pharmaceutical products are filled and sealed in combination devices, it’s critical for manufacturers to ensure that the components function well together. Hence, design and distribution considerations are critical to the early design of both the drug and the container. Manufacturing inconsistencies and tolerance differences in packages containing multiple components are primary contributors to distribution issues. Often, such inconsistencies result in container closure failure, causing serious implications down the supply chain. For instance, glass vials and pre-filled syringes may not seal properly at critical fill-finish closure points. Such a failure can cause oxygen or other environmental contaminants to enter the product and compromise the efficacy of the drug in the barrel. At this point, it is critical to use the most precise leak testing method possible.

In such situations, helium leak detection is the most effective sensitive test for ensuring container closure integrity. By utilizing helium leak detection early in development, companies can make considerable improvements in the quality of their drug delivery system. This not only saves cost and time, but will also raise standards of safety.

Understanding helium leak detection technology

Helium is used as a tracer gas because it is non-toxic, non-flammable, non-condensable and its presence in the atmosphere is not more than 5ppm.Being the second smallest molecule on the periodic table, helium can expose virtually any opening. Further, helium does not react with other materials, so it is relatively safe to use. Under this method, a helium leak detector otherwise known as Mass Spectrometer Leak Detector (MSLD) is used to identify and calculate size of the leak. The test part is first connected to a leak detector and then the tracer gas, helium is introduced. In the presence of a leak, helium escapes from the test parts and this partial pressure is measured and results are displayed on the meter.

Applications of Helium Leak testing

• Ensuring Container Closure Integrity
• Selecting closure formulation and configuration
• Seal integrity monitoring during stability studies
• Extremely valuable in early stage pharmaceutical product package system development

What is helium leak detection?

Helium leak detection refers to the process of identifying leaks in an enclosed or sealed system using helium as a tracer gas. Helium is an ideal choice of tracer gas to find leaks because it is non-toxic, non-flammable, non-condensable, and its presence in the atmosphere is limited to 5ppm. Helium can pass easily through leaks because of its small atomic size. Additionally, helium is safe to use because it does not react with materials of parts being tested.

Overview of sniffer probe leak detection

Sniffer leak testing is a common tracer gas leak detection method that uses a sniffer probe to detect the presence of tracer gas and identify an area that is leaking. Under sniffer probe helium leak detection, helium is used as a tracer gas in combination with instrumentation to detect the presence of helium and more precisely an increase in helium due to the leaking part.

The prime objective behind conducting a sniffer probe leak detection test is to locate leaks in parts or systems so that they can be identified and repaired. The part or system is first pressurized with the tracer gas and then systematically scanned with a sniffer probe so as to detect possible leaks. Sniffer probe leak detection cannot be considered as a quantitative leak detection technique because the test results may vary depending on skill of the operator and the technique used. However, with the use of calibrated instruments, calibrated leak standards, and well-trained operators, quantitative results may be achieved. Sniffer leak testing is considered as an economical leak detection method that involves relatively low tool cost investment depending on the tracer gas used. Although sniffer probe leak testing is very effective in locating micro leaks, it may not be an ideal choice in high volume production environment.

How does sniffer probe leak detection work?

Sniffer probe leak testing begins by first filling the test object with tracer gas. The pressure inside the test object is increased to a pre-determined rate in order to create a differential in pressure. The outside of the test object is scanned using a sniffer probe that is connected to a leak detector. Because of the innate properties of helium, it readily penetrates through leaks and is sucked into the sniffer probe. The leak rate meter shows a display of the signal. On reaching maximum leak rate display, leak is located. Although the sniffer probe leak detection technique is very sensitive, its accuracy can be affected due to the amount of helium present in the atmosphere.

Advantages of Sniffer Probe leak detection

• Sniffer probe is very effective in locating minute leaks.
• Does not require expensive fixtures or test chambers and can be employed at low cost.
• Useful in testing small parts as well as complex systems.
• Higher test sensitivity can be achieved by increasing tracer gas pressure.
• Capable of detecting leaks in the range of 1.6x10-1 to 1x10-5 scc/s.

Container closure integrity plays an integral role in maintaining the stability of sterile pharmaceutical products. Most often, defects that cause vials to leak cannot be detected by a visual inspection process. Examples of such defects include microscopic cracks & scratches in the glass or temporary defects such as stopper pop-up that result in temporary container leakage. In such situations, helium leak testing ensures high sensitivity leak detection, which cannot be attained by many other leak test methods.

Overview of helium leak testing

Helium leak testing refers to the process of finding leaks in some type of enclosed or sealed system using helium as a “tracer” gas and measuring its concentration as it escapes due to leakage. It is an effective container closure integrity test method, aimed at evaluating the integrity of pharmaceutical and parenteral products. Helium leak detection works in the following way: Initially, the package is helium filled and subjected to vacuum. Then using a helium leak detector, the amount of helium escaping the package is quantitatively measured and stated as a leak rate. Apart from analyzing container closure integrity, helium leak testing is also applicable in product design, product quality analyses, failure analyses and validation. Helium leak testing is a flexible method that can be used with or without a test chamber in order to test "in-leakage" or "out-leakage", as well as leak location.

Why use helium as a tracer gas?

Helium is considered as an ideal choice of tracer gas because of the following reasons:

• Helium is non-toxic, non-condensable, non-flammable.
• It is inert, making it safe for use as it will not interact with the components being tested.
• The atom size of helium is really small, allowing it to breach pathways reliably and easily.
• Compared to other tracer gases, helium is less expensive and readily available.
• Its presence in the atmosphere is not more than ppm.

Glass vial leak testing using SIMS 1915+

Seal Integrity Monitoring System (SIMS) 1915+ is an ideal choice for helium-based leak detection of vials, blister cards, syringes, and cartridge systems. Compared to conventional vacuum bubble and dye penetration test methods, packages can be quantitatively tested using helium as the tracer gas that ensures higher levels of accuracy. Proven to be an affective leak detection method, SIMS1915+ can also be used for package design, tooling qualification, production line setup and on-going product quality monitoring. Designed specifically for the needs of pharmaceutical and medical device industries, SIMS1915+features an oil-free pump, detector and integrated power system that ensures quantitative analysis of package systems at sensitivity levels as low as 1 x 10 -10 cc/s at room temperature. Based on the client’s specific requirement, each SIMS 1915+ Helium Leak Testing instrument manufactured by Leak Detection Associates can be customized. Given below is a list of SIMS 1915+ Leak Detection System specifications along with add-on components.

• Helium Leak Detector Module (HLDM): Oil Free, Production version in Console Frame Assembly, with Stainless Steel working surface and Dual Test Port Manifold (allows concurrent use of VTFM & HSAM on HLDM unit).
• Vacuum Test Fixture Model (VTFM) – custom designed for use in testing of vial container samples
• Head Space Analyzer Module (HSAM) – Model VM-2 that includes three (3) Puncture Probes (two spares) for determination of Helium Concentration in the headspace of vial containers.
• Integral Calibration Chamber (w/ Calibrant Gas Flow Meter/Controller) provided for HSAM Calibration and a Universal Holder to be used for various vial diameters.
• Helium Filling Device specific for vial testing sample prep to enable vials to be filled with helium
• LT Low Temperature Add on units specifically designed for testing products under ultra-cold storage testing down to –140 °C.

Leak Detection Associates ’ most current model, the Seal Integrity Monitoring System (SIMS) 1915+, is the ideal choice for your helium based leak detection system. Using helium as the tracer gas, packages can be quantitatively tested to levels far exceeding the vacuum bubble and dye penetration test methods. This Quantitative approach allows direct comparison across various packaging materials and forms, production line settings and stability storage conditions. The LDA SIMS 1915+ is a proven and effective tool for package design, tooling qualification, production line setup and on-going product quality monitoring of a variety of package types including cold form blister cards, foil pouches, parenteral vials, syringes, pre-filled syringes and unique medical devices.

Each SIMS 1915+ Helium Leak Testing instrument manufactured by Leak Detection Associates is custom built to client-specific standards. Key factors that determine instrument build specifications include:

What type of package(s) will you be testing with this instrument – Vials, Blister Cards, Syringes, Cartridge System or Medical Device? Size and closure type should be included and whenever possible a schematic of the package or device can be helpful in optimizing the test system.

Projected amount of use the instrument will see?

Country where the instrument will be installed?

Leak Detection Associates Seal Integrity Monitoring System (SIMS) Model 1915+ helium-based leak testing system features an oil-free detector and integrated power system that is designed for the needs of the pharmaceutical and medical device industries, enabling the client to quantitatively analyze package system at a sensitivity level as low as 1 x 10 -10 cc/s at room temperature. The most critical component, the Helium Leak Detector Module (HLDM), is engineered into a Console Frame Assembly that features a Stainless Steel working surface and Dual Test Port Manifold. The console has a locking wheel and will be fitted with an articulating arm system for mounting of the computer, monitor, key board and direct access printer, making the freestanding unit easy to use and maneuver.

The First Helium Leak Detectors

The genesis for the use of helium as a method for leak detection can be traced back to the 1940’s and the Manhattan Project. The first atomic bomb created used uranium isotope 235, which is taken by way of separation from uranium-238. The separation was accomplished in a huge “diffusion” plant using microporous tubing as the diffusion medium and this process needed to be done in a manner that prevented any trace of moist ambient air in the process chambers. In essence, it was imperative that all the equipment be free of any leaks. Equipment of this size and magnitude had never before been tested to such and extreme leak detection specification. A number of various leak detection devices were tried, and they all proved unsuccessful as they could not meet the required standard for sensitivity. Eventually, a simplified mass spectrometer based on the Nier 60 spectrometer tube was chosen for leak detection and helium was the gas of choice used with it. It was determined that helium flow as sensitive as 10−6 std cm3 could easily be detected.

Major Improvements in Helium Leak Detection

In the 70+ years since the inception of the Manhattan Project, helium leak detectors have understandably been drastically improved. The size of an actual helium detector that in 1945 required a large scale, multi-story warehouse building, can now fit on a standard laboratory benchtop and the level of detection has been improved to levels that meet or exceed flows rates of 10−10–10−11 std cm3. With the inception of computers, operation of a helium detector has been fully automated. Based upon these developments, the use of helium as a medium for leak detection has become common and wide-spread practice and thus has a presence in almost every conceivable industry from refrigeration, semi-conductors, automotive and food and drug packaging components.

Modes of Operations using Helium Leak Detection

Conceptually, the principle of operations has not changed much in the past 50 years although, as noted, the size has been drastically reduced. The central piece of the helium leak detector is the cell in which the residual gas is ionised and the resulting ions accelerated and filtered in a mass spectrometer. Most of the current detectors use, as in the original design, a magnetic sector to separate the helium ions from the other gases. Permanent magnets are generally used to generate the magnetic field. The adjustment needed for the selection of the helium peak is made by varying the ion energy. At the highest sensitivity range, currents as low as femtoamperes have to be measured. This is achieved with the use of an electron multiplier in the most modern detectors. If the cell of a leak detector is not much different from the original design, the pumping system has considerably changed with the original diffusion pumps now being replaced by turbomolecular pumps or dry molecular-drag pumps. The sensitivity of the helium leak detector is given by the ratio between the helium flow through the leak and the partial pressure increase in the cell. In order to increase the sensitivity, the pumping speed of the tracer gas has to be reduced. This must be done without diminishing the pumping speed for the other gases (mainly water as leak detection usually takes place in unbaked systems) in order to keep the appropriate operating pressure for the filament emitting the ionising electrons. Selective pumping is therefore needed to provide a high pumping speed for water and a low pumping speed for helium

We hope that you have learned something regarding the history of helium leak detectors. In future installments, we will address various test methods and case studies that will provide more specific insight into the use of helium applied to the package leak testing needs of the pharmaceutical and life sciences industries.

In a recent blog, we discussed the application of helium leak detection (HeLD) as part of a capping optimization study or assembly validation for glass and plastic vials. A defining characteristic of helium leak detection, instruments such as the SIMS 1284+ have sensitivity capable of measurement below the maximum allowable leakage limit (MALL) of many pharmaceutical and medical device products. This allows for study-based comparisons and data-informed decision making at a very fine scale. More importantly, these types of studies can be used to support regulatory documentation and in fulfillment of guidance such as USP <1207>.

While applications of this approach to vials are well established, if increasingly popular, very similar approaches can be taken for other common package systems used in the industry. Cartridges, which are frequently used as part of a device delivery system, are one such format. Similar to a traditional vial, one end of a cartridge is typically sealed with an elastomer-lined crimp. Compared to that of a 20mm or 13mm vial, cartridge crimp seals are relatively small and intricate. On the other end, a cartridge is typically sealed by an elastomeric plunger, similar to that which may be found on a syringe. Each of these unique sealing interfaces present specific challenges from a CCI perspective.

Considering the crimp interface of the cartridge, similar studies as for a vial can be performed to optimize and validate component choice as well as assembly parameters and processes. Comparative studies can be performed to choose the most robust cartridge-seal combination given machinability limits. Studies involving multiple crimp configurations, in conjunction with HeLD and RSF, can help elucidate a set of capping parameters that consistently yields an integral seal with low leakage. As with vials, it is possible that dimensional stack-ups, in conjunction with limitations in machinability, yield defects such as loose crimps, misaligned seals, stress cracking from high crimp force, etc. Characterizing these risks through quantitative, deterministic analyses can inform mitigation strategies and quality decision making about the assembly process. With final components and assembly parameters chosen, assembly validation using cartridges capped real-time can be performed, fulfilling best practices outlined through industry standard guidance such as USP <1207>.

Unlike the crimp-sealed end, the barrel end of a cartridge is less a function of an applied force. However, similar optimization and assembly validation practices apply. As with any package system requiring a high degree of leak protection, early on in the development process, the inherent integrity of the chosen product-package system should be evaluated, essentially answering the question: “Are these components, when mated optimally, capable of creating an integral seal?”. This extends to the choice of suitable barrel-plunger interfaces as well. Arguably, since the barrel-plunger interface is not a function of a controllable process such as crimping, inherent integrity evaluations become even more critical. The achieved seal will be primarily a function of the dimensional overlap between the cartridge inner diameter and the plunger outer diameter.

In a laboratory setting, consider a study designed to evaluate barrel-plunger samples paired at dimensional extremes. Within their respective dimensional tolerances, the widest barrel inner diameter paired with the smallest plunger presents the highest risk for leakage, as there may be insufficient or inconsistent compression of the plunger against the cartridge wall. On the other hand, consider the smallest barrel inner diameter paired with the widest plunger. In this case, it is critical to ensure proper function, lack of stress-related defects such as cracking or fitment-related issues risking leakage, such as mis-aligned plungers. A study exploring these dimensional extremes provides confidence that components, within their dimensional stack-up ranges, will provide integral seals. This can be further confirmed by assessing real-world cartridges assembled on the line.

This type of work can be performed at a production facility, using client-owned instrumentation or in-house contract services. Additionally, LDA’s sample filler allows for sample preparation at time of test, enabling analysis of samples previously produced and sealed, or transfer of samples between manufacturing and testing sites. With increasing regulatory scrutiny as well as risk in poor package development and validation practices, helium leak detection, as enabled by the LDA SIMS 1284+ system, is a versatile tool in generating a robust foundation of CCI data for modern package systems

EGG HARBOR TOWNSHIP, N.J. (PRWEB) MAY 22, 2019

Leak Detection Associates (LDA), the world’s premier manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is excited to announce that a formal partnership agreement with Industrial Production Processes (IPP) Ltd has been signed. The agreement will grant exclusive rights for IPP group to represent LDA in the countries of England and Ireland. With locations in Cork, Ireland and Worcestershire, UK, IPP is well positioned in both locations to meet the needs of LDA clients who are in need of helium-based leak testing instruments and systems and the ancillary services that go with them. IPP maintains of staff of 24 service and sales engineers that will be in the ready to serve existing and new clients. As a leading package system instrument and service provider in these geographic areas, IPP has the local knowledge and experience to enhance the already strong Leak Detection Associates’ brand.

“Global expansion is a key initiative of the new Leak Detection Associates management team and we are excited to partner with IPP to make this possible in Ireland and the UK,” commented Brian Mulhall, CEO of Leak Detection Associates. “I have known and worked with Jack Daly and the IPP group in previous settings and the team always brings a high level of knowledge, experience and client care to their work. They are a leading provider of package equipment and laboratory instruments in these countries and we are happy they will be our partners.”

Commented IPP Managing Director Jack Daly, “Partnering with LDA was an easy and natural decision as we are already well established in the relevant packaging instrument field and their technology allows the IPP team to better serve our client base with a broader product and service offering.”

IPP will serve as the exclusive product and service provider for Leak Detections Associates complete line of products and services. The current model SIMS 1284+ helium leak detection instrument is the only custom designed and manufactured helium leak testing instrument that meets the regulatory requirements of the pharma, biotech and medical device industries. In addition, LDA and IPP will offer a full suite of support services that will include custom designed change parts to address various container and package configurations, system parts and add-on options as well as local service, repair and qualification programs.

TO READ THE FULL PRWEB PRESS RELEASE PLEASE CLICK HERE

EGG HARBOR TOWNSHIP, N.J. (PRWEB) MAY 13, 2019

Leak Detection Associates (LDA), the world’s premier manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is excited to announce the go-live of a completely new Heliumleak.com company website. The redesigned website aims to improve LDA’s ability to communicate directly with the marketplace; serving as a destination to learn LDA’s product and service offerings, news and events, but also as a knowledge center for those interested in helium leak detection applications and CCIT in general.

“For those first exploring any topic, whether it be CCI or unrelated, the first step will be to seek information online.” commented Brian Mulhall, CEO of Leak Detection Associates. “In redesigning LDA’s Heliumleak.com, this was kept in mind. In addition to more detailed descriptions of products, services, and applications of helium to specific package systems, the Resource Center will serve as an industry-leading destination for up-to-date information on all aspects of CCI. Blogs and Whitepapers will routinely be released discussing unique applications of helium leak detection and CCI in general, and an entire section is dedicated to topics such as FDA, EMA, USP, and ASTM guidance.”

The Products section now includes more detail about LDA’s flagship detector, the SIMS 1284+, but also will serve to highlight current and future complimentary offerings, such as LDA’s proprietary vial filling kit and Headspace Analyzing Module (HSAM), which allow for testing of pre-sealed vials. The redesigned services section now clearly highlights LDA’s 20+ years of experience in qualification, calibration, but also consultation, feasibility, and method development services. Uniquely, an entirely new section was added for Applications, which discusses helium-leak approaches for specific package systems, such as vials, pre-filled syringes, combination products, blisters, and more.

READ THE FULL PRWEB PRESS RELEASE